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ABSTRACT OF THE DISSERTATION 
 
 
Characterization of a New Family of Bacillithiol Transferases Encoded by 
Bacillus subtilis and Staphylococcus aureus 
 
by 
 
Varahenage Ranmali Perera 
Doctor of Philosophy in Biology 
University of California, San Diego, 2017 
Professor Kit Pogliano, Chair !
Bacteria have evolved an arsenal of molecular weaponry to combat 
environmental stressors. Some of the oldest and most widespread protective systems 
are the low molecular weight thiols, which react readily with a number of molecules 
through their nucleophilic sulfur atom. Low molecular weight thiols are found in 
aerobic organisms and are involved in maintaining the redox status of the cytoplasm, 
detoxifying xenobiotics, and protecting cells against oxidative stress. Bacteria produce 
! xix 
a diverse selection of low molecular weight thiols, which include glutathione, 
mycothiol, ergothionine, and bacillithiol. Glutathione was discovered in 1914 and 
since then, has drawn the attention of several fields, ranging from the cosmetics 
industry to the pharmaceutical industry. Very little is known about bacillithiol, the 
newest protective thiol identified, or about the enzymes that catalyze bacillithiol-
dependent reactions, such as bacillithiol transferases. While there are a number of 
parallels between bacillithiol and glutathione, it is unclear whether the bacillithiol 
system partakes in additional reactions and/or developmental pathways.  
The focus of this work has been to characterize bacillithiol and the predicted 
bacillithiol transferases that are members of the S-transferase like (STL) superfamily, 
a new superfamily of thiol transferases that are related by structural rather than 
sequence similarity. We first selected the single predicted STL bacillithiol transferase, 
BstA, encoded in Staphylococcus to characterize the enzyme using saturation kinetics, 
identify natural product inhibitors, and identified one in vitro antibiotic substrate. 
Using S. aureus BstA as a model, we then confirmed the activity of the seven 
remaining uncharacterized STL bacillithiol transferases encoded by Bacillus subtilis.!
To better understand the physiological roles and natural substrates of the enzymes, we 
studied the expression patterns of all eight bacillithiol transferases encoded in B. 
subtilis during different stages of growth and development. Finally, identified proteins 
that were modified by S-bacillithiolation of cysteine residues during non-stress 
conditions. Together, our studies will aid in understanding the significance of the 
bacillithiol system and its contribution to the physiological fitness of bacteria. !
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Chapter 1 
 
Introduction  
  
 2 
Summary 
Bacillithiol is a low molecular weight thiol analogous to glutathione and is 
found in several Firmicutes, including Staphylococcus aureus. Since its discovery in 
2009, bacillithiol has been a topic of interest because it has been found to contribute to 
resistance during oxidative stress and detoxification of electrophiles, such as the 
antibiotic fosfomycin, in S. aureus. The rapid increase in resistance of methicillin-
resistant Staphylococcus aureus (MRSA) to available therapeutic agents is a great 
health concern, and many research efforts are focused on identifying new drugs and 
targets to combat this organism. This review describes the discovery of bacillithiol, 
studies that have elucidated the physiological roles of this molecule in S. aureus and 
other Bacilli, and the contribution of bacillithiol to S. aureus fitness during 
pathogenesis. Additionally, the bacillithiol biosynthesis pathway is evaluated as a 
novel drug target that can be utilized in combination with existing therapies to treat S. 
aureus infections.   
 
Thiols in aerobic bacteria 
 Aerobic bacteria live in an oxidizing environment and often require this 
environment for life, yet they maintain a reducing intracellular environment. 
Generating and maintaining this reducing environment requires not only energy but 
also specialized molecules in the cell that store this reducing potential and use it for 
various biochemical processes. These molecules include low molecular weight thiols 
such as glutathione (GSH), cysteine (Cys) and coenzyme A (CoA), each of which play 
different cellular roles(1). Free cysteine levels are typically kept low because cysteine 
 3 
is prone to metal catalyzed oxidation(2), which produces hydrogen peroxide, which 
can damage both DNA and proteins. CoA has a high thiol pKa compared to cysteine 
and glutathione (see “Biophysical Properties” below, (3-5)), such that the availability 
of the thiolate anion form of CoA required for reaction with electrophiles and thiol-
disulfide exchange reactions is very limited. CoA is not a storage form of cysteine and 
cannot resupply the cell with Cys for protein synthesis during times of shortage, which 
can occur during oxidative stress.  GSH is oxidized more slowly than is Cys and it can 
be broken down to release Cys when necessary, so it plays a key role in redox 
reactions and redox homeostasis. GSH is present in Gram-negative bacteria and also in 
eukaryotic cells, and was at one time assumed to be present in all living aerobic cells. 
However, many Gram-positive bacteria were subsequently shown to lack GSH and to 
contain instead other low molecular weight thiols(1, 6, 7). For example, the 
Actinobacteria, which include human pathogens such as Mycobacterium tuberculosis, 
use mycothiol (MSH), whereas several Firmicutes, including the human pathogens 
Bacillus anthracis and Staphylococcus aureus, use bacillithiol (BSH). Since its 
discovery, BSH has become the focus of considerable biochemical and physiological 
attention. In this review we summarize this work and we evaluate the BSH system in 
Staphylococcus aureus as a potential target for the development of chemotherapeutic 
agents. 
 
The Discovery of Mycothiol and Bacillithiol  
Once it became clear that GSH was not ubiquitous, the search was underway 
for alternative low molecular weight thiols. An assay was developed for detection and 
 4 
study of these thiols that utilizes the thiol-labeling compound monobromobimane and 
a reverse phase separation of the resulting fluorescent thiol-bimane derivatives 
(RSmB)(8, 9). The bimanes (such as the widely used 9,10-dioxa-syn-
dimethylbimanes(10)) are among the smallest sulfhydryl-reactive fluorophores known 
and allow the thiol moiety to dominate the physical chemical properties of the 
conjugate and its chromatographic behavior.  Another advantage of the bimane label is 
that it is highly conjugated and has a simple proton NMR spectrum, which is 
beneficial in solving novel biological thiol structures(11-14). Application of the 
bimane assay to a variety of bacteria revealed novel thiols, but most were present at 
low levels relative to GSH or CoA. An exception was the Actinomycetes where a 
major novel thiol, U17, was identified in Streptomyces clavuligerus and in other 
actinobacteria(15). The structure of U17 was solved by three laboratories and renamed 
mycothiol (Figure 1.1, (11, 12, 16)). Mycothiol would later guide the determination of 
the structure and discovery of the biosynthetic pathway for bacillithiol.  
Although the Firmicutes were recognized to lack glutathione(7), the 
biologically relevant low molecular weight thiol in these bacteria remained unclear for 
several years because the bimane derivative of bacillithiol (BSmB) coeluted with the 
cysteine bimane derivative (CySmB)(17) in the sodium acetate buffer that was used in 
the HPLC separation method #1(9). The addition of an online mass detector in parallel 
with the HPLC proved extremely productive because bimane-thiol derivatives ionize 
easily in electrospray mass spectrometry. During a systematic thiol survey of B. 
anthracis in 2006, an unknown thiol was found to coelute with CySmB on the HPLC 
analysis, and had a different mass.  After the pH of the buffer was adjusted from 3.4 to 
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4.0, this novel thiol was fully resolved from CySmB. In retrospect this was due to the 
ionization of the malate carboxylates of bacillithiol at the higher pH. U12 had a mass 
of 398, which did not match any of the biological thiols identified in previous 
surveys(19). Subsequently, it was reported that treatment of Bacillus subtilis with 
cumene hydroperoxide led to the formation of mixed disulfides between the organic 
hydroperoxide regulator OhrR and either cysteine, CoA or an unknown thiol of the 
same mass as U12(20). U12 was reported soon afterwards in Deinococcus 
radiodurans(14). Thus the common occurrence of the novel thiol justified solving the 
structure. 
The structure of U12-bimane from D. radiodurans was determined from a 2D 
NMR and analysis of acid hydrolysis products, the same strategy used to solve the 
bimane derivative of mycothiol(12). U12 was found to be the α-anomeric glycoside of 
L-cysteinyl-D-glucosamine with L-malic acid (Figure 1.1) and was named BSH 
because of its widespread occurrence within the Bacilli(14).  Bacillithiol resembles 
mycothiol in that it has the same central cysteine moiety amide bonded to 
glucosamine, but it has L-malate in an α-glycosidic bond to glucosamine in place of 
the inositol moiety in mycothiol, and the cysteine of MSH is N-acetylated (Figure 1.1). 
Bacillithiol was found in seven species of Bacillus, in Geobacillus, and in some but 
not all species of Staphylococcus and Streptococcus(14). A survey of Firmicutes 
growing exponentially in trypticase soy broth with shaking at 37°C, including B. 
subtilis and S. aureus, revealed BSH levels at 0.2-0.7 µmole/gm dry weight [0.1-0.2 
mM], some 10-fold lower than the concentration of GSH in Gram-negative bacteria or 
of MSH in Actinomycetes, but similar to the levels of Cys and CoA in these 
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organisms. Thus, the Firmicutes appear to have three major low molecular weight 
thiols (cysteine, coenzyme A, and bacillithiol) that are maintained at similar, low 
levels during exponential growth. 
 
Biophysical Properties of Bacillithiol 
 The solution structure of BSH is dominated by its zwitterionic character at 
physiological pH(18), which also contributes to its biological activities.  The redox 
potential and the microscopic and macroscopic pKas for each ionizable group were 
determined by a combination of spectroscopic techniques. The redox potential for 
BSH is -221 mV, which is similar to that of most biological monothiols including Cys 
(-223 mV), CoA (-234 mV) and GSH (-240 mV). In contrast, all of the pKa values for 
BSH are lower than the corresponding values for Cys or GSH. The first two pKa 
values of BSH (3.1 and 4.4) correspond to those of the malate moiety, which are lower 
than the respective values for malic acid alone (3.4 and 5.1). This indicates that the 
malate moiety in BSH is a dianion at physiological pH (Figure 1.2). The most unusual 
aspect of BSH ionization is the microscopic amine pKn of 7.63, which is just ~0.3 pH 
units below that of the thiol pKs of 7.97. Hence when BSH is at the physiological pH 
of 7.7, there will be two major forms of BSH dianion, the -+-- and the 00-- forms 
((18), Figure 1.2). The amount of BSH in the reactive thiolate form (RS-, 21.9%) is 
greater than that of Cys (14.6%) and much greater than that of CoA, the two other 
major thiols found in the B. subtilis and in S. aureus. Thus, the major nucleophilic 
thiol available for reaction with electrophiles or disulfides in these organisms is BSH. 
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Figure 1.2: Comparison of the Major forms of Bacillithiol, Cysteine, and CoA 
at pH 7.7. Proportions of each form are based on microscopic pKa values (Sharma 
et al 2013(18)). The four major forms of bacillithiol are depicted. The ionizable 
phosphate groups of CoA are not listed. Figure adapted from Sharma et al. 
2013(18). 
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Many of the unique biophysical properties of BSH may be clarified by the 
solution structure of this thiol. A 3D structure for a major physiologically relevant 
form of BSH shows a close proximity of the carboxylate of malate to the amine of 
cysteine, which may contribute to the deprotonation of the amine and the low amine 
pKa (Figure 1.3).  When the major 0+-- ionized form of bacillithiol (see Figure 1.2) 
was analyzed in ChemDraw 3D, the energy minimized structure rapidly converged to 
that shown in Figure 1.3.  The proximity of the ammonium, carboxylate and thiol 
groups in BSH have previously been postulated to contribute to metal chelation(14). 
Bacillithiol has recently been shown to chelate Cu+ as the (BSH)2:Cu complex 
(β2(BSH)= 4 x 1017 M-2) (21)and Zn2+ as the (BSH)2:Zn2+ complex with (Ka)= 1.9 x 
1012 M-2, 21) with high affinity.   Importantly, in B. subtilis BSH has be shown to act 
as a Zn2+ buffer for metal homeostasis(22). B. subtilis wild type and a bacillithiol 
(bshC) mutant did not show a Zn2+ or Cd2+ stress phenotype in the wild type 
background, however a double metal exporter mutant, cadA czcD, did show increased 
sensitivity to Zn2+ and Cd2+ in the absence of BSH(22). Bacillithiol dependent Zn2+ 
sensitivity has not been reported for S. aureus, but BSH mutants of S. aureus USA300 
were reported to be sensitive to Cd2+(23). Gene expression studies revealed that metal 
sensing regulators are more responsive to zinc perturbation in a mutant lacking 
bacillithiol, presumably because BSH buffers the zinc labile pool. This suggests that 
bacillithiol plays a role in zinc homeostasis by holding free zinc in a cytoplasmic pool, 
perhaps keeping the metal available for the estimated 5-10% cellular enzymes that 
require a Zn2+ cofactor(24). It has been noted that during S. aureus infection, 
neutrophil proteins sequester and limit 
10 
 
Figure 1.3: 3-dimensional structure of bacillithiol in the ionized 0+-- form (see 
Figure 1.2).   The proximal location of thiol, amine and carboxylate moieties in the 
energy-minimized structure may support divalent metal ion chelation. Atom labels: C, 
green; N, blue; O, red; H, white, and S, yellow. !
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Zn2+ availability to the pathogen, reducing S. aureus growth and making it more 
vulnerable to oxidative stress(22, 25). 
 The dianion character of BSH drives the substrate specificity of the BSH 
biosynthesis enzymes BshB1 and BshB2 and of the fosfomycin detoxification enzyme 
FosB (see below)(26, 27). The catalytic efficiency (kcat/Km) of BshB1 and BshB2 was 
diminished by ~104-105 when GlcNAc-Mal was replaced with the des-malate analog 
GlcNAc. This specificity is likely determined by opposing arginines (Arg53 and 
Arg109) present in the active site near the malate moiety when GlcNAc-Mal is 
computationally docked in the crystal structure of B. cereus BshB (BC1534, (26)). 
Similarly, the catalytic efficiency of FosB was diminished by 103 when BSH (Cys-
GlcN-Mal) was replaced with the des-malate analogs Cys-GlcN-O-methyl or Cys-
GlcN-O-benzyl(27). In the catalytic sites of the crystallized FosB proteins, Arg35 and 
Lys36 (B. cereus and B. anthracis), or Lys35 and Lys36 (S. aureus) are positioned in 
the active site ~10 Å apart in an orientation to bind the malate moiety of BSH(27).  It 
may be possible to find BSH-binding enzymes by identifying opposing positively 
charged residues with the appropriate geometry for malate binding near their active 
sites. 
Bacillithiol Biosynthesis Enzymes  
BshA 
 The structural similarity of MSH and BSH made identification of the first two 
BSH biosynthetic genes relatively straightforward since they encoded homologs of the 
previously identified MSH biosynthetic enzymes(28).  For example, the first step in 
mycothiol biosynthesis is the formation of the glycosidic linkage between 1-L-inositol-
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1-phosphate (Ins-P) and UDP-N-acetylglucosamine (UDP-GlcNAc), which is 
catalyzed by the glycosyltransferase (MshA)(29).  B. subtilis has 5 
glycosyltransferases with low sequence homology to MshA, but the prime bshA 
candidate with ~25% identity over 40% of the sequence was ypjH, which is located 
immediately downstream from the mshB homolog ypjG.  ypjH was shown to be 
essential for BSH biosynthesis and the purified YpjH protein catalyzed the production 
of N-acetylglucosamine-malate (GlcNAc-Mal). The BshA glycosyltransferase reaction 
was able to utilize UDP-GlcNAc and L-malate as substrates (Figure 1.4), but not D-
malate.  The B. anthracis homolog of B. subtilis BshA (BA_1558, 65% identity) had 
been crystallized without ligands prior to the discovery of BSH and was observed to 
have an active site that was similar to MshA (PDB entry 2JJM, (30)). This structure 
aided in the solution of a ternary complex of B. anthracis BshA, UDP, and L-malate  
(PDB entry 3MBO, (31)). Kinetic studies of the B. anthracis BshA(31) and the S. 
aureus BshA(32), which share ~56% sequence homology, indicated that the proteins 
perform similar catalytic functions. Allosteric inhibition of B. subtilis BshA by BSH 
(IC50~0.7 mM) suggests that the enzyme is subject to feedback regulation to modulate 
the intracellular level of BSH by inhibiting the first biosynthetic enzyme in the 
pathway, as is the case for many pathways, including those involved in GSH and MSH 
biosynthesis(32). Significantly, the heterologous expression of bshA in non-BSH 
containing bacteria led to the production of significant quantities of GlcNAc-Mal, 
providing a source for this non-commercially available substrate for BshB. 
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BshB 
The second bacillithiol biosynthesis gene bshB is analogous to the 
corresponding MSH biosynthesis gene mshB, which encodes a deacetylase. bshB 
(ypjG) is immediately upstream of the bshA gene in some BSH-producing organisms, 
such as B. subtilis, and its product was proposed to catalyze the deacetylation of 
GlcNAc-Mal. The BSH levels in a B. subtilis bshB1 deletion strain were at about 40% 
of wild-type levels. A second unlinked homolog of bshB1, bshB2 (yojG), was then 
discovered in the B. subtilis genome, and deletion of both bshB1 and bshB2 yielded a 
mutant that failed to produce bacillithiol(28). Thus, the B. subtilis BshB1 and BshB2 
enzymes have redundant functions, but BshB1 can provide all of the necessary 
deacetylase activity since the bshB2 mutant has wild-type levels of bacillithiol(28). 
The genome of B. anthracis appears to have one bshB1 and two bshB2 homologs.  The 
B. anthracis bshB1 gene (BA_1557) was cloned into E. coli, and the purified protein 
showed high deacetylation activity with GlcNAc-Mal(28, 31). Unlike B. subtilis, the 
genome sequence of S. aureus USA300 indicated that there was only one deacetylase 
gene closely related to bshB2, leading to the prediction that a mutation in this gene 
would produce no BSH. Analysis of a S. aureus USA300 strain containing a 
transposon insertion in bshB demonstrated this (23). 
 A Bacillus cereus BC1534 (BshB1) crystal structure, published before the 
discovery of BSH, revealed a metalloprotein with structural similarity to the 
metalloproteins LpxC and MshB from M. tuberculosis(36). Although the native 
substrate of the BC1534 was not known, the protein was reported to deactylate 
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GlcNAc and chitobiose(37). However, a detailed analysis of the substrate specificity 
of BshB1 and BshB2 type proteins from B. cereus and B. anthracis failed to confirm 
this activity(26), perhaps because the malate moiety of the native substrate GlcNAc-
Mal is a major determinant for BshB substrate specificity. Deacetylation of GlcNAc 
by BshB proteins is found to be at least 105 fold lower (kcat/Km) than that of the native 
substrate GlcNAc-Mal(26, 31). Interestingly, the BshB enzymes have a second 
function in addition to their deacetylation activity, as they can also act as a bacillithiol 
conjugate amidase (BCA) and cleave bacillithiol S-conjugates during detoxification 
reactions (Figure 1.4). This activity is described below. 
 
BshC 
 The enzyme utilized in the third step in mycothiol biosynthesis is the L-Cys, 
GlcN-Ins ligase MshC.  This enzyme was purified from crude extracts of M. 
smegmatis by following activity, and the protein was identified by amino-terminal 
sequencing(38). The corresponding open reading frame (ORF) in the M. tuberculosis 
genome, ORF Rv2130c, had been designated cysS2 and annotated as a second Cys 
tRNA synthase. However, neither the B. subtilis nor S. aureus genome encoded a 
MshC homolog or a second gene annotated as a putative Cys tRNA synthase, and no 
BshC activity was associated with the one Cys tRNA synthase in S. aureus(28). 
Therefore, to identify candidate BshC proteins, EMBL STRING was queried with a 
BshA input sequence to identify genes that that co-occur with bshA in the genomes of 
bacteria that produce bacillithiol.  This phylogenetic profiling identified yllA as a bshC 
candidate in B. subtilis. The product of this gene is a member of DUF2317, but it has 
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no recognizable Pfam domains. The null mutant lacked BSH and produced excess 
GlcN-Mal, which would be the expected substrate for BshC(28). Thus, the bshC gene 
is essential for BSH production, and in both B. subtilis and S. aureus bshC mutants are 
completely devoid of BSH(23, 28). However, when the Bacillus subtilis bshC gene 
was cloned and expressed in E. coli, activity was not detected when purified BshC was 
assayed under conditions that had been used to assay MshC activity(28).  The lack of 
activity may have been due to the assay conditions or to misfolding of the 539 amino 
acid BshC protein. Recently, B. subtilis BshC was crystallized as a dimer with an 
overall architecture of the Rossman fold active site similar to MshC and Cys t-RNA 
synthase except for the absence of the canonical adenylate and zinc binding residues in 
MshC(39).  However, because BshC was enzymatically inactive it is difficult to 
evaluate the biological significance of this structure. It remains possible that additional 
cofactors or protein partners are necessary for BshC enzymatic activity. 
 
Bacillithiol as a Redox Buffer 
Any thiol that serves as a redox buffer in aerobic organisms must have the 
ability to regenerate the reduced thiol after it is oxidized to the disulfide form.  
Glutathione disulfide reductase (Gor) was originally isolated from E. coli and was 
thought to be necessary for reduction of GSH during redox stress(40). The first 
complete genome of Mycobacterium tuberculosis H37Rv(41) contained a gene that 
was annotated as glutathione disulfide reductase (gor). It seemed likely that the 
mycobacterial gor was instead a gene for a mycothiol disulfide reductase because M. 
tuberculosis contains millimolar levels of mycothiol but no glutathione. This was 
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demonstrated when the M. tuberculosis gene product Mtr was found to reduce only 
disulfides of mycothiol and truncated versions containing at least cysteinyl-
glucosamine, but not oxidized GSH (GSSG) or cystine(42). 
Identifying a redox thiol in the Firmicutes was more difficult than in the 
Actinomycetes given the variety of low molecular weight thiols present at low levels 
in the cell and the absence of likely candidates for proteins involved in redox recycling 
of these molecules. CoA disulfide reductase (CoADR) was identified in 
Staphylococcus aureus and some Bacillaceae including Bacillus anthracis(43-45).  A 
paradox arose in the model organism Bacillus subtilis when a CoADR homolog was 
not identified in the complete genome sequence. Additionally, no cystine disulfide 
reductase from Firmicutes had been reported, so the search began for a bacillithiol 
disulfide reductase in Bacillus subtilis.  Although candidate proteins for the bacillithiol 
disulfide reductase have been proposed, no flavin-containing, NADH-, or NADPH- 
utilizing reductase has been identified in either B. subtilis or S. aureus(14, 23).  It is 
possible that the highly reduced state of bacillithiol(14, 18) is maintained by a 
thioredoxin-thioredoxin reductase type system as found for glutathione in gor mutants 
of E. coli K12(46).  
Interestingly, a fluorescent reporter system has recently been used to image 
real-time changes in the redox status of MSH during M. tuberculosis infection of 
macrophages(47). This technology could in principle be applied in S. aureus to 
evaluate the BSH redox status during various stages of growth and mammalian cell 
infection. 
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Bacillithiol and Fe(S) Cluster Biogenesis in B. subtilis and S. aureus  
Glutathione has been implicated in iron-sulfur (Fe(S)) cluster biogenesis, 
including Fe(S) synthesis (48, 49), trafficking (50), insertion (51) and repair (52), in 
both eukaryotes and prokaryotes. Thus, it was important to determine whether 
bacillithiol is also involved in Fe(S) biosynthesis. Although mutants deficient in 
bacillithiol production grow normally in nutrient rich media, they grow slowly in 
minimal media in both B. subtilis (53) and S. aureus (54). This slow growth phenotype 
is rescued by addition of iron or the four amino acids isoleucine, leucine, glutamine, 
and glutamate (53, 54). Aconitase, isopropyl malate isomerase, dihydroxyacid 
dehydratase and glutamate synthase, which all contain an Fe(S) cluster, display ~40%-
50% lower activity in a bacillithiol-deficient mutant of S. aureus cultured in minimal 
media (54). A bacillithiol-deficient mutant of B. subtilis cultured in minimal media 
displayed 20%-50% lower aconitase, isopropyl malate isomerase and glutamate 
synthase activity (53). Similarly, a reduction in aconitase activity was observed in 
glutathione-deficient mutants of E. coli (55). Additionally, in bacillithiol-deficient 
mutants of both S. aureus and B. subtilis, there is a decrease in expression of Fe(S) 
cluster-requiring enzymes (53, 54). Together, these data lead to the hypothesis that 
like glutathione (49), bacillithiol might provide iron for Fe(S) cluster biogenesis and 
buffer the cellular iron pool, similar to the way it buffers the zinc labile pool (22). 
Further experiments are needed to test whether bacillithol directly binds iron as it does 
with zinc. 
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The role of bacillithiol in Firmicutes: phenotypes of biosynthesis defective 
mutants  
 The first BSH mutants were produced in the genetically tractable B. 
subtilis(28).  Deletion of bshA, or of both bshB1 and bshB2, or of bshC gives rise to 
completely bacillithiol-deficient B. subtilis.  Each of these deletion strains was readily 
constructed and appeared to grow normally, demonstrating that BSH is not essential 
for growth in nutrient-rich media. However B. subtilis BSH mutants were reported to 
be sensitive to salt stress and to acid stress, and mildly sensitive to oxidants and 
electrophiles such as N-ethylmaleimide, iodoacetamide, monobromobimane, diamide, 
and methyglyoxal(28). 
Bacillithiol also participates in the detoxification of fosfomycin by serving as 
the cosubstrate for the FosB enzyme(23, 28, 56).  FosB is a fosfomycin resistance 
protein found in Firmicutes that was initially thought to catalyze the reaction of 
cysteine with the epoxide moiety of fosfomycin, a cell wall inhibitor(57).  However, 
after the discovery of bacillithiol, several biochemical studies found that bacillithiol is 
the preferred FosB thiol co-substrate for fosfomycin detoxification, making FosB the 
first bacillithiol transferase to be described (see “Bacillithiol Transferases” section 
below)(27, 58, 59). The importance of bacillithiol in fosfomycin detoxification was 
confirmed in B. subtilis(23, 28, 56) and B. anthracis Sterne(31) as mutants lacking 
bacillithiol were as sensitive to fosfomycin as the fosB mutant. This has also been 
observed in S. aureus(23, 27) where mutants lacking bshA are 15-60 fold more 
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sensitive to fosfomycin than their corresponding wild type methicillin-sensitive 
(MSSA) and methicillin-resistant  (MRSA) S. aureus strains(56).  
 One sequenced S. aureus strain, NCTC 8325 (www.phe-
culturecollections.org.uk), harbors an 8 basepair frameshift mutation in the bshC 
gene(34, 56, 60).  This naturally occurring mutation is also found in lineages derived 
from this strain, such as RN4220 an SH1000, and was the first BSH mutant of S. 
aureus to be studied.  NCTC 8325 was found to lack BSH and contains elevated levels 
of GlcNAc-L-Mal and GlcN-L-Mal, the biosynthetic precursors of BSH(34). NCTC 
8325 and other S. aureus bacillithiol mutants do not exhibit growth defects in nutrient-
rich media, but are severely hindered when challenged with fosfomycin(23, 27, 28).  
Staphylococcus aureus bshA mutants are also sensitized to exogenous H2O2 
and diamide(56). As expected, a S. aureus strain with the bshC frameshift (SH1000) 
treated with monochlorobimane or the antibiotic rifamycin S did not show N-
acetylcysteinyl S-conjugates (mercapturic acid products) of the toxins in the medium.  
The production of mercapturic acid products (see Figure 1.4 and bacillithiol S-
conjugate amidase below) was dependent on the presence of bacillithiol even though 
SH1000 cells contained normal levels of cysteine, demonstrating that cysteine does 
not directly react with target substrates. Interestingly S. aureus SH1000 converted all 
of the monochlorobimane to dimethylbimane(34), indicating the presence of a source 
of electrons not normally utilized in the wild type strain.  Dimethylbimane was also 
observed during the labeling of spinach chloroplasts and was thought to be produced 
by electron transfer from photosystem II(61).  
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In a recent metabolomics study, a S. aureus NCTC 8325 derived natural bshC 
mutant strain (HG001) was treated with fosfomycin and UDP-GlcNAc, GlcNAc-Mal, 
GlcN-Mal levels were observed by LCMS(62). Interestingly, fosfomycin treatment 
significantly increased levels of UDP-GlcNAc (3.4-fold) and GlcNAc-Mal (the 
product of BshA, 2.2-fold), but levels of GlcN-Mal (product of BshB) were similar to 
treatment by the other drugs tested (ciprofloxacin, erythromycin, vancomycin and 
ampicillin). UDP-GlcNAc is a substrate for the first enzyme in BSH biosynthesis 
BshA, and the fosfomycin targets MurA and MurZ, which UDP-N-acetylglucosamine 
enolpyruvyl transferase activity.  Thus, it is possible that the inhibition of MurA and 
MurZ by fosfomycin can increase flux through the BSH biosynthesis pathway, leading 
to an increase in the thiol cofactor utilized in FosB-dependent resistance to 
fosfomycin.  This could limit the utility of BshA as a drug target during fosfomycin 
treatment of S. aureus (see “Expert Commentary and Five Year View”). 
 
Identification of Bacillithiol-Dependent and Bacillithiol-Related Enzymes 
Thiol Transferases 
Thiol transferases are enzymes that catalyze the addition of a low molecular 
weight thiol to target substrates forming a new thioether bond.  The native substrates 
for two mycothiol-dependent enzymes from the S-tranferase like (STL) 
superfamily(35), formerly known as the DinB/YfiT-like superfamily, have been 
characterized from Actinomycetes. Corynebacterium glutamicum was found to grow 
on aromatic hydrocarbons like gentisate as a sole carbon source in a mycothiol-
dependent manner. The key step in the degradation of gentisate in C. glutamicum is 
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the isomerization of malylpyruvate to fumarylpyruvate in which mycothiol serves as a 
cofactor for the STL enzyme Ncgl2918(63).  In Streptomyces lincolnensis LmbE, a 
mycothiol conjugate amidase (MCA), and LmbV, a STL mycothiol transferase, have 
been shown to be involved in the biosynthesis of lincomycin A(64). LmbV installs the 
sulfur moiety derived from mycothiol in a lincomycin A precursor that was activated 
by the LMWT ergothionine (ESH, (64)). ESH is a LMWT found in Actinobacteria, 
Cyanobacteria, and some species of fungi(65) and is less widespread than other major 
LMWTs. Interestingly, ESH biosynthesis itself has also been found to be dependent 
on an STL thiol transferase. In the model organism Mycobacterium thermoresistibile, 
EgtB is an enzyme that adds N-α-trimethyl histidine to γ-glutamyl cysteine during 
ESH biosynthesis (66).  This is the first example of mycothiol, a MCA, and a STL 
mycothiol transferase being used in the biosynthesis rather than the detoxification of 
secondary metabolites. 
In all three cases, it should be noted that the thiol transferases contain more 
than one functional domain, with the DinB domain being one of them. Ncgl2918 
contains an N-terminal DinB domain, which contains metal coordinating residues, and 
a C-terminal MDMPI domain, which is essential for the isomerization activity(67). 
LmbV is most related to proteins with both of these domains (64), thus, it is possible 
that in addition to its MSH transferase activity, LmbV has isomerase activity. 
Crystallography studies of the STL enzyme EgtB revealed that the enzyme is 
comprised of two functionally distinct domains: a formylglycine-generating enzyme 
(FGE) domain, which catalyzes the O2-dependent posttranslational maturation of 
sulfatases, and a DinB domain (66). The active site of EgtB maps to the interface 
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between the two domains, implying that both domains are important in determining 
substrate specificity. Based on these two studies, it appears that characterization of 
both domains of putative thiol transferases could lead to identification of their natural 
substrates and functions. However, the eight putative B. subtilis STL enzymes 
described here are single DinB domain proteins that are necessary and sufficient for in 
vitro C-S bond formation.  This indicates that if multiple domains are necessary for 
biological activity, the second domain could be a separate unidentified gene product. 
Bacillithiol Transferases 
The two bacillithiol transferases identified in the Firmicutes thus far are 
members of two distinct superfamilies. The first bacillithiol transferase to be identified 
in S. aureus is FosB (Figure 1.5), which confers resistance to the antibiotic 
fosfomycin.  FosB is a member of the vicinal oxygen chelate (VOC) superfamily. 
VOCs are metalloenzymes that catalyze a diverse set of reactions, but all coordinate a 
divalent metal cation through vicinal oxygen atoms of a substrate, intermediate, or 
transition state in the reaction(68).  FosB was identified before the discovery of 
bacillithiol, and cysteine was believed to be the thiol cofactor of FosB(57). Early 
studies with the B. subtilis FosB reported a Km value for cysteine of 35 ± 3 mM, which 
is well above the calculated cysteine concentration for this organism (~230 µM, (14)).  
Since the discovery of bacillithiol, the thiol cofactor of both the B. subtilis and S. 
aureus FosB enzymes was reevaluated and determined to be bacillithiol(27, 58, 59).  
The S. aureus FosB Km for bacillithiol was determined to be 4.2 ± 0.7 mM(27).  This 
value is also above the intracellular concentration of bacillithiol.  However, due to the 
low
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Figure 1.5:  Bacillithiol-dependent detoxification of fosfomycin is catalyzed by S. 
aureus FosB (Roberts et al 2013(27)).!
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thiol pKa of bacillithiol (see “Biophysical Properties” above) there is more of the 
reactive thiolate form of bacillithiol present than that of cysteine in S. aureus. Genetic 
data also support these findings: fosB and bacillithiol null mutants show similar 
sensitivity to fosfomycin(23, 28, 56). Thus, the thiol cofactor of FosB is bacillithiol.  
 The first non-FosB bacillithiol transferase identified was B. subtilis YfiT (B. 
subtilis BstA), a member of the STL superfamily(33). The single predicted S. aureus 
Newman STL enzyme (ORF ID NWMN_2591) was identified in a Superfamily search 
(http://supfam.org/SUPERFAMILY/) using B. subtilis BstA as a query sequence 
against the S. aureus Newman genome. The S. aureus enzyme was confirmed to be a 
bacillithiol transferase on the basis of biochemical studies of cell free extracts(23) and 
the purified protein, and was named S. aureus BstA(35). Kinetic studies with S. 
aureus BstA demonstrated that the Km for BSH is 16 ± 4 µM, which is ~10 fold lower 
than the intracellular concentration of bacillithiol in S. aureus, indicating that the 
enzyme is saturated with bacillithiol in vivo(35). S. aureus BstA was found to catalyze 
the addition of bacillithiol to cerulenin(23) at a low rate in vitro(35). This newly 
identified STL superfamily is a diverse protein family that contains ~30,000 proteins 
with structural similarity but very little sequence identity. Phylogenetic studies have 
demonstrated that B. subtilis BstA and S. aureus BstA are distantly related, but are 
more related to each other than they are to the non-STL bacillithiol transferase S. 
aureus FosB (Figure 1.6).  The number of predicted STL transferases varies between 
species, with only one predicted structural homolog of YfiT in S. aureus Newman 
(BstA) and eight in B. subtilis(33).  
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 Although additional substrates of S. aureus BstA have not been identified, the 
genomic context of bstA may give insight into its function (Figure 1.7).  Five genes 
downstream and in the same orientation as bstA is a gene encoding an N-
acetyltransferase, an enzyme that could N-acetylate the Cys-adduct product of the 
bacillithol conjugate amidase, and three genes downstream is a gene encoding RarD, 
an efflux transporter that might export acetylated Cys-adducts (mercapturic acids, 
Figure 1.4).  Products of these types of enzymatic reactions have been previously 
observed in the detoxification of electrophiles by S. aureus Newman(34).  A 2-
oxoglutarate/malate translocator is adjacent to the bstA gene, which is significant 
because L-malate is a BshA substrate.  Upstream of S. aureus bstA is a gene encoding 
PadR, a component of the phenolic acid stress response in B. subtilis that functions as 
a negative regulator of padC, a gene encoding a phenolic acid decarboxylase that 
converts toxic phenolic acids to their vinyl phenol derivatives(69).  The ortholog of 
padC in Lactobacillus plantarum, padA, is transcribed divergently from its negative 
regulator padR(70), just as S. aureus padR is transcribed divergently from bstA.  This 
organization of genes can indicate a negative regulation relationship.  In Lactococcus 
lactis, the padR analog lmrR encodes a negative regulator of lmrCD, which encodes an 
ATP binding-cassette transporter, and is in the operon with these genes(71).  The gene 
upstream of padR, Newman_2589, encodes a hypothetical protein that shares 
structural motifs with efflux pumps.  If PadR regulates expression of bstA, then the 
natural BstA substrate(s) might bind PadR and relieve transcriptional repression of 
bstA and could provide a method to identify the BstA natural substrate(s)
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 BshB has Bacillithiol Conjugate Amidase Activity in Addition to GlcNAc-Mal 
Deacetylase Activity 
 The first mycothiol-dependent enzyme identified was mycothiol conjugate 
amidase (MCA) from M. smegmatis (MSMEG_5261) and M. tuberculosis 
(Rv1082)(72). This enzyme cleaves a mycothiol S-adduct at the amide linkage 
between the cysteinyl and glucosamine moieties to generate a N-acetylcysteinyl S-
adduct. The adduct is excreted and the residual glucosaminyl-inositol pseudo-
disaccharide is retained in the cell and cycles back to MSH biosynthesis(72, 73).  This 
is a commonly observed detoxification reaction among mycothiol-containing 
actinomycetes.  Mycothiol conjugate amidase is a zinc-containing hydrolase and a 
close homolog of the mycothiol biosynthetic amidase, MshB(74). These enzymes have 
both mycothiol conjugate amide hydrolase and GlcNAc-Ins deacetylase activities(75).  
It appears there are specialized enzymes that control the degradation of the 
major low molecular weight thiols such as GSH, MSH and BSH, which can ultimately 
supply the cell with cysteine.  The unique γ-glutamyl peptide bond in GSH (γ-Glu-
Cys-Gly) prevents the unwanted breakdown of GSH by peptidases.  For example, γ-
glutamyltranspeptidase is required to hydrolyze the γ-glutamyl-cysteine peptide bond, 
which releases Cys-Gly, a substrate for carboxypeptidase.  γ-glutamyltranspeptidase is 
found in eukaryotes and GSH producing bacteria.  The obligate human pathogen M. 
tuberculosis, which does not produce GSH, contains a glutathione ABC transport 
protein and γ-glutamyltranspeptidase that can supply Cys to M. tuberculosis from host 
GSH(76). MSH-containing organisms possess MCA, which has been shown to 
hydrolyze the unusual Cys-GlcN amide bond of MSH to provide AcCys and 
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ultimately Cys for protein synthesis(72, 73, 77). It was predicted that the same holds in 
true in BSH-containing organisms: hydrolysis of the Cys-GlcN amide bond of BSH by 
bacillithiol conjugate amidase should release of Cys in the cell.   
A similar pathway was observed in the BSH containing organisms B. cereus 
and B. anthracis, which encode two BshB enzymes (BshB1 and BshB2) that have dual 
GlcNAc-Mal deacetylase and bacillithiol S-conjugate amidase activities(26). A 
sensitive assay that monitors hydrolysis of the fluorescent bimane derivative of 
bacillithiol (BSmB) to the corresponding derivative of cysteine (CySmB) was 
developed to measure bacillithiol conjugate amidase activity. Assays of purified B. 
anthracis BshB1 (BA_1557) showed low amidase activity, about 10-5 in comparison 
with the deacetylation rate with GlcNAc-Mal(26, 31). B. anthracis BshB2 (BA_3888) 
showed considerably more BSmB deacetylase activity, only 100-fold less than the 
GlcNAc-Mal deactylase activity.  Both B. anthracis enzymes show low amidase 
activity towards unmodified BSH that is about 10-3-10-4 of the GlcNAc-Mal 
deacetylase rate.  The authors indicated that this low level of BSH amide hydrolysis 
activity was unlikely to be sufficient to supply cysteine to the cell.  However, the 
MCA activity in M. smegmatis was also about 103 below that of the MSmB amidase 
reaction and was shown to be responsible for MSH degradation(72, 77). It remains 
unclear if this low level of BCA activity with BSH is capable of supplying Cys in a 
rapidly growing organism such as S. aureus. 
S. aureus contains only one BshB2 type enzyme and the bshB NARSA 
transposon mutant (SAUSA300_0552) was determined by thiol analysis to be a 
complete BSH knockout(23, 35). The same bshB transposon mutant also lacks 90% of 
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the wild type bacillithiol S-conjugate amidase activity, indicating that this protein is 
responsible for all of the BshB activity and the majority of bacillithiol conjugate 
amidase activity in S. aureus(35). An inhibitor of S. aureus BshB in combination with 
fosfomycin might provide a novel cotherapy method against S. aureus. Such a method 
would eliminate both BSH synthesis and BCA detoxification and would prevent 
fosfomycin detoxification. 
 
Glyoxylases GlxA and GlxB 
 Methylglyoxal is a toxic, electrophilic byproduct formed during many 
metabolic pathways such as glycolysis (e.g. the conversion of dihydroxyacetone 
phosphate (DHAP) to methylgloxal)(78) and can also diffuse into the cell from the 
environment (Figure 1.8)(79). Methylglyoxal detoxification in E. coli and can be 
separated into glutathione-dependent and -independent pathways. In the glutathione-
dependent pathway, methyglyoxal reacts spontaneously with glutathione to form GS-
hemithioacetal.  The glyoxylase enzyme GlxI then converts GS-hemithioacetal to S-
lactoyl-glutathione, which GlxII then converts to D-lactate and glutathione(80). 
Production of S-lactoyl-glutathione activates the KefGB and KefKC potassium efflux 
pumps, leading to cytoplasmic acidification and protection from methylglyoxal 
presumably by antagonizing its reaction with cellular targets(81).  
Recently bacillithiol-independent and dependent pathways for methylglyoxal 
detoxification in B. subtilis have been characterized(79). Unlike E. coli, the primary 
resistance pathway in B. subtilis is thiol-independent. The BSH-dependent pathway is 
similar to glutathione-dependent methylglyoxal detoxification. Methylglyoxal reacts 
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spontaneously with bacillithiol to form BS-hemithioacetal. The glyoxylase GlxA then 
converts BS-hemithioacetal to S-lactoyl-bacillithiol, which GlxB converts to D-lactate 
and bacillithiol. This pathway involves the acidification of the cytoplasm, which is 
both necessary and sufficient for bacillithiol-dependent methylglyoxal resistance. 
Acidification depends on both bacillithiol and a K+ efflux pump KhtU, which is in the 
same family of transporters as the E. coli KefGB and KefKC, and the ancillary 
proteins KhtS and KhtT (collectively called KhtSTU). The authors propose that the S- 
lactoyl-BSH conjugate gates the KhtU efflux pump in the manner similar to the gating 
of the E. coli efflux pump by S-lactoyl-glutathione, although direct evidence is still 
lacking.  Thus bacillithiol is proposed to mediate methylglyoxal resistance through 
cytoplasmic acidification rather than methyglyoxal detoxification (Figure 1.8).  
The closest B. subtilis KhtU analog in S. aureus Newman is NWMN_0880, a 
Na+/H+ transporter (23% sequence identity with 69% coverage) in the same CPA2 
family as the E. coli transporter. Interestingly, glxA shares 25-30% sequence identity 
with S. aureus FosB, depending on the subspecies.  Structural and biochemical studies 
could elucidate whether these enzymes also bind bacillithiol.  
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Figure 1.8: Bacillithiol-dependent methylglyoxal detoxification pathway in 
Bacillus subtilis. Methylglyoxal can enter the cell via diffusion or can be formed 
intracellularly (i.e. from dihydroxyacetone phosphate, abbreviated DHAP). 
Bacillithiol and both glyoxalase A (GlxA) and glyoxylase B (GlxB) are utilized to 
convert methylglyoxal to D-lactate. Cytoplasmic acidification is mediated by the 
interplay of the KhtSTU pump with bacillithiol and S-lactoyl-bacillithiol (model 
from Chandrangsu et al 2013(79)).!
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Bacilliredoxins Debacillithiolate Proteins  
Upon exposure of cells to oxidants such as cumene hydroperoxide or sodium 
hypochlorite (NaOCl), bacillithiol has been shown to form mixed disulfides with the 
cysteine residues of certain proteins. This process, termed S-bacillithiolation, protects 
protein cysteine residues from overoxidation and irreversible damage of the 
protein(20, 82, 83).  Transcriptomic and proteomic studies revealed that several 
proteins are bacillithiolated, including the redox-sensing regulator OhrR, the 
methionine synthase MetE, and two proteins of unknown function YtxJ and YphP.  
Inactivation of OhrR results in the upregulation of ohrA, which encodes a 
peroxiredoxin that contributes to NaOCl resistance. Bacillithiol biosynthetic gene 
mutants show the same sensitivity to NaOCl as do ohrA knockouts, suggesting that 
bacillithiolation of OhrR is essential for ohrA expression(82).  S-bacillithiolation of 
MetE decreased the expression of methionine biosynthesis genes resulting in transient 
methionine autotrophy(83), which also occurs during S-glutathionylation of E. coli 
MetE(84).  
Using the quantitative redox proteomics approach OxICAT, cysteine residues 
that were most susceptible to oxidations in S. aureus USA300 have been identified 
and NaOCl-sensitive proteins have been quantified (85). Under NaOCl stress, there is 
a 10% increase in the oxidation of 58 cysteine residues. As assessed by western blots, 
the major S-bacillithiolated protein is glyceraldehyde-3-phosphate, which showed a 
29% increase in oxidation during NaOCl treatment (85). In vitro, when 
glyceraldehyde-3-phosphate was S-bacillithiolated at Cys151 prior to NaOCl 
treatment, 85% of protein activity was restored after bacillithiol was removed via DTT 
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treatment, while <5% of the activity of the unmodified protein was restored after DTT 
treatment (85).  Future biochemical studies that analyze the function of S-
bacillithiolation during stress and non-stress conditions will help us understand the 
role of bacillithiol in the protection of proteins and the regulation of enzyme activity. 
Debacillithiolation of protein mixed disulfides was hypothesized to be 
analogous to deglutathionylation, which is a process catalyzed by glutaredoxins. The 
first evidence that Firmicutes contained glutaredoxin-like proteins emerged from a 
bioinformatics search for the bacillithiol biosynthesis gene BshC. An EMBL STRING 
analysis remarkably identified four putative thiol-disulfide oxidoreductase proteins 
that had yet to be characterized, including YtxJ, a putative monothiol (TCPIS) active 
site glutaredoxin-like protein, and YpdA, a thioredoxin reductase-like protein and 
putative bacilliredoxin reductase.  The other two proteins, YphP and YqiW, are 
paralogs of the DUF1094 family (53% identity) and contain a CxC motif that is 
typical of glutaredoxins(28). Both proteins were recently demonstrated to have 
bacilliredoxin activity and were renamed BrxA (YphP) and BrxB (YqiW)(86).  These 
proteins were found to debacillithiolate active site cysteine residues of OhrR and 
MetE, two bacillithiolated redox-sensing proteins(20, 82).  The missing part of the 
bacilliredoxin story is the disulfide reductase needed to recycle the bacillithiolated 
forms of BrxA and BrxB.  One candidate for this enzyme is the thioredoxin reductase 
like protein YpdA found in early bioinformatics studies of BSH(28), which was 
observed to be bacillithiolated in its putative active site(82, 83). 
The B. subtilis BrxA and BrxB proteins share a high level of sequence identity 
with their S. aureus Newman homologs NWMN_1339 (57% with 97% sequence 
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coverage) and NWMN_1420 (69% with 99% sequence coverage), respectively. Thus, 
bacilliredoxins are likely to participate in the oxidative stress response in S. aureus. 
 
Response of Firmicutes to Electrophilic and Oxidative Stress 
 Data on cellular responses to electrophiles and oxidants predates the discovery 
of bacillithiol, and reexamination of these transcriptomic and proteomic studies 
provides significant evidence for bacillithiol-dependent stress responses.  Catabolism 
of phenolic acids like salicylic acid occurs during the decay of plant material in the 
soil and the response of Bacillus subtilis to salicylic acid indicates a role for 
bacillithiol transferases in this process.  One of the eight putative STL enzymes from 
B. subtilis, yuaE, is upregulated in response to salicylic acid along with bshB2, which 
encodes an enzyme with both BshB deacetylase and bacillithiol conjugate amidase 
activity (Table 1.1 and Table 1.2, (26, 87)). Exposure of B. subtilis to the fungal-
related 
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Table 1.1: Bacillithiol-related genes in S. aureus and Bacillus strains 
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 antimicrobial compounds methylhydroquinone and 6-brom-2-vinyl-chroman-4-on 
elicited a response similar to that of salicylic acid: two bacillithiol transferases (yjoA, 
yuaE), the bshB2 gene yojG, and the bacillithiol biosynthesis gene bshC were 
upregulated (Table 1.1 and Table 1.2,(88)).  Bacilliredoxin (brxB) was also 
upregulated, indicating that excessive protein thiolation might be occurring.  
 Firmicutes are exposed to hydrogen peroxide during infection, where 
bacillithiol-dependent defenses function as an adjunct to catalase activity. In Bacillus 
anthracis exposed to H2O2, all three bacillithiol biosynthesis genes as well as bshB2 
and the bacilliredoxin reductase candidate ypdA are upregulated (Tables 1 and 2(89)). 
Exposure of S. aureus MW2 to H2O2 resulted in a 2-fold downregulation of bshA, but 
upregulation of bstA, the glyoxylase genes glxA, and glxB, and the two putative 
bacilliredoxins brxA and brxB (Tables 1 and 2). 
Furthermore, mammalian peptidoglycan recognition proteins (PGRP) are a 
component of the host response and have been shown to kill B. subtilis by a 
combination of oxidative stress, thiol depletion and metal stress from release of Zn2+ 
and Cu2+ ions(90). Treatment with one isoform of PGRP (PGLYRP4) increased 
expression of the bacillithiol transferase yuaE ~8 fold(90).  Diamide leads to disulfide 
stress by oxidizing cellular thiols to disulfides. S. aureus COL responds with 
upregulation of the bacillithiol biosynthesis genes bshA and bshC and downregulation 
of bstA(91).  The putative bacilliredoxin reductase gene ypdA is also upregulated, 
which is consistent with the observation that diamide increases protein thiolation(92). 
Oxidizing agents also induce bacillithiol-related genes in S. aureus.  Nitrite 
upregulates all three bacillithiol biosynthesis genes, glxA, and ypdA in S. aureus 
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Table 1.2: Transcriptomic and proteomic analyses of bacillithiol-related enzymes 
during treatment with stressors!
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Table 1.2: Transcriptomic and proteomic analyses of bacillithiol-related enzymes 
during treatment with stressors con’t!
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N315(93).  Nitric oxide leads to the upregulation of genes encoding the BSH 
detoxification proteins bshB2 and ypdA(94).  Oxidizing agents produced in 
neutrophils, hypochlorous acid, azurophilic granule proteins, and H2O2 downregulate 
bshA and brxA ~2-fold, but induce bstA, glxA and brxB  ~2-fold(91).  
 From these studies we see that electrophilic compounds tend to induce specific 
bacillithiol transferases in the Firmicutes whereas the major bacillithiol conjugate 
amidase protein BshB2 is upregulated in response to both electrophiles and oxidants.  
The bacillithiol biosynthesis genes are most often upregulated in response to oxidants 
such as H2O2, diamide and nitrite.  Thus, bacillithiol is likely to play a key role in 
responding to these toxic molecules for both B. subtilis in soil and S. aureus 
infections. 
 
Spontaneous Enzyme-Independent Reactions with Bacillithiol  
 Thiols can react spontaneously with electrophilic substrates such as 
monobromobimane and methylglyoxal.  Preliminary evidence indicates that 
bacillithiol participates in a wider range of spontaneous reactions than other major low 
molecular weight thiols, presumably because its thiol group is more acidic and thus 
more reactive at cytoplasmic pH (Figures 2 and 3).  This property would help ensure 
rapid detoxification of certain harmful substances. The uncatalyzed reaction of H2O2 
with bacillithiol was the first such reaction to be described, and it was found to 
proceed at a rate of ~80 nmol min–1 mg–1, 40-fold higher than the rate with glutathione 
or mycothiol(33).  Bacillithiol has been found to react in an enzyme-independent 
manner with a number of substrates, such as the antibiotic rifamycin S, and the thiol-
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reactive molecules etacrynic acid, 4-hydroxynonenal and sulforaphane(35). The 
antibiotic cerulenin also reacts with bacillithiol spontaneously(35), but the S. aureus 
bacillithiol transferase BstA enhances this rate of reaction 2 fold(18, 33, 35). These 
results suggest that bacillithiol may be more reactive than glutathione or mycothiol in 
uncatalyzed reactions with certain electrophiles.   
 
Contribution of Bacillithiol to Pathogenesis  
The Model for Bacillithiol-Dependent Detoxification  
 The models for GSH- and MSH-dependent detoxification pathways involve 
similar enzymatic components and both produce a mercapturic acid, an N-acetylated 
cysteine-toxin conjugate that is excreted from the organism and is usually non-
toxic(72, 73, 95, 96). In S. aureus, bacillithiol conjugate amidase and N-
acetyltransferase activity were both detected using cell free extracts(34). Studies with 
whole cells demonstrated that BSH was added to the toxins prior to the appearance of 
the cysteine-toxin conjugate, demonstrating that the cysteine-toxin conjugate was 
likely the product of cleavage of the bacillithol-conjugate. The cysteine-toxin 
conjugate is then N-acetylated and excreted from the cells. In support of this 
interpretation, the levels of GlcN-L-malate increased with the appearance of the 
cysteine-toxin conjugate(34).  
 
Bacillithiol Protects S. aureus against Mammalian Cells Involved in Immune 
Responses  
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Bacteria that have been engulfed by macrophages and neutrophils are exposed 
to a number of reactive oxygen and nitrogen species, and bacillithiol likely serves as a 
cellular redox buffer that can neutralize these highly damaging molecules. Indeed, the 
BSH deficient Staphylococcus aureus strain NCTC 8325 showed diminished survival 
in murine macrophages in comparison to strains that produce BSH(60). A similar 
deficiency was observed in whole blood with the BSH deficient S. aureus strain 
SH1000 as compared with the BSH containing methicillin-resistant S. aureus strain 
COL(56). Taken together with the increased sensitivity of bacillithiol deficient 
mutants to H2O2(56) and with the rapid rate of reaction of bacillithiol with H2O2(33), 
the decreased survival of the bacillithiol mutants in macrophages might be explained 
by their increased susceptibility to oxidative stress.  
Bacillithiol levels have been reported to be relatively low in exponentially 
growing S. aureus(14, 27, 56) compared with the glutathione levels in Gram-negative 
bacteria, but comparable to the bacillithiol levels in B. subtilis. Bacillithiol levels in B. 
subtilis continue to increase to ~5.2 mM during late stationary phase, but it is unclear 
whether the same occurs in S. aureus.  Cysteine and bacillithiol levels did rise rapidly 
in S. aureus in response to treatment with rifamycin S, however(34).   
Interestingly, S. aureus has been found to import glutathione from the growth 
medium during stationary phase(60).  Although S. aureus does not encode any known 
enzymes that utilize this thiol as a cofactor, glutathione can react spontaneously with 
thiol-reactive molecules and may still serve as a protective redox buffer for the 
bacterium. Other Gram-positive bacteria such as Streptococcus mutans(97) and 
Streptococcus pneumoniae have also been reported to import glutathione, which 
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conferred oxidative stress resistance and increased survival in the mouse model of 
infection(98).  Interestingly, the S. aureus genome encodes a protein (NWMN_0147) 
that shares 27% sequence identity with 91% coverage to the M. tuberculosis γ-
glutamyltranspeptidase, which is required to hydrolyze the γ-glutamyl-cysteine 
peptide bond of GSH to release cysteine in glutathione producing organisms(99). M. 
tuberculosis γ-glutamyltranspeptidase provides this intracellular pathogen the critical 
activity to utilize macrophage GSH as a source of cysteine for protein synthesis during 
infection(76). The S. aureus γ-glutamyltranspeptidase analog has not been studied to 
the same extent as the M. tuberculosis γ-glutamyltranspeptidase, and it is unclear 
whether this enzyme is expressed during uptake of GSH.  It remains an open question 
whether glutathione is imported by S. aureus during eukaryotic infection and whether 
it contributes to the fitness of the pathogen.  
 
The evolution of the low molecular weight thiol biosynthetic genes  
Glutathione: the first low molecular weight thiol discovered 
Low molecular weight thiols have been implicated in several other reactions, 
such as detoxification of noxious molecules and signaling pathways(1). Both 
glutathione and mycothiol both have been shown to be essential in some pathogenic 
bacteria, such as Mycobacterium tuberculosis (100, 101), which utilizes mycothiol to 
successfully survive in the oxidizing environment of the macrophage cytoplasm, and 
Francisella tularensis (102), which imports and utilizes glutathione from the host 
cytosol as a source of cysteine. However, low molecular weight thiols most likely first 
evolved to combat toxic reactive oxygen species once Earth became significantly 
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oxygenated (1). The presence of glutathione in phototrophic bacteria implies that 
glutathione synthesis evolved around the time that oxygenic photosynthesis evolved 
(103). Additionally, it has been hypothesized that genes for glutathione biosynthesis 
come from the alpha-proteobacterial mitochondrial progenitor (104). However, it has 
been shown that the eukaryotic glutathione synthetase (GshB), the second and final 
enzyme utilized in the glutathione biosynthesis pathway, did not evolve directly from 
a bacterial glutathione synthetase (104).  
Mycothiol biostynthesis and its connection with lincomycin biosynthesis  
While most Gram-negative bacteria produce glutathione, its absence in other 
aerobic bacteria indicates that these organisms evolved alternative low molecular 
weight thiols to combat reactive oxygen species. Mycothiol biosynthesis is thought to 
originate when a duplicated cysteinyl-tRNA synthetase gene evolved to mshC, the 
gene encoding the cysteine ligase enzyme (1, 38). Additionally, as discussed above, 
the sulfur of mycothiol has recently been found to be incorporated into the final 
lincomycin A metabolite (64). Interestingly, LmbE, a lincomycin biosynthetic 
enzyme, shares over 30% sequence homology with MshB and Mca, two amidase 
enzymes that are involved in mycothiol production and mycothiol conjugate 
processing, respectively. Thus, it has been postulated that the lincomycin and 
mycothiol systems evolved together or from a common ancestor (105).  
 
Bacillithiol biosynthesis: questions and possible clues 
The origins of the bacillithiol biosynthesis genes are currently unknown, 
although the bacillithiol biosynthesis pathway parallels the mycothiol biosynthesis 
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pathway (31). Bacillithiol partakes in evolutionary conserved reactions, such as zinc 
buffering (22), Fe(S) biogenesis (53, 54), and protein thiolation (82, 83). The 
observation that the B. subtilis bacillithiol biosynthesis genes are in the same operon 
as cca, which encodes tRNA nucleotidyltransferase and is also called CCAase, has led 
to the thought that tRNA maturation could be linked to oxidative stress (106). During 
oxidative stress, the transcription factor Spx will direct the expression of the ypjD 
operon, which contains bshA, bshB1, and cca. It is possible that cysteine will be 
directed to bacillithiol biosynthesis, which would lead to an increase in levels of 
uncharged tRNACys. The uncharged tRNACys molecules might then be degraded and 
the CCAase enzyme would be necessary to repair these molecules (106). Indeed, 
previous studies show that during mercury-induced oxidative stress, truncated versions 
of tRNACys were observed and were thought to be missing the 3’ CCA sequence (107). 
While these observations have not been tested, they suggest the intriguing link 
between oxidative stress, bacillithiol, and tRNACys maturation. Thus, information on 
the conserved functions of bacillithiol is still being gathered and could help shed light 
on the origins of the bacillithiol biosynthetic genes.  
 
Expert Commentary and Five-year View 
 The rapid rate of the development of resistance of methicillin-resistant S. 
aureus to the current therapeutic options is a great health concern, and many research 
efforts are focused on identifying new antibiotics and new antibiotic targets to combat 
this organism(108, 109). The cell wall synthesis inhibitor fosfomycin is currently used 
in the treatment of urinary tract and gastrointestinal S. aureus infections.  Fosfomycin 
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can enter the cell via the L-alpha-glycerophosphate transport system (GlpT) and/or the 
hexose-monophosphate transport system (UhpT)(110). Mutations in these transporters 
contribute to fosfomycin resistance and are presumably a major mechanism of 
fosfomycin resistance(111). The plasmid borne fosB gene has been identified in 34% 
of fosfomycin-resistant clinical Staphylococci isolates(112). Recently, deletion of the 
chromosomally encoded fosB or bshA in clinically relevant MRSA isolates was 
determined to be the major source of inherent fosfomycin susceptibility(56). The use 
of fosfomycin as a monotherapy has resulted in rapid development of resistance(113). 
The FDA recently recommended that one antimicrobial therapy that should be 
considered for streamlined development are those incorporating an agent that inhibits 
drug resistance. We predict that the bacillithiol biosynthetic enzymes would be good 
targets for neutralizing resistance, because mutants lacking bacillithiol show increased 
sensitivity both to oxidative stress and to drugs such as fosfomycin that are detoxified 
by a FosB/bacillithiol-dependent process(23, 28, 56, 60).  Thus, inhibition of BSH 
biosynthesis should sensitize S. aureus to the innate immune response and to 
antibiotics such as fosfomycin.  
The glycosyltransferase BshA may be a problematic drug target when used in 
combination therapy with fosfomycin due to increases in UDP-GlcNAc levels.  
Treatment of S. aureus with fosfomycin, which targets peptidoglycan biosynthesis by 
inhibiting MurA and MurZ, has been shown to increase levels of UDP-GlcNAc, the 
substrate of BshA(62). This accumulation of a BshA substrate could hinder the ability 
of a potential competitive inhibitor to effectively block BshA activity and decrease 
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bacillithiol levels. Thus, bacillithiol would still be synthesized at some level and 
would confer resistance to fosfomycin.  BshC, the final enzyme in the BSH 
biosynthesis pathway, has yet to be characterized, so significant development would 
be required before a BshC inhibitor screen could be devised. 
S. aureus BshB may be a good candidate drug target, as this enzyme is 
involved in bacillithiol biosynthesis and also provides most of the bacillithiol 
conjugate amidase detoxification activity(23, 26, 35).  Unlike the Bacillus species 
discussed in this review, there are no compensating activities for S. aureus BshB, so 
the appropriate drug could completely inhibit BSH biosynthesis. S. aureus BshB is 
~25% identical with M. tuberculosis MshB (Rv1170) and MCA (Rv1082), and is 
easily expressed in E. coli. A screen for natural product inhibitors yielded µM 
inhibitors of M. tuberculosis MCA and MshB (Figure 1.9, (114-116)) and these would 
constitute a logical starting point for S. aureus BshB2 inhibition studies. Inhibition of 
S. aureus BshB2 activity would diminish the production of bacillithiol and thereby 
render the organism more susceptible to being killed by the host defenses such as the 
oxidizing environment of macrophages, neutrophils and blood(56, 60).  Depletion of 
bacillithiol would also diminish the BCA detoxification activity of BshB2 and inhibit 
excretion of mercapturic acids. A decrease in bacillithiol levels could result in a 15-60 
fold decrease in resistance to fosfomycin(56), suggesting a combination therapy of 
fosfomycin and a BshB/BCA inhibitor could be effective against multidrug resistant S. 
aureus infections.  Identifying an inhibitor of this enzyme should be feasible within 
the next five years, especially with the numerous inhibitor chemotypes identified for 
the homologous M. tuberculosis MCA (Figure 1.9). 
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Figure 1.9. Natural product and synthetic inhibitors of M. tuberculosis 
metalloproteins MshB and MCA.  Oceanapiside (compound 1) is a non-
competitive inhibitor of M. tuberculosis MCA; a brominated derivative of 
tyrosine (compound 2) and psammplysin A (compound 3) are competitive 
inhibitors of MCA.  Psammaplin A (compound 5) and (compound 2) 
contain an oxime moieties, known to chelate metal ions. Compound 4 is a 
synthetic substrate analog of GlcNAc-Ins (substrate of MshB), and one of 
the few compounds that inhibits both M. tuberculosis MshB and MCA.!!!
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ABSTRACT 
 Bacillithiol is a low molecular weight thiol found in Firmicutes that is 
analogous to glutathione, which is absent in these bacteria. Bacillithiol transferases 
catalyze the transfer of bacillithiol to various substrates. The S-transferase-like (STL) 
superfamily contains over 30,000 putative members, including bacillithiol 
transferases. Proteins in this family are extremely divergent and are related by 
structural rather than sequence similarity, leaving it unclear if all share the same 
biochemical activity. Bacillus subtilis encodes eight predicted STL superfamily 
members, only one of which has been shown to be a bacillithiol transferase. Here we 
find that the seven remaining proteins show varying levels of metal dependent 
bacillithiol transferase activity. We have renamed the eight enzymes BstA-H. Mass 
spectrometry and gene expression studies revealed that all of the enzymes are 
produced to varying levels during growth and sporulation, with BstB and BstE being 
the most abundant and BstF and BstH being the least abundant. Interestingly, several 
bacillithiol transferases are induced in the mother cell during sporulation. We showed 
that proteins that are S-bacillithiolated during growth and sporulation, and used mass 
spectrometry to identify six enzymes that are modified (DhbB, TpiA, GlpX, DeoD, 
PpaC, GuaB). A strain lacking all eight bacillithiol transferases showed normal growth 
in the presence of stressors that adversely affect growth of bacillithiol-deficient 
strains, such as paraquat and CdCl2, and it maintained wild type levels of protein S-
bacillithiolation.  Thus, the STL bacillithiol transferases represent a new group of 
proteins that play currently unknown, but potentially significant roles in bacillithiol-
dependent reactions.  
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IMPORTANCE 
Thiol transferases are protective enzymes that can serve as possible drug 
targets in pathogenic bacteria. However, identifying the natural substrates of these 
enzymes can be a difficult task. A handful of STL thiol transferases have been 
implicated in detoxification reactions and the biosynthesis of sulfur-containing 
compounds. The physiological role of STL bacillithiol transferases is unknown. In this 
study we determine that all predicted STL bacillithiol transferases in Bacillus subtilis 
are indeed active. Importantly, we begin substrate identification studies by identifying 
growth phases in which the bacillithiol transferases are expressed and testing 
candidate substrates. We conclude that these enzymes are highly divergent, perhaps to 
cope with an equally diverse array of endogenous or exogenous toxic metabolites and 
oxidants. 
 
INTRODUCTION 
Low molecular weight thiols (LMWTs) are small, non-protein organosulfur 
molecules that play many roles in the cell. Notably, they serve as cytoplasmic redox 
buffers, protect cysteine residues from overoxidation, and they can detoxify harmful 
molecules that are either produced intracellularly and/or encountered from the 
extracellular environment(1, 2). The major LMWT produced in both eukaryotes and 
Gram-negative bacteria is glutathione, and the enzymes that catalyze the nucleophilic 
attack of glutathione to target substrates are glutathione transferases (GSTs,(3)). Thiol 
transferases are usually associated with conjugating thiols to small molecules in 
detoxification reactions. However, some thiol transferases have been found to add 
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thiols to protein substrates. GST Pi, a class of cytosolic human GSTs, have been 
shown to glutathionylate proteins in vivo in humans(4), and in vitro(5). Eukaryotic 
GSTs have garnered much attention due to their implications in mammalian disease 
states such as Parkinson’s and Alzheimer’s disease(3, 6, 7) and their ability to detoxify 
electrophilic toxins such as carcinogens(8) and cancer drugs(9), while bacterial GSTs 
have been implicated in antibiotic resistance, isomerization reactions, and 
bioremediation(10). Thus, glutathione and GSTs play a number of physiological roles 
and are central to several biochemical pathways.  
It has recently been recognized that some bacteria use alternate low molecular 
weight thiols rather than glutathione, including mycothiol, which is produced by 
Actinobacteria such as Mycobacterium smegmatis, and bacillithiol, which is produced 
by Firmicutes such as Bacillus subtilis and Staphylococcus aureus. The roles of these 
thiols are less well understood than those of glutathione. Mycothiol buffers the 
cytoplasm, detoxifies electrophiles(11), and, via dedicated mycothiol transferases, it 
participates in the isomerization of malylpyruvate to fumarylpyruvate(12) and forming 
new sulfur-carbon bonds during biosynthesis of the secondary metabolites lincomycin 
A(13) and ergothioneine(14). Bacillithiol been found to detoxify the cell wall 
biogenesis inhibitor fosfomycin(15), to protect cysteine residues during NaOCl stress 
(16, 17), and to be involved in Fe(S) cluster metabolism(18, 19). 
Thus far, two families of bacillithiol transferases have been identified in the 
Firmicutes that lack sequence and structural similarity. The first bacillithiol transferase 
identified in B. subtilis was FosB, which belongs the vicinal oxygen chelate (VOC) 
superfamily (15, 20). The FosB bacillithiol transferase catalyzes bacillithiol-dependent 
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detoxification of fosfomycin, and mutants in fosB and bacillithiol biosynthesis genes 
are sensitive to the antibiotic(15, 21). The second bacillithiol transferase to be 
identified in B. subtilis was BstA (YfiT; (22)), which is a member of the S-transferase-
like (STL, formerly DinB/YfiT) superfamily;(23)). The STL superfamily is large, 
containing more than 30,000 predicted enzymes from both Gram-negative and Gram-
positive bacteria. It is a remarkably diverse family, with membership defined not by 
primary sequence similarity, but rather by the ability to fold into similar structures as 
predicted by hidden Markov models ((24), http://supfam.org/SUPERFAMILY/).  
There is wide variation in the number of STL family members per genome:  while 
some species encode only a single STL family member, others encode as many as 30. 
For example, S. aureus encodes one bacillithiol transferase, while B. subtilis encodes 
eight distantly related family members, with only two of the enzymes sharing >30% 
sequence similarity and the rest sharing only predicted structural similarity.  However, 
it remains unclear if all the members of the STL superfamily are bacillithiol 
transferases, because thus far, only two of the STL proteins have been characterized 
and confirmed to be active bacillithiol transferases: B. subtilis BstA(22) and S. aureus 
BstA(23).  
Given the critical role of glutathione transferases in eukaryotic cells(3) and the 
role of FosB in detoxification of the antibiotic fosfomycin(15, 21), we hypothesized 
that characterization of this new family of proteins might provide insight into the role 
of bacillithiol in the Firmicutes and potentially allow identification of novel antibiotic 
and oxidative stress resistance pathways and possibly even new drug targets. This is 
especially important for pathogenic bacteria, such as B. anthracis, and industrially 
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relevant bacteria, such as B. subtilis, that encode several putative STL bacillithiol 
transferases. However, identifying the physiological roles and natural substrates of the 
STL bacillithiol transferases will be difficult without additional information about 
these enzymes.  
To address this limitation we chose to characterize the seven remaining 
putative bacillithiol transferases in B. subtilis, reasoning that they would provide an 
ideal system for testing if all the members of this diverse protein family in this species 
are bacillithiol transferases, and if so, that B. subtilis might be an ideal organism for 
investigating their role. B. subtilis is genetically and biochemically tractable soil-
dwelling organism with several well characterized developmental states, such as 
sporulation.  It lives in complex, mixed species communities, in an environment awash 
with antimicrobial toxins and metabolic byproducts, and it also produces a variety of 
secondary metabolites such as the polyketide bacillaene, which arrests protein 
translation in E. coli (25). B. subtilis is also used in industrial applications as a 
biological control agent for agricultural applications(26-28) and as a host for the 
overproduction of secreted proteins(29, 30). It is plausible that bacillithiol transferases 
might be necessary for survival in these complex conditions, either by directly 
contributing to antibiotic resistance mechanisms or biosynthetic pathways, or to other 
resistance mechanisms necessary to survive in harsh environments. Indeed conjugates 
of the analogous low molecular weight thiol from Actinobacteria, mycothiol, to 
natural products and antibiotics have been isolated from industrial fermentation 
cultures of actinomycetes(11).    
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In this study, we describe the activity and expression of the B. subtilis STL 
bacillithiol transferases. Bioinformatics studies of the eight B. subtilis STL proteins 
revealed that most are conserved in related Bacillus spp, and that all but one is also 
found in the pathogen Bacillus anthracis, indicating evolutionary pressure to retain the 
proteins. We have confirmed that the seven previously uncharacterized STL proteins 
encoded by B. subtilis are active bacillithiol transferases. We characterized the 
expression patterns of the proteins during different phases of growth and sporulation, 
and identified proteins that are S-bacillithiolated during growth. We constructed a 
strain lacking all eight bacillithiol transferases but thus far, have been unable to find a 
clear phenotype associated with this strain. Indeed, the strain lacks the phenotypes 
found in mutants that cannot synthesize bacillithiol, indicating that the bacillithiol 
transferases are not involved in the detoxification of those molecules. Thus, our 
studies demonstrate that all eight of the STL proteins encoded by B. subtilis are active 
bacillithiol transferases, but their role remains unclear.   
 
RESULTS 
Phylogenetic analysis shows the distribution of STL bacillithiol transferase homologs 
in Bacillus species  
Previously, we showed that the STL superfamily is extremely divergent, with 
family members sharing structural rather than sequence similarity(23). Whereas S. 
aureus encodes only one STL family member, the bacillithiol transferase BstA, 
Bacillus subtilis encodes a total of eight STL family members, seven of which are 
putative bacillithiol transferases. To understand the evolutionary relationships between 
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these proteins, we first performed alignments with the primary amino acid sequences 
of the B. subtilis enzymes (Fig. S3.1). This analysis showed that B. subtilis BstA 
(formerly YfiT;(23)) and the remaining seven putative B. subtilis bacillithiol 
transferases share very low sequence identity:  BstA showed between 9-23% identity 
to the remaining transferases, and the most closely related pair (YisT and DinB) 
showed just 37% sequence identity. Thus, B. subtilis 168 encodes eight STL family 
members distantly related to one another.  
To further understand the diversity of these enzymes and their distribution 
across other B. subtilis strains, we next constructed a phylogenetic tree that contains 
STL superfamily members from B. subtilis strain 168 and four other B. subtilis strains. 
Due to its lack of sequence or structural similarities to the STL superfamily bacillithiol 
transferases, B. subtilis FosB bacillithiol transferase served as outgroup for this 
analysis (black, Fig. 3.1). BstG/DinB and BstC/YisT are more closely related to each 
other than to any other putative bacillithiol transferase and therefore cluster closely 
together on a phylogenetic tree (green, Fig. 3.1). We found that seven STL homologs 
are conserved in all five strains, shown as proteins that branch and cluster together 
(Fig. 3.1A), and share ≥88% sequence similarity with the B. subtilis 168 protein 
sequences (Table S3.1). The eighth branch (defined by BstH/YizA) is found in B. 
subtilis 168 as well as the two B. subtilis spizizenii strains analyzed. Interestingly, B. 
subtilis subsp. spizizenii TU-B-10 encodes an extra STL enzyme (AEP87498.1) that 
even its closest relative, B. subtilis subsp. spizizenii W23, does not encode. This 
protein, AEP87498.1, does not cluster with any of the STL enzymes encoded in the 
five B. subtilis strains (Fig. 3.1A). In addition, a BLAST search shows that the same 
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protein (100% sequence identity and coverage) is found in Jeotgalibacillus marinus. 
Thus, the B. subtilis strains we examined encode seven of the eight STL-related 
proteins found in the B. subtilis 168 genome, and that two of these proteins 
(BstH/YizA from 168, and AEP87498.1 from TU-B-10) show a more limited 
distribution, perhaps indicating that they perform a specialized function.  This 
demonstrates that even within a single species, individual strains show a degree of 
variability in their repertoire of STL-family members.  
To study the conservation of STL proteins different Bacillus species, we 
performed a phylogenetic analyses on the proteins encoded by B. subtilis 168, Bacillus 
megaterium QM B1551, Bacillus amyloliquefaciens subsp. plantarum str. FZB42, 
Bacillus halodurans C-125, Bacillus anthracis str. Ames, and Bacillus thuringiensis 
str. Al Hakam (Fig. 1B). We find that most of the STL proteins are found in all six 
species analyzed, with some species even encoding more than one copy of the same 
STL homolog, while some homologs are missing (Fig. 1B, Table S2). For example, a 
B. subtilis BstC/YisT homolog is not present in Bacillus anthracis Ames. Additionally, 
there are a number of homologs that are encoded in other species but are not in B. 
subtilis 168. For example B. anthracis Ames and B. thuringiensis str. Al Hakam 
encode eight and eleven STL homologs, respectively, not encoded in B. subtilis.  
Thus, there is substantial variability in the STL superfamily of proteins between 
related species, indicating that there is evolutionary pressure to retain and diversify the 
STL superfamily of enzymes. 
The diversity of the STL-superfamily members encoded in different strains and 
species suggests that these enzymes might be part of the dispensable genome of 
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Figure 3.1: Phylogenetic analysis of STL bacillithiol transferases in Bacillus 
subtilis strains and Bacillus spp. Proteins are listed using NCBI locus tags. Bootstrap 
values are shown for selected branches and correspond to confidence levels. A) Black: 
B. subtilis 168 FosB (outgroup), green: Bacillus subtilis 168 proteins, orange: Bacillus 
subtilis subsp. natto BEST195 proteins, magenta: Bacillus subtilis subsp. spizizenii 
TU-B-10 proteins, cyan: Bacillus subtilis subsp. spizizenii str. W23 proteins, red: 
Bacillus subtilis subsp. subtilis str. RO-NN-1 proteins See Table S3.1 for additional 
information. B) Black: B. subtilis 168 FosB (outgroup), green: Bacillus subtilis 168 
proteins, orange: Bacillus megaterium QM B1551 proteins, purple: Bacillus 
amyloliquefaciens subsp. plantarum str. FZB42 proteins, cyan: Bacillus halodurans C-
125 proteins, red: Bacillus anthracis str. Ames, blue: Bacillus thuringiensis str. Al 
Hakam. See Table S3.2 for additional information. 
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Bacillus species, rather than the core genome. Indeed, a recent genomic study of the 
genomes of 20 Bacillus species identified 814 conserved genes that comprise the core 
genome of Bacillus species(31). This study revealed that the bacillithiol biosynthesis 
genes bshA, bshB2, and bshC, but none of the eight B. subtilis bacillithiol transferases, 
are part of the core genome(31). However, we note that the specific strains included in 
this study do encode STL-family proteins. Indeed, the published study included B. 
coahuilensis (NZ_ABFU00000000), which has the smallest genome reported for a 
Bacillus species. BLAST searches revealed that the B. coahuilensis genome encoded 
homologs of just two of the eight B. subtilis proteins, BstA (for which 
WP_010173769.1 showed 97% coverage and 51% sequence identity) and BstB/YuaE 
(for which WP_010173272.1 showed 85% coverage and 32% sequence identity). 
BstA and/or BstB/YuaE homologs were found in all the species we analyzed, except 
Bacillus clausii KSM-K16 (NC_006582) and Oceanobacillus iheyensis HTE831 
(NC_004193), which encoded other members of the STL superfamily that were 
identified by the PFAM analysis. Thus, all of the genomes we analyzed encode 
putative bacillithiol transferases, but none of the B. subtilis enzymes are conserved 
across all twenty species.  
 
Biochemical activity of the putative bacillithiol transferases  
In order to test if all the STL-related proteins encoded by B. subtilis strain 168 
were active bacillithiol transferases, we overexpressed and purified the His6-tagged 
proteins (Fig. S3.2, Table S3.3 and “Materials and Methods”).  We assessed the 
specific activities of the purified putative bacillithiol transferases using the 
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electrophile monochlorobimane.  Monochlorobimane reacts slowly with thiols, and 
upon addition of a bacillithiol transferase, the rate of product formation increases(23). 
Accumulation of the product (bacillithiol-biname) can be monitored over time using 
reverse phase HPLC and fluorescence detection. This analysis showed that all seven 
enzymes were active to varying degrees with bacillithiol and monochlorobimane, with 
all showing specific activities that are above the chemical rate background (Table 3.1). 
We therefore renamed the proteins BstB-H, replacing their provisional ORF names 
with bstB (yuaE), bstC (yisT), bstD (yjoA), bstE (yrdA), bstF (ykkA), bstG (dinB), bstH 
(yizA). Four of these enzymes (BstB, BstC, BstD, and BstE) have specific activities 
significantly higher than B. subtilis BstA(22). After subtracting the chemical rate (8.7 
± 0.1 pmol min-1), the specific activity of BstG is comparable to the specific activity 
reported for B. subtilis BstA, while that of BstF and BstH are lower than that of 
BstA(22). The low activity of these enzymes could be due either to the His6-tags, 
which could adversely affect enzyme activity or it could be due to a poor fit between 
the active site and monochlorobimame, which is unlikely to be the natural substrate 
for any of these enzymes. We next tested the specificity of these enzymes for its 
cosubstrate bacillithiol versus two other major low molecular weight thiols found in B. 
subtilis cells, cysteine and coenzyme A (CoA). The bacillithiol transferases were 
unable to catalyze formation of cysteine-bimane or CoA-bimane above the 
background chemical rates (Table 3.1). Thus, the B. subtilis bacillithiol transferases 
are inactive with either cysteine or CoA. Together, these data indicate that despite the 
low sequence similarity to each other or to S. aureus BstA, all eight of the putative 
bacillithiol transferases encoded by the B. subtilis  168 genome are active and that they  
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Table 3.1: Specific activities of the Bacillus subtilis bacillithiol 
transferases 
 
 
B. subtilis 
bacillithiol 
transferase 
 
 
Specific activity 
with bacillithiola 
(nmol min-1 mg-1) 
Rate of 
cysteine-mB  
adduct 
 formation 
 (pmol min-1) 
Rate of 
CoA-mB  
adduct  
formation 
(pmol min-1) 
Rate of 
bacillithiol-mB 
adduct formation 
+ EDTAb 
(pmol min-1) 
BstA (YfiT) 2.5 ± 0.4c 2.5 ± 0.2 0.3 ± 0.2 8.7 ± 0.2 
BstB (YuaE) 170 ± 13 2.5 ± 0.4 0.3 ± 0.1 8.7 ± 0.1 
BstC (YisT) 49 ± 9  2.2 ± 0.1 0.3 ± 0.2 8.9 ± 0.3 
BstD (YjoA) 113 ± 6 2.2 ± 0.4 0.3 ± 0.3 8.9 ± 0.2 
BstE (YrdA) 5.8 ± 0.7 2.4 ± 0.4 0.3 ± 0.1 8.9 ± 0.2 
BstF (YkkA) 1.3 ± 0.2 2.6 ± 0.1 0.3 ± 0.2 8.7 ± 0.1 
BstG (DinB) 2.5 ± 0.3 2.2 ± 0.3 0.3 ± 0.3 8.6 ± 0.0 
BstH (YizA) 1.8 ± 0.4 2.5 ± 0.4 0.3 ± 0.2 8.5 ± 0.2 
No enzymed - 2.6 ± 0.1 0.3 ± 0.3 8.7 ± 0.1 
Reactions consisted of 50 µM monochlorobimane and 50 µM thiol, and were 
conducted at pH=7.0 at 23°C for a total of 20 min. For reactions with bacillithiol, 
the following amounts of protein: BstA: 0.1 µg, BstB: 0.1 µg, BstC: 0.1 µg, BstD: 
0.2 µg, BstE: 0.5 µg, BstF: 0.8 µg, BstG: 0.5 µg, BstH: 0.8 µg. For reactions with 
cysteine, CoA, and bacilithiol +EDTA, 1 mg of protein was used. All values 
represent mean ± standard deviation (n = 3). 
aRate of chemical reaction was subtracted total rate to give net enzymatic rate. 
b Enzymes were incubated with 1 mM EDTA in assay buffer for 5 minutes prior to 
the addition of bacillithiol and monochlorobimane. 
cData from Newton et al 2011. 
d“No enzyme” rate is the background chemical reaction rate. 
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use bacillithiol as a cosubstrate. These results demonstrate that widely divergent 
members of the STL-superfamily retain a common enzymatic activity.  
 
BstA-H activity is metal dependent  
The crystal structure of B. subtilis BstA has been shown to have an active site 
geometry consistent with those of metalloenzymes, with three conserved histidines 
(H67, H160, and H164) that might coordinate an active site metal(32). The authors of 
this study therefore predicted that the proteins might be metal dependent, and indeed, 
we previously determined that the activity of bacillithiol transferase from S. aureus is 
metal dependent (23). An alignment of the eight bacillithiol transferases of B. subtilis 
168 (Fig. S3.1) revealed that these three histidines were the only completely conserved 
amino acids. To determine the metal ion requirement of the eight purified bacillithiol 
transferases, we added the divalent cation-chelating agent EDTA to the 
monochlorobimane enzyme assay to establish whether addition of this chelating agent 
would decrease enzyme activity. Upon addition of EDTA, the activity of all eight 
enzymes was decreased to a rate comparable to the chemical rate, which represents a 
>99% reduction in rate (Table 3.1). These data suggest that the activity of all eight 
bacillithiol transferases is metal-dependent, although further studies are required to 
determine which metal is normally used by the enzymes in vivo.  
 
Phenotypic analysis of the ΔbshC and ΔbstA-H mutants against select oxidants and 
stressors 
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Bacillithiol is implicated in a number of protective as well as physiological 
roles. It has been found to detoxify fosfomycin (15, 21), to serve as a buffer for 
cytoplasmic zinc (33), to protect cysteine residues from oxidative reactions during 
NaOCl stress (16, 17), and to contribute to the assembly of Fe(S) clusters (18) in B. 
subtilis. Bacillithiol-deficient mutants of B. subtilis have been reported to grow slowly 
in minimal media and to be sensitive to NaOCl, paraquat, CdCl2, and CuCl, which all 
cause oxidative stress in minimal media (18) and to high concentrations of NaCl(15). 
It is possible that bacillithiol-dependent protective reactions are catalyzed by 
bacillithiol transferases, so we tested the sensitivity of bst mutants to fosfomycin, 
paraquat, CdCl2, CuCl, and NaCl in both nutrient-rich LB and minimal media. We 
first constructed in frame deletions of all eight bst genes (as described in Materials and 
Methods). To account for potential functional redundancy among the proteins, we then 
combined these eight mutations into a single strain, generating a strain containing 
ΔbstA, ΔbstB, ΔbstC, ΔbstD, ΔbstE, ΔbstF, ΔbstG and ΔbstH (hereafter referred to as 
ΔbstA-H). This strain was compared to the bacillithiol deficient ΔbshC strain and the 
wild type strain PY79. The minimum inhibitory concentration (MIC) was determined 
24 hours after inoculation with the stressor. As expected, the ΔbshC, but not the 
ΔbstA-H mutant, was more sensitive to fosfomycin than PY79 in both minimal and 
rich media. However, the wild type PY79, the ΔbshC and ΔbstA-H strains shared the 
same MIC in both types of media against the other stressors (Table S3.4), suggesting 
that these strains were not sensitized to any of the stressors. However, the MIC is an 
endpoint assay that could miss decrease in growth rate and longer lag phases, so we 
also performed growth curves for all three strains in the presence of stressors. The 
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ΔbstA-H strain showed growth that was identical to the wild type strain under all 
conditions, demonstrating that the proteins are not involved in resistance to these 
agents. The ΔbshC mutant showed a slightly increased lag in growth with CdCl2, 
NaOCl and paraquat (Fig. S3.3), although the growth defects we observed were less 
severe than previously reported(16, 34). Thus, the strain lacking all eight of the 
bacillithiol transferases identified so far shows normal growth in the presence of a 
variety of stressors.   
 
Mass spectrometry analysis and fluorescence microscopy show that bacillithiol 
transferases and bacilliredoxins are expressed during growth and sporulation  
We reasoned that studying the regulation of the bacillithiol transferases might 
help reveal their endogenous functions.  For example, the four genes required for 
bacillithiol biosynthesis, bshA, bshB1, bshB2, and bshC, are under the control of the 
Spx transcription factor(35), which is activated by stressors such as oxidants, 
electrophiles, and heat.  In addition, bshA and bshB1 have been reported to be under 
the control of the sporulation-specific transcription factor sE, which controls early 
mother cell-specific transcription(36). However, there is very little documentation in 
the literature about the expression of the bacillithiol transferases. We first used mass 
spectrometry analysis to examine the expression of bacillithiol transferase during 
different stages of growth. To do so, we used spectral counting of native peptides from 
a B. subtilis PY79 extract to assess the total number of spectra identified for a peptide 
to quantify the relative abundance of each bacillithiol transferase(37-39). Using a 
single injection of extract separated using a low pH capillary HPLC separation online 
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with QTOF mass spectrometer we were able to detect a total of 762 proteins, with 390, 
238, 521 and 690 proteins (Supplemental Data) detected in exponential phase, 
stationary phase, t0 and t3 of sporulation, respectively. We detected BstB expression 
during exponential phase (OD600=0.4), stationary phase (OD600=4.0), t0, and t3 of 
sporulation, while BstD expression was detected during exponential phase, t0, and t3 of 
sporulation (Fig. 3.2A). BstD was expressed constitutively whereas BstB appeared to 
increase 2.9-fold between t0 and t3 of sporulation. Interestingly, the confirmed 
bacilliredoxin BrxA (40) and the putative bacilliredoxin YtxJ(15) are also expressed 
during growth and sporulation, with YtxJ increasing 2.3-fold during sporulation, 
following a pattern similar to that of BstB (Fig. 3.2A).  
It is possible that we failed to detect other bacillithiol transferases because high 
abundance peptides masked those from lower abundance proteins of interest in these 
complex extracts. To remedy this and allow for increased protein and peptide 
identification, we used a high-pH reversed-phase fractionation method where single 
samples were separated offline into 96 fractions, pooled, dried, and injected as 12 
individual samples as previously described(41, 42). These methods complemented the 
low pH, single injection method used in Fig. 3.2A. We also utilized a more sensitive 
instrument, a Thermo Orbitrap Fusion, to gain greater coverage of the B. subtilis 
proteome (43, 44). For quantitation purposes, samples were labeled with tandem mass 
tag (TMT) reagents as previously described(45). We chose to examine cells at the 
initiation of sporulation (t0), and three hours after the initiation of sporulation (t3) 
because this would give us information about stationary phase as well as sporulation. 
Indeed, using these methods we identified 2837 proteins (Supplemental Data), a large 
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proportion of the 4100 theoretical B. subtilis proteins, as compared to the 762 proteins 
identified in Fig. 3.2A. We detected all of the bacillithiol transferases except for BstF 
and BstH during both time points (Fig. 3.2B). We also detected all four bacillithiol 
biosynthesis genes, the three confirmed and putative bacilliredoxins, and the putative 
bacilliredoxin reductase YpdA. Notably, BstA and BstE expression increased almost 
3-fold during sporulation.  
We further examined expression of the bacillithiol transferases by using GFP 
reporter constructs to determine if the proteins were expressed uniformly in cells 
within the population and to see if we could detect expression of BstF and BstH.  Our 
mass spectrometry analysis suggested that some of these proteins were induced during 
sporulation, and we were therefore also interested in determining if they were 
expressed in the vegetative or the sporulating cells in these cultures, and if the latter, if 
induction was occurring in a cell specific manner. We therefore constructed strains 
containing fusions of the promoters for each of the eight bacillithiol transferase genes 
(bstA-H), to superfolder green fluorescent protein (sfGFP) and monitored the cells 
during growth and sporulation using fluorescence microscopy. We were able to detect 
expression of all of the bst genes except bstF and bstH immediately after the initiation 
of sporulation by resuspension (t0, Fig. 3.3A) at levels similar to that seen in stationary 
phase cells (data not shown). The bstB and bstE genes were expressed at the highest 
levels, and most cells showed similar levels of expression. The other genes were 
expressed at lower levels, with substantial cell-to-cell variability. Many bst genes were 
also expressed during sporulation, and several appeared to be substantially upregulated  
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Figure 3.2: Mass spectrometry analysis of the expression of the bacillithiol 
transferases and bacillithiol-related proteins during growth and sporulation. 
Blue: bacillithiol transferases, red: bacillithiol-related proteins, green: sporulation 
specific proteins. A) Bar graph depicting the adjusted spectral counts of the bacillithiol 
transferases and bacillithiol-related proteins relative to other proteins detected in an 
LC-MS/MS analysis. Protein levels were assessed during exponential phase (Exp, 
OD600=0.4), stationary phase (Stat, OD600=4.0), at the initiation of sporulation (t0), and 
3h after the induction of sporulation (t3). Total spectral counts for all proteins sum to 
1, and the spectral counts for these proteins were multiplied by 104 for ease of 
visualization. B) Bar graph depicting results from a parallel protein extract. Peptides 
prepared from PY79 was separated by high pH reverse phase HPLC, fractionated and 
recombined to produce 10 individual injections of tandem mass tag (TMT, isobaric tag 
analysis). The protein levels of the bacillithiol transferases and bacillithiol-related 
proteins were analyzed 0h after the induction of sporulation (t0) and 3h after the 
induction of sporulation (t3). Signal to noise values of the reporter ions were used for 
quantitation.   
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in the larger mother cell during sporulation, including bstB, bstD, bstE, and bstF.  In 
some of these strains, low levels of GFP expression were also seen in some vegetative 
cells (Fig. 3.3A bstB and bstE, arrowheads). Some genes, such as bstA, bstC, bstG, 
and bstH, were expressed in both vegetative and sporulating cells, in most cases with 
substantial heterogeneity in expression levels in both cell types.   
To more readily compare GFP intensity and gene expression across strains and 
time points, the GFP intensity was adjusted in an identical manner relative to the 
brightest strain and timepoint (bstB at t6) for images collected with the same exposure 
time (Fig. 3.3B).  This indicated that of the eight genes, bstB and bstE showed the 
highest expression, and that they were induced in the mother cells of sporangia at t3 
and t6 of sporulation. Using these adjustment methods, GFP from the other genes 
could not be detected. Quantification of bstB and bstE expression at t3 (as described in 
Materials and Methods) revealed that expression of PbstB-GFP and PbstE-GFP was 30-
50x higher in the mother cell than background. Similar results were obtained with 
BstB-GFP and BstE-GFP protein fusions (data not shown). Thus, of the eight bst 
genes, low and often heterogeneous levels of expression was detected in vegetative 
cells and in the mother cell of sporulating cells for several proteins, with high mother 
cell specific expression observed for the two most highly expressed bst genes, bstB 
and bstE. Together, our mass spectrometry and microscopy data show that all of the 
bacillithiol transferases are produced to variable levels under at least one condition 
during growth and sporulation, although most are expressed at substantially lower 
levels than bstB and bstE.  
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Figure 3.3: Expression patterns of the bst genes during sporulation. Fluorescence 
microscopy of the eight bst promoter fusions to sfGFP during exponential growth (t0), 
3 hours (t3) and 6 hours (t6) after induction of sporulation by resuspension. Cell 
membranes are stained with FM 4-64 (red) and the DNA with DAPI (blue; not 
shown). Phase images are shown to visualize cells that are late in the sporulation 
pathway and contain phase bright forespores.  A) Micrographs of the 8 promoters 
fusions. GFP intensities for each strain and timepoint were adjusted individualy to 
determine which genes were expressed under all conditions. Arrowheads show PbstB-
sfGFP and PbstE-sfGFP expression in vegetative cells.  B) Micrographs from Fig. 3.3A 
with the GFP intensity at each panel adjusted to the brightest GFP (PbstB-sfGFP at t6) to 
illustrate the relative levels of gene expression. Phase images are shown for t6 images 
to allow visualization of phase bright intracellular spores at late stages of 
development.  
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Bacillithiol, bacillithiol transferases, and bacilliredoxins are not essential for 
sporulation  
We next tested if bacillithiol and the bacillithiol transferases are required for 
sporulation, as suggested by the above results. To test this hypothesis, spore titers 
were determined by enumerating the number of heat resistant colony forming units per 
mL after 24 hours growth in DSM for the wild type strain PY79, ΔbshA, ΔbshC, 
ΔbstA-H, and Δspo0A. We also constructed a strain deficient in the confirmed 
bacilliredoxins brxA and brxB and the putative bacilliredoxin ytxJ, hereafter referred 
to as ΔbrxAΔbrxBΔytxJ, to assess the role of bacilliredoxins in spore formation and 
germination. The ΔbshA and ΔbshC mutants were included to assess the role of 
bacillithiol in sporulation. We included two sporulation defective control strains, 
Δspo0A which is defective in biofilm formation and early sporulation specific gene 
expression, and ΔsigH, an alternative sigma factor that directs the transcription of 
genes that function during the transition from exponential growth to stationary phase. 
We found that the ΔbshA, ΔbshC, ΔbstA-H, ΔbrxAΔbrxBΔytxJ, and wild type strains 
produced similar number of heat resistant spores (Table 3.2). This is in contrast to a 
previous report that deleting bshA causes a 100-fold reduction in spore titer (15), 
which could be due to differences in strains used. We also monitored the timing of 
engulfment and germination for the ΔbshA, ΔbshC and ΔbstA-H strains using 
microscopy, and both processes appeared to occur normally (data not shown). To test 
for more subtle defects in spore assembly or function, we tested the ΔbshC and ΔbstA-
H spores for resistance to oxidants, lysozyme, ethanol, etc. finding them to be as  
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Table 3.2: Spore titers of 
relevant strains  
Strain Spore titer (cfu mL-1)a 
PY79 2.6 x 108 
Δspo0A ≤102 
ΔsigH ≤102 
ΔbshA 2.3 x 108 
ΔbshC 2.2 x 108 
ΔbstA-H 1.2 x 108 
ΔbrxAΔbrxBΔytxJ 1.9 x 108 
aTiters were determined as 
described in the “Materials and 
Methods.” The values shown are 
averages of at least two 
experiments. All mutant strains are 
in a PY79 background.  
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resistant as wild type (Table S3.5). Thus, there is no apparent change in the assembly 
or durability of the mutant ΔbshC and ΔbstA-H spores, indicating that the integrity of 
thespore coat and the dehydration of the spore appear to remain uncompromised in the 
absence of bacillithiol and all eight identified bacillithiol transferases in the STL 
superfamily. Thus, it remains unclear why these proteins are expressed to in 
sporulating cells. 
 
Identification of S-bacillithiolated proteins during growth and sporulation 
It is possible that the bacillithiol transferases might be involved in the S-
bacillithiolation of proteins that has been observed in B. subtilis during oxidative stress 
and non-stress conditions(16, 17). In order to detect S-bacillithiolation of proteins 
during growth and sporulation, we generated an anti-bacillithiol polyclonal antibody 
and affinity purified the immune serum to remove non-specific antibodies that reacted 
with ΔbshC mutant lysate (Fig. S3.4 and Materials and Methods). B. subtilis lysates 
were prepared from cells during exponential growth (OD600=0.4), stationary phase 
(OD600=4.0), the initiation of sporulation (t0), and three hours after the initiation of 
sporulation (t3). Exponential and stationary phase lysates were prepared from wild 
type PY79, ΔbshC mutant, ΔbstA-H mutant, and ΔsigH mutant, while t0 and t3 lysates 
were prepared from PY79, ΔbshC mutant, ΔbstA-H mutant, and Δspo0A mutant. 
Mutants in ΔsigH, which regulates gene expression during the transition from 
exponential growth to stationary phase, and Δspo0A, the master regulator of 
sporulation, served as controls to assist in the identification of stationary phase-
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specific and sporulation-specific bacillithiolated proteins.  The ΔbshC mutant served 
as a negative control. As expected, the ΔbshC mutant completely lacked bands 
corresponding to bacillithiolated proteins, indicating that the affinity-purified antibody 
is specific for bacillithiol. A variety of reactive products were observed in the other 
strains at various times during growth and sporulation. However, no major differences 
were detected between PY79 and the ΔbstA-H mutant indicating that the protein S-
bacillithiolation detected here did not depend on the eight bacillithiol transferases 
identified so far.  
Sporulating cultures showed an increase in abundance of a high MW S-
bacillithiolated protein in the laboratory strain PY79 (Fig. 3.4D, asterisks). This band 
appeared in lysates from wild type and ΔbstA-H and was faint in lysate prepared from 
Δspo0A, indicating that expression or modification of the protein required the Spo0A 
transcription factor, which controls the expression of proteins required for biofilm 
formation and the onset of sporulation. We excised the high molecular weight band 
from a Coomassie Blue stained gel and performed mass spectrometry analysis, and 
found that it was comprised of SrfAA and SrfAB, two proteins involved in the 
biosynthesis of the metabolite surfactin. Mass spectrometry identified a S-
bacillithiolated peptide of identical amino acid sequence to both SrfAA or SrfAB (Fig. 
S3.5), homologous proteins that share regions of identical sequence. However, 
because PY79 is an sfp0 strain and does not produce surfactin, we decided to check the 
wild strain B. subtilis 3610. We found that protein levels of SrfAA/AB, as assessed by 
the Coomassie stain gel, were reduced and the intensity of the S-bacillithiolation signal  
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Figure 3.4: S-bacillithiolation occurs during different stages of growth in B. 
subtilis. All samples were analyzed on non-reducing SDS PAGE gels. For each 
sample, two gels were analyzed in parallel, with one gel stained for total protein using 
Coomassie Blue, and the other gel used for immunoblot analysis using affinity 
purified α-bacillithiol antibody to detect protein S-bacillithiolations. Cells were 
iodoacetamide-alkylated during harvest to avoid random S-bacillithiolation during 
processing (see Materials and Methods). Total loaded protein in each lane is 5 µg.  A) 
Coomassie stained gel of PY79, ΔbshC, ΔbstA-H, and ΔsigH strains during 
exponential (Exp, OD=0.4) and stationary phase (Stat, OD=4.0). B) Immunoblot of 
PY79, ΔbshC, ΔbstA-H, and ΔsigH strains during exponential and stationary phase.  
C) Coomassie stained gel of PY79, ΔbshC, ΔbstA-H, and Δspo0A at 0h and 3h after 
induction of sporulation by resuspension (t0 and t3).  D) Immunoblot of PY79, ΔbshC, 
ΔbstA-H, and Δspo0A at 0h and 3h after induction of sporulation by resuspension. 
Asterisks indicate S-bacillithiolated SrfAA and/or SrfAB.   
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was reduced as well in t3 samples (Fig. S3.6) compared to the t3 samples of PY79 (Fig. 
3.4C&D). The role of this modification remains unclear.  
Our mass spectrometry analysis showed that several bacillithiol-related 
proteins are expressed during growth and sporulation, including the bacilliredoxins 
BrxA, BrxB, and the putative bacilliredoxin YtxJ. Bacilliredoxins, which catalyze the 
reduction of S-bacillithiolated proteins, are induced and are active during NaOCl 
stress(16, 46). Thus, we hypothesized that the ΔbrxAΔbrxBΔytxJ triple mutant might 
show an alteration in protein S-bacillithiolation, perhaps with additional bands 
compared to wild type. However, western blot analysis of lysate prepared from a 
ΔbrxAΔbrxBΔytxJ mutant showed a level and pattern of protein S-bacillithiolation 
similar to PY79 and the ΔbstA-H mutant (data not shown). These results indicate that a 
variety of proteins are S-bacillithiolated in both growing and sporulating cells, even in 
the absence of stress, although this does not depend on the bacillithiol transferases or 
the bacilliredoxins. 
 
Mass spectrometry analysis identifies S-bacillithiolated proteins under physiological 
conditions 
  We next sought to identify the proteins that were subject to S-bacillithiolation. 
There was extensive overlap in the S-bacillithiolation patterns during growth, 
stationary phase and sporulation, so we chose to study the t0 and t3 sporulation samples 
to gain information about stationary phase as well as sporulation. Whole cell lysates 
were prepared from wild type PY79 and the ΔbshC strain, which served as a negative 
control, digested by trypsin and subjected to mass spectrometry analysis. The resulting 
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mass spectrometry data was queried for modifications of cysteine with bacillithiol 
(+396.08387 Da) and the cysteine blocking agent iodoacetamide (+57.02146 Da), 
which was added during lysis to prevent spontaneous disulfide bond and bacillithiol 
adduct formation to reduced cysteines.  In total, we found six high confidence S-
bacillithiolated peptides (Table 3.3, Fig. 3.S7-12) in the PY79 samples from DhbB 
(isochorismatase), TpiA (triosephosphate isomerase), GlpX (fructose-1,6-
bisphosphatase), DeoD (purine nucleoside phosphorylase), PpaC (manganese-
dependent inorganic pyrophosphatase), and GuaB (inosine-5'-monophosphate 
dehydrogenase), and no S-bacillithiolated peptides in the ΔbshC samples.  These 
peptides were found in both growing cells and sporulation. Interestingly, bacillithiol  
modifications of GuaB and PpaC were found on non-active site residues different  
from the residues previously shown to be bacillithiolated under NaOCl stress (16, 17).   
These types of posttranslational modifications can activate, inactivate, or 
modulate protein activity. We selected DhbB, which is involved in biosynthesis of the 
iron chelating siderophore bacillibactin, to begin to evaluate the effect of the S-
bacillithiolation modification.  Bacillithiol plays a role in Fe(S) cluster biogenesis(18, 
19) and there might be possible cross-talk between bacillithiol and iron 
acquisition/utilization. The catecholic siderophore bacillibactin is a cyclized trilactone 
(DHB-glycine-threonine)3 and is synthesized by the dhbACEBF operon. Bacillibactin 
production requires the phosphopantetheinyl transferase Sfp for the posttranslational 
activation of DhbB and DhbF. The sfp0 strain PY79 strain only produces 2,3-
dihydroxybenzoic acid (DHB) and the glycine conjugate DHB-Gly, which are both 
precursors of bacillibactin and are weak iron chelators. It is possible that S-
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Table 3.3: Identification of S-bacillithiolated proteins in 
growing cells and t3 of sporulation 
Protein/Description Functiona 
Modified 
cysteine 
residue 
DhbB/Isochorismatase Bacillibactin biosynthesis  C67 
TpiA/Triosephosphate 
isomerase 
Glycolysis/ 
gluconeogenesis C41 
GlpX/Fructose-1,6-
bisphosphatase class 2 Gluconeogenesis C132 
DeoD/Purine nucleoside 
phosphorylase 
Metabolism of 
nucleotides and 
nucleic acids 
C128 
PpaC/Manganese-
dependent inorganic 
pyrophosphataseb 
Metabolism of 
phosphate C18 
GuaB/Inosine-5'-
monophosphate 
dehydrogenasec 
Metabolism of 
nucleotides and 
nucleic acids 
C327 
All modifications were found in both phases of growth. No 
modified proteins were found in the ΔbshC mutant controls. 
aBiological pathway information recorded from 
http://genolist.pasteur.fr/SubtiList/ 
bCys158 of PpaC is S-bacillithiolated during NaOCl stress(Chi et 
al 2011) 
cCys308 of GuaB is S-bacillithiolated during NaOCl stress (Chi et 
al 2011) 
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bacillithiolation of DhbB in wild strains such as B. subtilis 3610 could affect 
production of the siderophore bacillibactin and bacillibactin intermediates DHB, 
DHB-Gly, and the linear monomer DHB-Gly-Thr. To compare production of 
bacillibactin and its intermediates between 3610, PY79, and the ΔbshC mutants in the 
two strain backgrounds, all four strains were cultured in liquid iron-limiting medium, 
and the supernatant of each culture was extracted with the organic solvent ethyl 
acetate as previously described(47-49). The crude extracts were subjected to HPLC 
analysis (Fig. S3.13), and the resulting peaks were collected and submitted for mass 
spectrometry analysis to identify bacillibactin and the bacillibactin intermediates. 
From this analysis we identified the peaks corresponding to DHB, bacillibactin, the 
linear trilactone (DHB-Gly-Thr)3, and the DHB-Gly-Thr monomer, (Fig. S3.14 and 
S15). Some of the products observed were acid hydrolysis products formed as a result 
of crude extract preparation and sample preparation for mass spectrometry, so we used 
only the intact bacillibactin and DHB for quantification and comparison between 
strains. The peaks areas of DHB and bacillibactin were used to estimate the 
concentration of each product using a standard curve of commercial DHB (Fig. 
S3.16). This analysis showed no difference in the levels of DHB between PY79 and 
ΔbshC in a PY79 background. Furthermore, bacillibactin levels were found to be the 
same in 3610 and ΔbshC mutant in a 3610 background (Table S3.6). Thus, it is 
unclear how the S-bacillithiolation modification affects DhbB and the other five 
modifications identified in our mass spectrometry analysis.  
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Discussion 
The STL superfamily of thiol transferases is a large, divergent family of 
enzymes that are related by structural rather than sequence similarity. Most of the STL 
bacillithiol transferases encoded in Bacillus subtilis share less than 30% sequence 
similarity and would not be considered to be part of the same family. Yet, we here 
demonstrate that each of the predicted STL enzymes(22) is active to varying degrees 
with the model substrate monochlorobimane. Our data indicates that like S. aureus 
BstA(23), these enzymes are active with bacillithiol, but not with cysteine or 
Coenzyme A, and that they are metalloenzymes. The lowest activity was observed for 
BstF, BstG and BstH, while BstB and BstD showed a very high enzymatic activity 
under the conditions used here. We have therefore renamed the enzymes according to 
the STL nomenclature used previously in order to avoid confusion with the old 
DinB/YfiT-like nomenclature(23).  It is possible that the lower activity of some of 
these enzymes is due to the use of the incorrect metal cofactor, inclusion of the His6 
tag (50), or a mismatch between the active site and monochlorobimane.  
Phylogenetic analysis shows that none of the eight bacillithiol transferases 
encoded by B. subtilis 168 are part of the core genome (31), although seven are found 
in four related B. subtilis strains. Two strains do not encode BstH/YizA, while 
Bacillus subtilis subsp. spizizenii TU-B-10 which is an environmental strain isolated 
from Nefta, Tunisia(51), encodes an additional bacillithiol transferase that is not 
encoded in the other B. subtilis strains. Interestingly, this enzyme is found in 
Jeotgalibacillus marinus, which is a marine strain that is also found in the traditional 
Korean food jeotgal(52, 53). When the phylogenetic analysis is expanded to include 
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other Bacillus species, we find an even greater diversity of STL enzymes. We find 
many homologs of the B. subtilis enzymes are conserved in other strains, however 
different species encode different homologs. The homologs that seem to be the most 
variable are BstC, which is not found in B. anthracis, B. halodurans. B. megaterium, 
or B. thuringiensis, BstD, which is not found in B. anthracis, B. halodurans,  or B. 
thuringiensis, and BstF, which is not found in Bacillus megaterium. Like B. subtilis, 
B. amyloliquefaciens encodes a total of eight STL enzymes, but one enzyme does not 
share homology with any of the B. subtilis STL bacillithiol transferases. B. 
halodurans, B. anthracis, B. thuringiensis, and B. megaterium encode four, eight, 
eleven, and six additional STL enzymes, respectively. Thus, different strains and 
species show variability in their suite of putative bacillitiol transferases.     
Currently the natural substrates of any of the B. subtilis bacillithiol transferases 
are unknown. However, recent studies show two mycothiol transferases in the STL 
family are involved in the biosynthesis, rather than the detoxification, of secondary 
metabolites, which is a new and interesting role for thiol transferases. The STL 
superfamily member LmbV transfers mycothiol to a precursor molecule during 
lincomycin A biosynthesis in Streptomyces lincolnensis, incorporating the sulfur of 
mycothiol into the final Lincomycin A molecule (13). Additionally, the STL 
superfamily enzyme EgtB was determined to catalyze the transfer of γ-glutamyl 
cysteine to N-α-trimethyl histidine during ergothioneine biosynthesis in 
Mycobacterium thermoresistibile(14). In both cases, the authors note that the STL 
mycothiol transferases contain two Pfam domains: the first being the DinB domain 
responsible for thiol transfer, the second being a domain with a different function. This 
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second domain most likely drives the specificity toward the non-thiol co-substrate. 
Characterization of the second domain could aid in the quest to find the natural 
substrates of multi-domain thiol transferses. In the case of the eight B. subtilis STL 
bacillithiol transferases, however, each enzyme contains only a single DinB domain. 
Thus, a different strategy must be used to identify the natural substrates of these 
enzymes.  
To begin the task of identifying physiological roles and natural substrates of 
the bacillithiol transferases, we took three different approaches. First, we took a 
candidate approach in which we tested the sensitivity of the ΔbstA-H mutant lacking 
all members of the STL family to molecules that bacillithiol-deficient strains are 
sensitive to in nutrient rich and nutrient limiting media. We assessed sensitivity in 
MIC format, where growth is assessed 24 hours after inoculation, and in growth 
curves, where growth is monitored from the time of inoculation through stationary 
phase. In both cases we found no molecules that ΔbstA-H is sensitive to and in fact, 
determined that growth of the ΔbshC mutant was not as severely reduced by stressors 
as previously reported (16, 34), with the exception of fosfomycin. The reasons for this 
discrepancy is unclear, but may be due to differences in the levels of trace metals or 
other components in the media, or in the different strains used. Thus, we were unable 
to find a growth defect associated with the absence of the bacillithiol transferases, in 
the presence or absence of various stressors.  
In the second approach, we monitored bst gene expression during different 
phases of B. subtilis growth and development, hypothesizing that they might mediate 
resistance to endogenous toxins and oxidants that are produced during different phases 
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of growth. We used GFP fusions and two complementary mass spectrometry methods 
to look for expression of bacillithiol transferases during vegetative growth and 
sporulation.  Using mass spectrometry, we were able to demonstrate expression of all 
bacillithiol transferases except BstF and BstH, the bacillithiol biosynthesis proteins, 
and the confirmed and putative bacilliredoxins during growth and sporulation.  We 
also used GFP reporter strains to visualize the spatial and temporal expression of bst 
promoter fusions to GFP during growth and sporulation. Using this method, we 
determined that six of the bst genes are expressed at variable and low levels at during 
growth, and that all eight bst genes are expressed during sporulation. Several of the 
promoters are induced in the mother cell, with very high mother cell specific 
expression of bstB and bstE.  Further studies are necessary to determine the role of this 
mother cell specific expression, but it is possible that the bacillithiol transferases 
contribute to mother cell specific processes, such as assembly or modification of the 
proteinaceous spore coat, or that they protect the developing spore from exogenous 
toxins and oxidants.   
In the third and final approach, we used mass spectrometry analysis and 
western blots with bacillithiol-specific antibodies to monitor the S-bacillithiolation of 
proteins during exponential phase, stationary phase, and sporulation. We hypothesized 
that the bacillithiol transferases may catalyze S-bacillithiolation of proteins. However, 
we found no changes in the S-bacillithiolation pattern using 1D SDS PAGE analysis 
during the different phases of growth and development, including sporulation, and the 
mutant lacking all eight bacillithiol transferases showed no detectable changes in S-
bacillithiolation. It has previously been demonstrated that S-bacillithiolation occurs 
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during oxidative stress and other stress responses, so it would be interesting to 
determine if the bacillithiol transferases play a role in protein S-bacillithiolation during 
stress.  
We used two approaches to identify S-bacillithiolated proteins. Using in 
solution digest of crude protein extracts and mass spectrometry analysis, we identified 
six proteins involved in various steps in metabolism that are modified during 
stationary phase and sporulation (Table 3.3). We also used identified S-bacillithiolated 
proteins via western blots, excised the bands and used mass spectrometry to identify 
the bacillithiolated peptides. This approach identified a bacillithiolated peptide that is 
of identical sequence in SrfAA and SrfAB, two proteins involved in surfactin 
biosynthesis. The significance of this modification is unclear.  Our mass spectrometry 
analysis likely identified only a subset of the population of S-bacillithiolated proteins, 
due to the high complexity of whole cell lysate samples and the low abundance of the 
modifications; indeed our western blot analysis suggests that there are many S-
bacillithiolated proteins.   
Among the proteins identified, two were previously shown to be modified 
under NaOCl stress, PpaC and GuaB (16, 17). Interestingly, we found that these 
proteins are modified on different residues from the active site residues found to be 
modified during NaOCl stress(16, 17). It has previously been shown that S-
bacillithiolation during oxidative stress inactivates proteins and protects cysteine 
residues until after the intracellular oxidant is neutralized and/or detoxified(16, 17). 
Thus, it is possible that the modifications observed during growth are involved in 
modulating the activity of the protein, while the modifications observed under NaOCl 
  
134 
!
stress inactivate the protein.  Interestingly, we found that SrfAA and/or SrfAB and 
DhbB were modified even though the strain we used in our studies does not produce 
the metabolites that these enzymes synthesize. It is possible that S-bacillithiolation 
might serve as a way to allosterically regulate these enzymes, in the case that the 
active site is not occupied by substrates. Additional studies will be required to 
determine how the S-bacillithiolation of these enzymes affects their activity. 
The genomic context of the genes encoding the bacillithiol ttransferases may 
also provide information about the physiological roles and the natural substrates for 
these enzymes. Many of the genes in the vicinity of the bacillithiol transferases are 
involved in efflux and transcription, suggesting a possible role for some enzymes in 
detoxification of specific molecules (Fig. 3.5). Prior studies have demonstrated that 
after bacillithiol is conjugated to the target substrate, a bacillithiol conjugate amidase 
hydrolyzes the bacillithiol, and that an N-acetyltransferase in the GNAT family 
transfers acetyl to the resulting cysteine to form a mercapturic acid adduct, which exits 
the cell via passive diffusion or transport(22, 34, 54-56). BshB2 has been shown to 
have bacillithiol conjugate amidase activity in B. anthracis and S. aureus (23, 34, 56), 
but the N-acetyltransferases and efflux pumps have yet to be identified. Interestingly, 
several genes encoding proteins with sequence similarity to the GNAT family of N-
acetyltransferases and efflux transporters are found in close proximity to bst genes, 
including yisL and vlmR, which are found next to each other. Other interesting genes 
in the vicinity include a wide array of transcription factors that might provide insight 
into bacillithiol expression and yisP, which encodes a farnesyl diphosphate 
phosphatase involved in the synthesis of squalene. Farnesol, the product of YisP, 
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contributes to biofilm formation in B. subtilis and modifies lipid bilayer structure to 
convey oxidative resistance much like the S. aureus virulence factor 
staphyloxanthin(57). Staphyloxanthin biosynthetic genes are upregulated during thiol 
stress in a bacillithiol deficient mutant of S. aureus, although staphyloxanthin levels 
are the same in the different strains(58). Thus, it would be interesting to see if 
bacillithiol affects biofilm formation and membrane integrity in Bacillus subtilis.  
Our studies have confirmed the activity of a new superfamily of bacillithiol 
transferases encoded in Bacillus subtilis. We show that these enzymes are extremely 
divergent in sequence and display a wide range of biochemical activity. The high level 
of divergence among the B. subtilis bacillithiol transferases suggests that they are 
under selective pressure, perhaps to cope with an equally diverse array of endogenous 
and/or exogenous toxic metabolites and oxidants. Indeed additional characterization 
studies of the enzymes are needed to determine the physiological roles of these 
enzymes. Given the data presented here, we believe stationary phase and sporulation 
might be appropriate places to start. Lastly, we explored basal levels of S-
bacillithiolation present under non-stress, physiological conditions and the potential 
implications these modifications have on protein activity and/or protein-protein 
interactions. Further studies on the impact of these modifications during growth and 
sporulation are necessary.   
 
MATERIALS AND METHODS 
Strains and culture conditions  
All the strains used in this study are derivatives of B. subtilis PY79, except for 
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the siderophore studies, which included B. subtilis NCIB 3610. The ΔbshC mutant in a 
B. subtilis NCIB 3610 background was produced by SPP1 phage-mediated 
transduction(59). The B. subtilis strain KP1302 was used for cloning purposes only. 
Plasmid constructions were performed in E. coli Top10. Sporulation was induced by 
growing cells in ¼ LB and re-suspension (60, 61) at 37°C. All cultures were grown in 
LB medium or Spizizen’s minimal medium at 37°C. Spizizen’s minimal medium was 
supplemented 0.05% casamino acids (Difco) and 1x trace metal solution was added 
(100x trace metal solution contains 62 mM MgCl2, 5 mM CaCl2, 1.3 mM ZnCl2, 500 
µM MnCl2, 250 µM CuCl2, 460 µM CoCl2, 250µM Na2MoO4). Metals were 
purchased from Sigma Aldrich and Fisher Scientific.  
 
Plasmid and strain construction  
A list of plasmids, strains and oligonucleotides used in this study can be found 
in Tables S3.7-S3.9. All strains were constructed using Gibson Assembly (Synthetic 
Genomics, Inc, (62, 63)). Either Velocity (Bioline) or Phusion (NEB) DNA 
polymerase was used to PCR amplify all fragments. The integration vector pDG1730 
(64) was used to insert the promoter region (>400 base pairs upstream of the gene) of 
each bst fused to the sfGFP gene at the amyE locus for the bacillithiol transferase 
promoter fusion strains. After strain construction, sequencing was performed to ensure 
that mutations had not been introduced into the fragments.  
For all deletion strains, the backbone, an antibiotic cassette, the region 
upstream of the gene and the region downstream of the gene were assembled to form 
the final plasmid. The backbone was amplified from pJLG38(65), which contains a 
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kanamycin cassette flanked by loxP sites. Different versions of this plasmid replacing 
the kanamycin cassette with chloramphenicol, erythromycin, tetracycline, and 
spectinomycin were constructed (Table S3.7, S3.8). The chloramphenicol, 
spectinomycin, and erythromycin antibiotic markers for the deletion strains were 
amplified from integration vectors obtained from the Bacillus Genetic Stock Center 
(http://bgsc.org), while the tetracycline marker was amplified from the Bacillus 
megaterium vector pWH1520 (http://www.mobitec.com). The loxP sites flanking each 
gene were arranged in the same orientation to avoid Cre-mediated inversions in the 
genome (yfiT, yuaE, and ykkA are in the opposite orientation of the other bst genes). 
Single mutants were confirmed by sequencing to ensure that mutations had not been 
introduced into the fragments. The ΔbstA-H mutant was constructed by consecutively 
transforming single bst mutants, each with their antibiotic marker flanked by loxP 
sites, into PY79. The strain EBS42, which contains cre under the control of SpoIIR, 
was used to remove antibiotic resistance markers. Marker removal was performed by 
sporulating cells overnight at 37°C in DSM, heating the culture for 20 min at 80°C to 
kill vegetative cells, and plating cells out on LB. Cells were patched on antibiotic 
plates to check for the loss of antibiotic resistance, and each strain was tested by PCR 
to confirm the absence of the markers. After deleting dinB, yizA, yrdA, yuaE, yfiT, and 
ykkA, the sacA locus was restored by transforming a plasmid containing the intact 
sacA gene linked to a tet marker. We selected on tetracycline plates the next day and 
patched cells on spectinomycin plates to check for the loss of spectinomycin 
resistance. The final two bst mutants ΔyisT::loxP-cm-loxP and ΔyjoA::loxP-spec-loxP 
were transformed to form the final ΔbstA-H mutant.  
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Phylogenetic analysis 
The first phylogenetic tree contains STL superfamily members from five 
different strains of Bacillus subtilis: the parent strain of PY79 B. subtilis 168 
(NC_000964.3), B. subtilis subsp. natto BEST195 (NC_017196.2), B. subtilis subsp. 
spizizenii TU-B-10 (NC_016047.1), B. subtilis subsp. spizizenii str. W23  
(NC_014479.1), B. subtilis subsp. subtilis str. RO-NN-1  (NC_017195.1). See Table 
S3.1 for additional information on the individual proteins found in each strain. The 
second tree contains STL superfamily members from other Bacillus species, including 
B. subtilis 168 FosB, B. subtilis 168 proteins B. megaterium QM B1551 proteins, B. 
amyloliquefaciens subsp. plantarum str. FZB42 proteins, Bacillus halodurans C-125 
proteins, Bacillus anthracis str. Ames, Bacillus thuringiensis str. Al Hakam. See Table 
S3.2 for additional information. 
ClustalX was used to align sequences using the PAM series and to construct 
phylogenetic trees. Trees were generated by the neighbor-joining clustering method 
with 1000 bootstrap trials and were visualized using FigTree v1.4.0 
(http://tree.bio.ed.ac.uk/software/figtree/). B. subtilis FosB was used as an outgroup in 
both trees. Similar trees were obtained regardless of the method used. 
 
Bacillithiol transferase recombinant protein cloning, purification, and assessment of 
biochemical activity  
The protein sequences of the putative B. subtilis bacillithiol transferases YuaE, 
YisT, YjoA, YrdA, YkkA, DinB, and YizA were codon optimized for expression in E. 
coli and synthesized by GenScript (Piscataway, New Jersey, USA) and cloned into the 
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pET28a+ expression vector to append the N-terminal His6 tag sequence to the bst 
sequences, giving a total of 20 additional amino acids at the N-terminus (Genscript, 
New Jersey). As was the case for S. aureus BstA, the recombinant proteins appeared 
to be toxic to many commercial E. coli expression hosts, including BL21(DE3), and it 
produced inclusion bodies after induction with IPTG. We therefore expressed the 
proteins in E. coli strain C41(DE3), which was selected to allow expression of toxic 
proteins(66). One liter of Luria Broth containing kanamycin (50 µg/mL) was 
inoculated with cells and grown to late exponential phase. Cells were induced with 1 
mM IPTG for 3 hours at 30°C, and cells were lysed and the proteins were purified on 
a Zn2+ resin as previously described(23). Protein concentration was estimated using 
the following extinction coefficients (assuming all cysteine residues are reduced): 
BstB= 0.776 mg mL− 1, BstC= 1.334 mg mL− 1, BstD= 0.373 mg mL− 1, BstE= 1.517 
mg mL− 1, BstF= 1.608 mg mL− 1, BstG= 1.106 mg mL− 1, and BstH= 2.0 mg mL− 1 
(ExPASy ProtParam tool; http://ca.expasy.org). The purified proteins were analyzed 
on an SDS PAGE gel (Fig. S3.2). Proteins were analyzed on BOLT 4-12% Bis-Tris 
SDS PAGE gels using BOLT MES SDS running buffer (Invitrogen; Fig. S3.2). The 
protein standard used was SeeBlue Plus 2 Pre-stained ladder (Thermo Fisher 
Scientific, myosin: 198 kDa, phosphorylase: 98 kDa, BSA: 62 kDa, glutamic 
dehydrogenase: 49 kDa, alcohol dehydrogenase: 38 kDa, carbonic anhydrase: 28 kDa, 
myoglobin red: 17 kDa, lysozyme 14, aprotinin: 6 kDa, and insulin, B chain: 3 kDa). 
Purified proteins were sequenced by the University of California, San Diego 
Biomolecular and Proteomics Mass Spectrometry Facility (Table S3.3).  
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Biochemical activity was determined with the model substrate 
monochlorobimane (Thermo Fisher Scientific) as previously described (22, 23, 67). 
Briefly, reactions were performed in 0.1 M NaCl, 25 mM NaPO4, 5% glycerol, 
pH=7.0 at 23°C with 50 µM thiol and 50 µM monochlorobimane. The following 
amounts of protein were used for assays with bacillithiol alone:  with the following 
amounts of protein: BstB: 0.1 µg, BstC: 0.1 µg, BstD: 0.2 µg, BstE: 0.5 µg, BstF: 0.8 
µg, BstG: 0.5 µg, BstH: 0.8 µg.  Reactions with cysteine, CoA, and bacillithiol + 
EDTA were performed with 1 mg of each enzyme. Samples were taken every 5, 10, 
and 20 minutes, and 15 µL samples were quenched in 55 µL 40 mM methanesulfonic 
acid. HPLC analysis was performed using a 4.6 x 250 mm Beckman Ultrasphere IP 
C18 column with a linear gradient of 0% of solvent A (0.25% acetic acid, pH=4.0) to 
100% of solvent B (MeOH) over 35 minutes.  To determine the metal ion dependence 
of the enzymes, a solution of enzyme and 1 mM EDTA was incubated in assay buffer 
for 5 minutes prior to the addition of bacillithiol and monochlorobimane.  
 
Minimal Inhibitory Concentration (MIC) Determination and Growth Curves 
Minimum inhibitory concentration (MIC) assays in LB were performed by 
growing cultures to an OD600 of 0.35–0.5 and diluting cells to 5 × 107 CFU/mL in LB. 
Either LB medium or Spizizen’s minimal medium supplemented with 0.5% casamino 
acids and 1x trace metals were used in MIC assays, while growth curves were 
performed in Spizizen’s minimal medium only. For MIC assays in LB medium media, 
cells were grown in LB to OD600 of 0.35–0.5, diluted 1:10, and 10 µL of cells were 
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diluted 1:10 into a 96-well plate containing different concentrations of each antibiotic. 
For MIC and growth curve assays in minimal medium, cells were grown in LB to 
OD600 of 0.35–0.5, washed in minimal medium twice, and re-suspended to OD600=1.0, 
diluted 1:10, and 10 µL of cells were diluted 1:10 into a 96-well plate containing 
different concentrations of each antibiotic. MIC results were obtained after 24 h 
incubation at 30°C for LB and 37°C for minimal medium. Plates for growth curves 
were incubated at 37°C with rotatory shaking and growth was monitored at OD600 
using an Infinite 200 plate reader from Tecan. Dilutions showing hindered ΔbshC 
mutant growth were selected for analysis. MIC values reported and growth curves 
shown were calculated from the mean of triplicates (n = 3). 
 
Fluorescence microscopy data acquisition and analysis  
Samples of sporulating cultures were taken for imaging at the initiation of 
sporulation (t0), and 3 hours (t3), and six hours (t6) after the induction of sporulation. 
Eight microliters of cells were added to 2 microliters of a stain mix containing 
30 µg ml−1 FM 4–64 and 5 µg ml−1 DAPI prepared in 1×T-base. Cells were 
immobilized on an agarose pad (1/10 LB in 1x sporulation medium) and imaged on 
visualized on an Applied Precision DV Elite optical sectioning microscope equipped 
with a Photometrics CoolSNAP-HQ2 camera. Pictures were deconvolved using 
SoftWoRx v5.5.1 (Applied Precision) and the medial focal planes are shown. 
Exposure times for FM 4–64 and GFP were kept constant throughout all experiments. 
For all images, the phase contrast and FM 4–64 images were adjusted for best 
visualization. For Fig. 3.3A, the GFP intensity was adjusted for best visualization, and 
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for Fig. 3.3B GFP intensities were normalized between all images to allow for 
comparisons between strains. To quantify GFP intensity, we manually drew a Region 
of Interest (ROI) that contains the mother cell and measured the average GFP pixel 
intensity in ImageJ, and divided by the average GFP pixel intensity of the background 
(areas in the field that do not contain cells) to calculate fold changes in intensity 
similar to previous methods(68). The average of 20 cells is reported here.  
 
Preparation of lysate for immunoblot analysis and mass spectrometry analysis  
Growing cells and sporulating cells were harvested at OD600=0.4, OD600=4.0, t0 
and t3 of sporulation by centrifugation, suspended in HMS buffer (20 mM HEPES-
NaOH, 20 mM MgCl2 and 20% sucrose, pH 7.6) containing 100 mM iodoacetamide 
and treated with 1 mg ml−1 lysozyme at 37°C in the dark for 30 min. Spheroplasts 
were harvested by centrifugation and re-suspended in ice-cold buffer A (20 mM 
HEPES-NaOH, 150 mM NaCl and 1 mM EDTA, pH 7.6) containing a 1:1000 dilution 
of protease inhibitor VI, EDTA free (AG Scientific), 10 µg each of DNAse RNAse I,  
and then treated with 0.5% octylthioglucoside (Thermo Fisher Scientific) on ice for 40 
min. The insoluble fraction was removed by centrifugation for 30 minutes at 13,000 
RPM at 4°C. Protein amounts were quantified using the Pierce BCA protein assay kit 
(Thermo Fisher Scientific). 
 
Preparation of affinity-purified α-bacillithiol polyclonal antibody 
Bacillithiol was coupled to Imject Maleimide-Activated mcKLH (Thermo 
Fisher Scientific) according to the manufacturer’s instructions. The conjugate was 
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dialyzed against phosphate buffered saline (PBS) and used to immunize one New 
Zealand white rabbit through Cocalico Biologicals (Reamstown, PA). The resulting 
antiserum was affinity purified using bacillithiol coupled to Imject Maleimide-
Activated BSA (Thermo Fisher Scientific), which was then coupled to sepharose via 
cyanogen bromide. See “Supplementary Materials” for details and additional 
information.  
 
Immunoblot Analysis  
Western blot samples were prepared as described above, heated 10 min at 
80°C in LDS sample buffer (Thermo Fisher Scientific), loaded on a Bolt Bis-Tris Plus 
4-12% gel (Thermo Fisher Scientific), and transferred to nitrocellulose membrane 
(Bio-Rad) using a Mini-PROTEAN Cell (Bio-Rad). A dilution of 1:2000 of affinity-
purified anti-BSH was used to probe proteins. The secondary antibody goat anti-rabbit 
IgG-AP (Santa Cruz Biotechnology) was used at a 1:1000 dilution. The alkaline 
phosphatase substrate NBT/BCIP (Thermo Fisher Scientific) was used for detection.  
 
Mass spectrometry methods  
I.Spectral counting methods and analysis   
Sample preparation and mass spectrometry methods: Lysates were prepared as 
described above in the presence of alkylating agent iodoacetamide to prevent various 
reactions of reduced cysteine. Mass spectrometry samples in Fig. 3.2A were prepared 
and analyzed by the University of California, San Diego Biomolecular and Proteomics 
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Mass Spectrometry Facility (http://bpmsf.ucsd.edu/). For in solution digest methods, 
samples were diluted in TNE (50 mM Tris pH 8.0, 100 mM NaCl, 1 mM EDTA) 
buffer. RapiGest SF reagent (Waters) was added to the mix to a final concentration of 
0.1% and samples were boiled for 5 min. Proteins samples were digested with trypsin 
(trypsin:protein ratio - 1:50) overnight at 37°C. RapiGest was degraded and removed 
by treating the samples with 250 mM HCl at 37°C for 1 h followed by centrifugation 
at 14000 rpm for 30 min at 4°C. The soluble fraction was then added to a new tube 
and the peptides were extracted and desalted using Aspire RP30 desalting columns 
(Thermo Fisher Scientific). Trypsin-digested peptides were analyzed by HPLC 
coupled with tandem mass spectroscopy (LC-MS/MS) using nanospray ionization as 
previously described(69). Briefly, the nanospray ionization experiments were 
performed using a TripleTof 5600 hybrid mass spectrometer (ABSCIEX) interfaced 
with nano-scale reversed-phase HPLC (Tempo).  Peptides were eluted from the C18 
column into the mass spectrometer using a linear gradient at a flow rate of 250 µl/min 
for 3h. MS/MS data were acquired in a data-dependent manner. The collected data 
were analyzed using MASCOT (Matrix Sciences) and Protein Pilot 4.0 (ABSCIEX) 
for peptide identifications.  
Spectral counting:  Spectral counting was performed as previously described(39). 
Spectral counting counts the number of spectra identified peptide in a sample and then 
integrates the results for all measured peptides of the proteins. For each sample, the 
adjusted spectral count was calculated for the proteins by counting the number of peptides 
with at least 95% confidence that were identified, divided by the total amino acid length 
of the protein. This calculation takes into account that longer proteins generate more 
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peptides and are identified more often because of protein length rather than abundance. 
Spectral counts were also normalized to the total number of peptides detected in the four 
growth phases to permit comparisons between samples. The normalized spectral counts 
were then adjusted by multiplying counts by 104 to allow for ease of visualization.  
II. TMT methods and analysis 
Sample preparation and mass spectrometry methods: Lysate samples in Fig. 3.2B and 
Table 3.3 were prepared as described above in the presence of alkylating agent 
iodoacetamide to prevent various reactions of reduced cysteine.  Samples were TCA 
precipitated then re-solubilized in 1M urea and digested with LysC and then trypsin 
digested. Peptides were desalted using C18 Sep-Paks. Samples were labeled with 10-
plex tandem mass tag (TMT) reagents (Thermo Fisher Scientific(70, 71)), which are 
amine-reactive chemical tags, as previously described (45).  This labeling method 
utilizes tags that are identical in chemical structure, however each tag contains 
isotopes substituted at various positions resulting in mass reporter and mass 
normalization regions that have different molecular masses. During MS/MS 
fragmentation, the reporter ion is released from the labeled peptide and can be used for 
quantitation. Labeled peptides were fractionated by basic pH reverse-phase liquid 
chromatography (41) with fraction combining as previously described (72). Briefly, 
samples were separated into 96 fractions, pooled into 24 fractions, and 12 fractions 
were selected for analysis. Fractions were dried and analyzed by LC-MS2/MS3 for 
identification and quantitation. LC-MS2/MS3 experiments were conducted on an 
Orbitrap Fusion (Thermo Fisher Scientific) with an in-line Easy-nLC 1000 (Thermo 
Fisher Scientific).  
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TMT analysis: Resultant data files were processed using Proteome Discoverer 2.1 
(Thermo Fisher Scientific). Reporter ion intensities from TMT reagents were extracted 
from MS3 spectra for quantitative analysis, and signal to noise values were used for 
quantitation.  See “Supplementary Materials” for details and additional information. 
Protein level quantitation values were calculated by summing signal to noise values 
for all peptides per protein meeting the specified filters.  Data were normalized and 
final values are reported as normalized summed signal to noise per protein per sample 
 
Bacillibactin studies  
Bacillibactin and bacillibactin derivatives are not produced under iron replete 
conditions. We prepared iron-limiting media using Spizizen’s minimal medium 
supplemented 0.05% casamino acids. Excess iron was removed from this media using 
Chelex100 (BioRad) according to the manufacturer’s instructions. 1x trace metals 
were added to make a 1x solution and the medium was filtered and used immediately. 
Polystyrene, rather than glassware, was used during preparation and growth.  
Strains were grown in LB medium to OD600 of 0.4. Cells were washed 2 times 
and re-suspended in an equal volume of iron-limiting medium. Cells were inoculated 
into 5 mL of fresh iron-limiting medium at an OD600 of 0.01 and grown for 10 hours in 
polystyrene tubes. The supernatant of each culture (4.5 mL) was processed as 
previously described(47-49). Briefly, cells were removed by centrifugation and the 
supernatants were acidified to ~pH=2 and filtered using a 0.2 µm filter. The filtered 
supernatants were then extracted 3 times with equal volumes of ethyl acetate. The 
ethyl acetate fractions were dried completely using a SpeedVac and re-suspended in 
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100 µL of 100% MeOH. Crude extracts were analyzed using HPLC analysis using a 
4.6 x 250 mm Beckman Ultrasphere IP C18 column with detection at 250 nm using 
the following gradient: 95%/5% of 0.1% TFA/ACN to 50%/50% of 0.1% TFA/ACN 
over 40 minutes. A standard curve of commercially available DHB (Sigma) was 
prepared (Fig. S3.16) and used to quantify the products (Table S3.4). Low-resolution 
mass spectrometry analysis of bacillibactin and bacillibactin intermediates was 
performed by the Molecular Mass Spectrometry Facility (UC San Diego). 
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SUPPLEMENTARY MATERIAL  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S3.1: Bioinformatic analysis of the eight B. subtilis bacillithiol transferases. A) 
Percent sequence identity of the bacillithiol transferases B) Full sequence alignments of the 
bacillithiol transferases.  
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Figure S3.2: SDS PAGE analysis of the purified His6-tagged B. subtilis STL bacillithiol 
transferases. Analysis of recombinant His6-tagged BST enzyme purification on a reducing 4-
12% Bis-Tris SDS-PAGE gel. Lane 1, ladder; lane 2, BstA/YfiT (purified protein published 
previously(1)); lane 3, BstB/YuaE; lane 4, BstC/YisT; lane 5, BstD (YjoA); lane 6, BstE (YrdA); 
lane 7, BstF (YkkA); lane 8, BstG (DinB); lane 9, BstH (YizA).  
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Figure S3.3: Growth curves of wild type B. subtilis PY79, ΔbstA-H mutant, and ΔbshC 
mutant in the presence of stressors. Cultures were grown in Spizizen’s minimal media 
supplemented with 0.5% casamino acids and 1x trace metals solution (see Materials and 
Methods). The cell growth rate was monitored at OD600 using an Infinite 200 plate reader from 
Tecan. Filled symbols: untreated; open symbols: treated. Circles: PY79, squares: ΔbstA-H 
mutant, triangles: ΔbshC mutant. The curves shown are calculated from the mean of three 
experiments. A) CuCl treated cells 4x below the MIC (0.6 mM) B) CdCl2 treated cells 4x below 
the MIC (6.25 µM) C) Paraquat treated cells 4x below the MIC (6.25 µM) D) NaOCl treated 
cells 4x below the MIC (125 µM) E) NaCl treated cells 2x below the MIC (625 mM). 
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Table S3.3: Proteomic sequence analysis of 
the B. subtilis bacillithiol transferases 
B. subtilis BST 
Proteomic analysis of 
recombinant BSTs 
(% sequence coverage) 
BstA (YfiT) 79% 
BstB (YuaE) 80% 
BstC (YisT) 97% 
BstD (YjoA) 87% 
BstE (YrdA) 91% 
BstF (YkkA) 98% 
BstG (DinB) 96% 
BstH (YizA) 99% 
Gel bands were excised from Coomassie stained 
SDS PAGE gels. Sequence coverage values 
represent peptides with >95% confidence. 
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Table S3.4: Minimum inhibitory concentration (MIC) 
values for B. subtilis strains against various stressors 
 Strain 
Stressor PY79 ΔbshC ΔbstA-H 
Paraquat 0.025 0.025 0.025 
CdCl2 0.025 0.025 0.025 
CuCl 2.4 2.4 2.4 
Fosfomycin 500 8 500 
NaCl 1250  1250  1250  
NaOCl 0.5 0.5 0.5 
Paraquat 0.05 0.05 0.05 
CdCl2 0.1 0.1 0.1 
CuCl >4.8 >4.8 >4.8 
Fosfomycin 500 8 500 
NaCl 1250  1250  1250  
NaOCl >2.0  >2.0 >2.0 
MIC values are expressed in mM except for fosfomycin, 
which is expressed in µg/mL. Black text: Spizizen’s 
minimal media supplemented with 0.05% casamino acids 
and 1x trace metals solution; grey text: LB media. 
Growth inhibition was surveyed 24 hours after 
inoculation of cells.  
  
177 
!
  
Table S3.5: Spore titers for B. subtilis strains against 
various stressors 
Stressor PY79 ΔbshC 
NaOCla 5.0 x 107 4.8 x 107 
H2O2b 1.5 x 108 1.2 x 108 
Lysozymec 3.1 x 108 2.7 x 108 
Ethanolc 2.7 x 108 2.8 x 108 
Methanolc 2.5 x 108 3.2 x 108 
Toluenec 2.3 x 108 2.9 x 108 
Glutaraldehyded  2.4 x 108 2.1 x 108 
aA suspension of spores at OD600=1.0 were treated with 
150 µM NaOCl in 50 mM KPO4 buffer for 10 minutes 
and quenched by diluting the sample into 1% sodium 
thiosulfate solution as previously described(73).  
bA suspension of spores at OD600=1.0 were treated with 4 
M  H2O2 in 50 mM KPO4 buffer for 10 minutes. H2O2 
was inactivated by diluting the sample into 5000 U 
bovine catalase as previously described(74). 
cAssays performed as previously described using  
OD600=1.0 spores(75).  
d1 mL of a suspension of spores was diluted to a final 
OD600=1.0 in 9 mL of 2% glutaraldehyde (pH=8.0) for 
10 minutes. 1 mL of the reaction was quenched in 9 mL 
of 2% glycine as previously described(76).  
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Table S3.6: DHB and Bacillibactin levels in B. subtilis PY79 
and NCIB 3610 
Strain DHB  
(pmole/109 cells)a 
Bacillibactin 
(pmole/109 cells)b 
PY79 0.081 ± 0.003 N/A 
ΔbshC, PY79 
background  
0.084 ± 0.002 N/A 
ΔbstA-H, PY79 
background 
0.079 ± 0.01 N/A 
3610 0.16 ± 0.02 0.014 ± 0.003 
ΔbshC, 3610 
background 
0.15 ± 0.02 0.014 ± 0.006 
Samples contain approximately 4.5x109 cells.  
aPeak area was used to determine the amount of DHB (moles) 
using the standard curve of commercial DHB 
bThe peak area conversion factor was divided by three 
(bacillibactin contains 3 DHB molecules) to estimate 
bacillibactin concentration using the standard curve of 
commercial DHB (Fig. S16). Strains in PY79 background do not 
contain bacillibactin (N/A).  
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Table S3.7: List of plasmids used in this study 
Strain  Description Reference or source  
pJLG38 sfGFPΩloxP-kan-loxP Shin and Lopez-
Garrido, et al. (65) 
pRP81 ΔbshC::cat This study  
pRP43 amyE::PyizA-sfGFPΩspec This study  
pRP49 ΔdinB::loxP-cat-loxP This study  
pRP50 ΔyizA::loxP-erm-loxP This study  
pRP53 ΔyrdA::loxP-tet-loxP This study  
pRP73 ΔyuaE::loxP-kan-loxP This study  
pRP54 ΔyfiT::loxP-kan-loxP This study  
pRP181 ΔykkA::loxP-kan-loxP This study  
pRP149 ΔyisT::loxP-cat-loxP This study  
pRP223 ΔyjoA::loxP-spec-loxP This study  
pRP225 sacAΩtet This study 
pRP260 ΔytxJ::loxP-spec-loxP This study  
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Table S8: List of strains used in this study 
Strain  Genotype or description Reference, source or 
construction 
PY79 Prototrophic derivative of B. subtilis 168 Youngman et al., 1984 (8)  
NCIB 3610  Prototroph, undomesticated parent of B. subtilis 
168 
Branda et al., 2001 (9) 
KP1302 NCIB 3610 lacking pBS32  Konkol et al., 2013 (10) 
BER657 ΔsigH::kan Lab stock 
HB11002 ΔbshA::mls Gaballa et al., 2010 (11) 
AD3304a ΔbshA::mls HB11002 → PY79 
EBS42 sacA::PspoIIR-creΩspec Becker et al 2006 
KP648 Δspo0A::erm Jaacks et al 1989 
RP82 ΔbshC::cat, PY79 background pRP81 → NCIB 3610 
RP148a ΔbshC::cat, 3610 background RP82  
RP36 amyE::PyfiT-sfGFPΩspec, KP1302 background This study  
RP24 amyE::PyuaE-sfGFPΩspec, KP1302 background This study  
RP35 amyE::PyisT-sfGFPΩspec, KP1302 background This study  
RP37 amyE::PyjoA-sfGFPΩspec, KP1302 background This study  
RP31 amyE::PyrdA-sfGFPΩspec, KP1302 background This study  
RP23 amyE::PykkA-sfGFPΩspec, KP1302 background This study  
RP28 amyE::PdinB-sfGFPΩspec, KP1302 background This study  
RP98 amyE::PyfiT-sfGFPΩspec RP36 → PY79 
RP84 amyE::PyuaE-sfGFPΩspec RP24 →  PY79 
RP127 amyE::PyisT-sfGFPΩspec RP35 → PY79 
RP128 amyE::PyjoA-sfGFPΩspec RP37 → PY79 
RP83 amyE::PyrdA-sfGFPΩspec RP31 → PY79 
RP97 amyE::PykkA-sfGFPΩspec RP23 → PY79 
RP118 amyE::PdinB-sfGFPΩspec RP28 → PY79 
RP117 amyE::PyizA-sfGFPΩspec pRP43 → PY79 
RP238 ΔyisT::loxP-cat-loxP, ΔyjoA::loxP-spec-loxP, 
ΔdinB::loxP, ΔyizA::loxP, ΔyrdA::loxP, 
ΔyuaE::loxP, ΔyfiT::loxP, ΔykkA::loxP, sacAΩtet 
This study  
RP259 ΔbrxA::loxP-cat-loxP, ΔbrxB::loxP-erm-
loxP, ΔytxJ::loxP-spec-loxP 
This study  
Plasmid or genomic DNA employed (right side of arrow) to transform an existing 
strain (left side the arrow) to create the new strain listed. 
aConstructed using phage-mediated transduction 
  
181 
!
Table S3.9: List of oligonucleotides used in this study 
Descrip-
tion 
Sequence 
pDG1730 
vector 
F GAATTCCTGCAGCCCTGGCGAATGGC 
R ATTGGAAATCGCGGCATAATC 
sfGFP  F GCTAAAGGCGAAGAACTGTT 
R GATTATGCCGCGATTTCCAAT 
yuaE 
promoter 
region 
F 
GCCATTCGCCAGGGCTGCAGGAATTCAGGATGCAAGATAA
AAGCGC 
R AACAGTTCTTCGCCTTTAGCAAAGATACTCATCATATCTC 
ykkA 
promoter 
region 
F 
GCCATTCGCCAGGGCTGCAGGAATTCACTGGATGGCGAAA
TCCTTG 
R AACAGTTCTTCGCCTTTAGCTAAGTCCTTCATGTTCAGTT 
yfiT 
promoter 
region 
F 
GCCATTCGCCAGGGCTGCAGGAATTCTCCTTGATAGAAGT
AAGTGC 
R AACAGTTCTTCGCCTTTAGCGACTGATGTCATGAATGTTC 
dinB 
promoter 
region 
F 
GCCATTCGCCAGGGCTGCAGGAATTCCTCTTATGTACATTT
TGGTA 
R AACAGTTCTTCGCCTTTAGCAAAATCTGACATGTTAAAAT 
yizA 
promoter 
region 
F 
GCCATTCGCCAGGGCTGCAGGAATTCTCAGTATCGGCAGC
AGCATC 
R AACAGTTCTTCGCCTTTAGCAAATTTCATCACTAAACTCA 
yisT 
promoter 
region 
F 
GCCATTCGCCAGGGCTGCAGGAATTCACAATCTCTCTTATG
ATTGA 
R AACAGTTCTTCGCCTTTAGCTGCATCAGTCATCAGCATGC 
yrdA 
promoter 
region 
F 
GCCATTCGCCAGGGCTGCAGGAATTCAGCAGGAAATGATG
GACATT 
R 
AACAGTTCTTCGCCTTTAGCGGTTTGAAACACAAAAATCC 
yjoA 
promoter 
region 
F 
GCCATTCGCCAGGGCTGCAGGAATTCGATCAATTGATCTGT
ATATC 
R AACAGTTCTTCGCCTTTAGCGGATTGGCACATTATGATCT 
Used to 
replace 
the kan of 
pJLG38 w 
F 
CATTTGAGGTGATAGGTAAGCGGCAATAGTTACCCTTATTA 
R 
GGGACCCCTATCTAGCGAACCGAAGTGGCGAGCCCGATCT 
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Table S3.9: List of oligonucleotides used in this study con’t 
Used to 
replace 
the kan 
marker of 
pJLG38 
with erm 
F 
CATTTGAGGTGATAGGTAAGTACTGCAATCGGATGCGATT
ATTG 
R 
GGGACCCCTATCTAGCGAACATTTAGGTGTCACAAGACAC 
Used to 
replace 
the kan 
marker of 
pJLG38 
with tet 
F 
CATTTGAGGTGATAGGTAAGTATTGTTGTATAAGTGATGAA 
R GGGACCCCTATCTAGCGAACCCTTTCGTCTTCAAGAATTC 
Used to 
replace 
the kan 
marker of 
pJLG38 
with spec 
F 
CATTTGAGGTGATAGGTAAGGTAACGTGACTGGCAAGAGA
T 
R 
GGGACCCCTATCTAGCGAACCCTATGCAAGGGTTTATTGTT 
Backbone 
for all 
deletion 
constructs 
amplified 
from 
pJLG38 
F GCACTTTTCGGGGAAATGTG 
R GATGCATATGATCAGATCTTA 
Deletion 
construct 
antibiotic 
marker 
for (cat, 
spec, erm, 
and tet) 
F ATGAGAGAGGAAGAAAACGG 
R AATTGGGACAACTCCAGTG 
Kanamyci
n marker  
for yuaE, 
yfiT, and 
ykkA 
deletions 
F AAATGAGAGAGGAAGAAAACGG 
R AAAGTTCTTCTCCTTTACTA 
 
yfiT 
upstream 
region 
F 
TAGTAAAGGAGAAGAACTTTGACTGATGTCATGAATGTTC 
R CACATTTCCCCGAAAAGTGCTCCTTGATAGAAGTAAGTG 
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Table S3.9: List of oligonucleotides used in this study con’t 
yfiT 
downstrea
m region 
F 
CATGATAAAGTCGAAATCTGCTATCCCGTCATATGTCGAAC
AG 
R 
CCGTTTTCTTCCTCTCTCATTTAGACGGATGGGGTGGTCTTA
A 
yuaE 
upstream 
region 
F 
TAGTAAAGGAGAAGAACTTTAAAGATACTCATCATATCTC
C 
R 
CACATTTCCCCGAAAAGTGCCATTATAATCGGCATTGTCAT 
yuaE 
downstrea
m region 
F 
CATGATAAAGTCGAAATCTGCTGTCTAAAGAAGCAATGAA
AG 
R 
CCGTTTTCTTCCTCTCTCATTTAGATAGAAAGGGCCTGATTT
A 
yisT 
upstream 
region 
F 
CATGATAAAGTCGAAATCTGCACATTATACATTTGGCTGGT
TC 
R 
CCGTTTTCTTCCTCTCTCATTGCATCAGTCATCAGCATGCC 
yisT 
downstrea
m region 
F 
CACTGGAGTTGTCCCAATTAAAAGAGAAAGCAAGGGCTAA 
R 
CACATTTCCCCGAAAAGTGCCACACATGGTGATATGATCAT
C 
yjoA 
upstream 
region 
F 
CATGATAAAGTCGAAATCTGCTCGAATCTATATCCTCGATG
AC 
R 
CCGTTTTCTTCCTCTCTCATGGATTGGCACATTATGATCTC 
yjoA 
downstrea
m region 
F CACTGGAGTTGTCCCAATTTTCTATCAGCAGCGCATGTAG 
R 
CACATTTCCCCGAAAAGTGCCCGCTGACTAAAATAATGGA
AGCC 
yrdA 
upstream 
region 
F 
CATGATAAAGTCGAAATCTGCATGCGAAGTGAGCAGGAAA
TGA 
R 
CCGTTTTCTTCCTCTCTCATGGTTTGAAACACAAAAATCCT 
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Table S3.9: List of oligonucleotides used in this study con’t 
yrdA 
downstream 
region 
F 
CACTGGAGTTGTCCCAATTTTGGAAGCCCCGAAAATGTA
A 
R 
CACATTTCCCCGAAAAGTGCTCTCTGCTTTATTTCAGCGT
A 
ykkA 
upstream 
region 
F 
TAGTAAAGGAGAAGAACTTTAAGTCCTTCATGTTCAGTTC 
R 
CACATTTCCCCGAAAAGTGCGGGTATTTTTACTGAAGCCA 
ykkA 
downstream 
region 
F 
CATGATAAAGTCGAAATCTGCGTCTCACATGAGATTGAC
TCT 
R 
CCGTTTTCTTCCTCTCTCATTTCGAAGTATGAACGCTAAA
ACG 
dinB 
upstream 
region 
F 
CATGATAAAGTCGAAATCTGCACTTGAATTTGATGATTGC
TC 
R 
CCGTTTTCTTCCTCTCTCATAAAATCTGACATGTTAAAATT 
dinB 
downstream 
region 
F 
CACTGGAGTTGTCCCAATTACAAAAACTGAAAAAGCATA
A 
R 
CACATTTCCCCGAAAAGTGCCGAGAGGATAAACCCGTGC
AT 
yizA 
upstream 
region 
F 
CATGATAAAGTCGAAATCTGCCAGCCCGGTGCAAATGAA
GAG 
R 
CCGTTTTCTTCCTCTCTCATAAATTTCATCACTAAACTCAC 
yizA 
downstream 
region 
F 
CACTGGAGTTGTCCCAATTAAACCTATTCATTCTTATTGA 
R 
CACATTTCCCCGAAAAGTGCCAAATATGAAGAAACCTTG
GC 
brxA 
upstream 
region 
F 
CATGATAAAGTCGAAATCTGCGCGCTATCATTAAAACAG
GCG 
R CCGTTTTCTTCCTCTCTCATCATTGACATAAAAAAAGCC 
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Table S3.9: List of oligonucleotides used in this study con’t 
brxA 
downstream 
region 
F 
CACTGGAGTTGTCCCAATTCACTGCTAAATGCCCGTTCTC 
R 
CACATTTCCCCGAAAAGTGCAGAGTTGTCAGGGAGCTGC
TT 
brxB 
upstream 
region 
F 
CATGATAAAGTCGAAATCTGCGTTGATTTGATTCGACGTT
TC 
R 
CCGTTTTCTTCCTCTCTCATCATGTTCAATGAAGACCTCTC 
brxB 
downstream 
region 
F 
CACTGGAGTTGTCCCAATTGAAGTATAAGACGAACAACC
C 
R 
CACATTTCCCCGAAAAGTGCATATGGTTCGCTGTGTAATA
C 
ytxJ 
upstream 
region 
F CATGATAAAGTCGAAATCTGC 
R CCGTTTTCTTCCTCTCTCAT 
ytxJ 
downstream 
region 
F CACTGGAGTTGTCCCAATT 
R CACATTTCCCCGAAAAGTGC 
sacA 
upstream 
region 
F 
CATGATAAAGTCGAAATCTGCGATATCGCTCTTCTCGGCT
AC 
R 
CTTACCTATCACCTCAAATGCTACATAAGTGTCCAAATTC
C 
sacA 
downstream 
region 
F 
GTTCGCTAGATAGGGGTCCCAAAATCCTTCTATTTTCTTA
TG 
R 
CACATTTCCCCGAAAAGTGCCATTCTGCACTGCGCCTGAA
TC 
Tet 
antibiotic 
marker for 
sacAΩtet 
construct 
F TATTGTTGTATAAGTGATGAA 
R GGGACCCCTATCTAGCGAAC 
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SUPPLEMENTARY MATERIALS AND METHODS  
Preparation of affinity-purified α-bacillithiol polyclonal antibody 
Preparation of BSH-KLH Immunogen 
Bacillithiol (6 mg) was coupled to Imject Maleimide-Activated mcKLH (4 mg, 
Thermo Fisher Scientific), which is a 1.5 molar excess of thiols to maleimide, 
according to the manufacturer’s specifications. The resulting immunogen was 
aliquoted in 1 mL vials at a concentration of 1 mg/mL and frozen at -80°C. After a 
sample of pre-immune bleed was obtained the rabbit was immunized with 500 µg of 
immunogen in Freund’s complete adjuvant on day 0. Boosts with 250 µg of 
immunogen in Freund’s incomplete adjuvant were performed on days 14, 21, 49, 77, 
and 105, and test bleeds on days 35, 56, and 91 were used to monitor titers via ELISA. 
The exsanguination was performed on day 116, and antiserum was frozen at -80°C.  
Preparation of affinity purified antibody 
Antiserum was initially centrifuged at 5000g for 10mins to remove residual red 
blood cells and supernatant carefully removed.  A saturated solution of ammonium 
sulfate was prepated to precipitate the immunoglobulin fraction of the antiserum. The 
solution was stored on ice for 10 mins and centrifuged for 10 minutes at 13,000 rpm. 
The pellet was dissolved with PBS equal to the initial volume, and the precipitation 
and reconstitution procedure was repeated twice more. The immunoglobulin fraction 
was dialyzed against PBS with 3 changes of buffer re-suspended in PBS containing 
sodium azide and stored short term at 4°C. 
To remove antibodies directed against the SMCC linker region of the activated 
! 187 
mcKLH, a column of Maleimide-Activated BSA was prepared  by coupling it to 
cyanogen bromide activated sepharose 4B (GE Healthcare Life Sciences) according to 
the manufacturer’s instructions. Briefly, 5 mL of 1 mg/mL BSA in PBS was coupled 
to 1 mL of prepared resin for 1 hour with end over end rotation. After preparation, the 
resin was used immediately. A column was prepared from about 2 mL of wet resin. 
The immunoglobulin fraction was passed over the Maleimide-Activated BSA column, 
and the column was washed with PBS until the A280 reading was at baseline. The flow 
through fraction containing bacillithiol specific antibody was retained.  
Bacillithiol (3 mg) was coupled to Imject Maleimide-Activated BSA (2 mg, 
Thermo Fisher Scientific) using a 1.5 fold molar excess according to the 
manufacturer’s instructions. Bacillithiol-BSA was then conjugated to cyanogen 
bromide activated sepharose 4B as described above (bed volume=3ml). A column of 
the resulting BSH-BSA conjugate was used to purify BSH-specific polyclonal 
antibodies from SMCC adsorbed immunoglobulin flowthrough fraction from above. 
The column was washed with PBS until the A280 nm reading was at baseline. 
Antibodies with affinity for bacillithiol were eluted using a two bed volumes (6 mL) 
of 0.1 M glycine-HCl, pH 3.0. The eluted fraction was collected and neutralized to pH 
7.0 with 1 M Tris-HCl pH= 8.0. Protein was quantified spectrophotometrically at A280 
nm using an extinction coefficient of 1.4. The specificity of the BSH-affinity purified 
antibody was checked using wild type and ΔbshC mutant lysate in Western blots.  
Proteomics Methods  
Trypsin-digested peptides were analyzed by HPLC coupled with tandem mass 
spectroscopy (LC-MS/MS) using nanospray ionization. The nanospray ionization 
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experiments were performed using a TripleTof 5600 hybrid mass spectrometer 
(ABSCIEX) interfaced with nanoscale reversed-phase HPLC (Tempo) using a 10 cm-
100 micron ID glass capillary packed with 5-µm C18 ZorbaxTM beads (Agilent 
Technologies, Santa Clara, CA).  Peptides were eluted from the C18 column into the 
mass spectrometer using a linear gradient (5–60%) of ACN (Acetonitrile) at a flow 
rate of 250 µl/min for 1h. The buffers used to create the ACN gradient were: Buffer A 
(98% H2O, 2% ACN, 0.2% formic acid, and 0.005% TFA) and Buffer B (100% ACN, 
0.2% formic acid, and 0.005% TFA). MS/MS data were acquired in a data-dependent 
manner in which the MS1 data was acquired for 250 ms at m/z of 400 to 1250 Da and 
the MS/MS data was acquired from m/z of 50 to 2,000 Da. For Independent data 
acquisition (IDA) parameters MS1-TOF 250 milliseconds, followed by 50 MS2 events 
of 25 milliseconds each. The IDA criteria; over 200 counts threshold, charge state of 
plus 2-4 with 4 seconds exclusion window. Collected data were analyzed using 
MASCOT® (Matrix Sciences) and Protein Pilot 4.0 (ABSCIEX) for identifications. 
Protein Digestion and TMT Labeling 
Insoluble debris was pelleted by centrifugation at 14000 RPM for 5 minutes. 
Proteins were precipitated with trichloroacetic acid (TCA) then re-solubilized in 1M 
urea (Fisher) in 50mM HEPES, pH 8.5. Proteins were digested in a two-step process; 
3µg of LysC (Wako) was added to each sample and then incubated overnight at room 
temperature.  Next, 3µg of trypsin was added and samples were digested for 6 hours at 
37°C. Digestion was quenched with trifluoroacetic acid  and desalted(12).   
 Samples were labeled with 10-plex TMT reagents (Thermo Fisher Scientific) 
(13, 14) as previously described (15).  TMT reagents were solubilized in dry 
! 189 
acetonitrile (Sigma) at 20µg/µL.  Peptides were re-suspended in 30% dry acetonitrile 
in 200mM HEPES, pH 8.5 and 7µL of the appropriate TMT reagent was added to 
each sample.  Labeling was conducted for 1 hour and was quenched by addition of 
8µL of 5% hydroxylamine (Sigma).  Samples were then acidified by addition of 50µL 
of 1% TFA and pooled.  The pooled sample was desalted with C18 Sep-Paks. 
Basic pH Reverse-Phase Liquid Chromatography Fractionation 
Fractionation was carried out by basic pH reverse-phase liquid 
chromatography (16) with fraction combining as previously described (12).  Briefly, 
samples were solubilized in 5% formic acid in 5% acetonitrile and separated on a 
4.6mm x 250mm C28 column (Thermo Fisher Scientific) on an Ultimate 3000 HPLC 
fitted with an auto sampler, fraction collector, degasser and variable wavelength 
detector.  Separation was performed over a 22% to 35%, 60-minute linear gradient of 
acetonitrile in 10mM ammonium bicarbonate (Fisher) at a flow rate of 0.5 mL/min.  
The resultant 96 fractions were combined as previously described (12).  Fractions 
were dried and re-suspended in 5% formic acid/5% acetonitrile and analyzed by LC-
MS2/MS3 for identification and quantitation. 
LC-MS2/MS3 Protein Identification and Quantitation 
LC-MS2/MS3 experiments were conducted on an Orbitrap Fusion (Thermo 
Fisher Scientific) with an in-line Easy-nLC 1000 (Thermo Fisher Scientific).  Home-
pulled, home-packed columns (100µm ID x 30cm, 360µ OD) were used for analysis.  
Analytical columns were triple-packed with 5µm C4 resin, 3µm C18 resin and 1.8µm 
C18 resin (Sepax) to lengths of 0.5cm, 0.5cm and 30cm respectively.  Samples were 
loaded on the column at 500 bar and eluted with a linear gradient of 11% to 30% 
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acetonitrile in 0.125% formic acid over 165 minutes at a flow rate of 300nL/minute 
with the column heated to 60°C.  Nano-electrospray ionization was achieved by 
applying 2000V through a stainless steel T-junction at the inlet of the column. 
 The Orbitrap Fusion was run in data-dependent mode, where a survey scan was 
collected over 500-1200m/z at a resolution of 120000 in the Orbitrap.  Automatic gain 
control (AGC) was set to 5x105 for the survey scan, with a maximum ion injection 
time of 100ms.  The S-lens RF was set to 60 and centroided data were collected.  For 
subsequent MS2/MS3 analysis, top speed mode was enabled to select the most 
abundant ions for analysis in a 5 second cycle. 
 For MS2/MS3 analysis, the decision tree option was used, with charge state 
and m/z range as qualifiers.  Ions with a +2 charge state were analyzed from the m/z 
range of 600-1200, and +3/+4 ions were selected from the m/z range of 500-1200.  An 
ion intensity trigger threshold of 5x103 was used.  MS2 spectra were obtained with 
quadrupole isolation with a 0.5 Th window and fragmented with collision induced 
dissociation using a normalized collision energy of 30%.  Fragment ions were detected 
and centroided data collected in the linear ion trap using rapid scan rate with an AGC 
target of 1x104, maximum ion injection time of 35 ms. 
 MS3 analysis was conducted using the synchronous precursor selection (SPS) 
option to maximize TMT quantitation sensitivity (13).  For SPS, a maximum of 10 
MS2 precursors was specified, which were simultaneously isolated and fragmented for 
MS3 quantitation.  Higher-energy collisional dissociation was used as fragmentation 
for MS3, with a normalized collision energy of 50%.  Resultant fragments were 
detected in the Orbitrap with a resolution of 60000 and a low mass cut-off of 110m/z.  
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AGC for MS3 spectra was set to 5x104 with a maximum ion injection time of 250ms.  
MS2 ons from a range of 40m/z below and 15m/z above the precursor m/z were 
excluded by SPS.  Centroided data were collected for all MS3 scans. 
Data Processing and Analysis 
Resultant data files were processed using Proteome Discoverer 2.1 (Thermo 
Fisher Scientific).  MS2 data were queried against the Uniprot Bacillus subtilis 
database using the Sequest algorithm (17).  A decoy search was also conducted with 
sequences in reversed order (18-20).  For MS1 spectra, a mass tolerance of 50ppm was 
specified and for MS2 spectra a 0.6Da tolerance was used.  Static modifications 
included TMT 10-plex reagents on lysine and peptide N-termini (+229.162932Da).  
Variable oxidation of methionines (+15.99492Da), bacillithiol modification of 
cysteines (+396.08387Da) and carbamidomethylation of cysteines (+57.02146Da) 
were also included in the search parameters.  Data were filtered to a 1% peptide and 
protein level false discovery rate using the target-decoy strategy (18). 
 Reporter ion intensities from TMT reagents were extracted from MS3 spectra 
for quantitative analysis, and signal to noise values were used for quantitation.  
Spectra were used if the average signal to noise was greater than 10 across samples 
and if isolation interference was less than 25%.  Protein level quantitation values were 
calculated by summing signal to noise values for all peptides per protein meeting the 
specified filters.  Data were normalized in a two-step process, whereby they were first 
normalized to the mean for each protein.  To account for variation in the amount of 
protein labeled, values were then normalized to the median of the entire dataset.  Final 
values are reported as normalized summed signal to noise per protein per sample. 
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This dissertation presents the work I have completed characterizing the activity 
and expression of the S-transferase like bacillithiol transferases encoded in 
Staphylococcus aureus and Bacillus subtilis. Prior to this work, only one STL 
bacillithiol transferase had been confirmed to be active with bacillithiol. I 
demonstrated that this enzyme and the eight additional enzymes encoded in B. subtilis 
are metal-dependent, supporting the prediction that the STL enzymes are 
metalloenzymes. In chapter 2, I demonstrate that the single bacillithiol transferase 
encoded in S. aureus, renamed BstA, is active with bacillithiol and none of the other 
LMWTs commonly found in bacteria. The low Km for bacillithiol (16 ± 4 µM) 
indicates that BstA is likely saturated with the co-substrate bacillithiol and poised for 
catalysis in vivo. While screening for BstA substrates against candidate molecules, I 
determined that cerulenin is a weak BstA substrate in vitro, with BSH-ceruelenin 
adduct formation occurring 2-fold over the background chemical rate in the presence 
of BstA. However additional molecules and/or stressors that a bacillithiol deficient 
mutant or a ΔbstA mutant were sensitive to were not identified. Notably, I found that 
kinase inhibitors that inhibit STL mycothiol transferase activity also inhibit BstA 
activity.  
In chapter 3, I demonstrate that the seven unpublished B. subtilis bacillithiol 
transferases are active to varying degrees. Four of the proteins are as active or more 
active than BstA (formerly YfiT), the first B. subtilis STL bacillithiol transferase to be 
characterized. In collaboration with the UCSD Biomolecular and Proteomics Mass 
Spectrometry facility and the Gonzalez lab at UCSD, I determined that six of the eight 
bacillithiol transferases are expressed during growth and sporulation using quantitative 
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proteomic analysis. I confirmed this observation by using fluorescence microscopy, 
showing that six of the bst genes are expressed at low levels during sporulation 
induction, while two are expressed at high levels in the mother cell compartment of 
sporulating cells.  
In addition to my studies with the bacillithiol transferases, I examined the 
physiological role of bacillithiol. Although I was unable to identify stressors that 
bacillithiol-deficient mutants are sensitive to, I examined other bacillithiol-dependent 
reactions. I show that bacillithiol reacts spontaneously with a number of molecules 
that other LMWTs are not reactive with, providing evidence for the high reactivity of 
bacillithiol compared to other thiols at physiological pH. Previous studies have 
determined that bacillithiol has a low thiol pKa, which could be the physical chemical 
basis for our observations.  Using an affinity-purified anti-bacillithiol antibody I 
generated, I show that bacillithiol modifies proteins during normal growth under non-
stress conditions. Interestingly, these modifications differ from those found during 
oxidative stress conditions. These studies will help to draw attention to basal levels of 
S-bacillithiolation in protein regulation, which at times tends to be undervalued 
compared to modifications induced by oxidative stress.  
 
A. Evaluating the bacillithiol system as a potential drug target  
Mechanisms of bacterial resistance to stressors have been a topic of interest in 
biology and medicine for decades. As a consequence of the increased usage of 
antibiotics, there has been here has been emergence and spread of drug-resistant 
pathogens. This problem is compounded by the many challenges in finding new 
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antibiotics and new drug targets. The discovery of bacillithiol led many groups to 
evaluate the bacillithiol system as a potential drug target. As discussed in Chapter 1, a 
combination therapy of fosfomycin and a bacillithiol biosynthesis inhibitor, 
specifically a BshB inhibitor, could be used as a novel treatment for MRSA infections. 
After identifying candidate inhibitors of BshB in vitro, a whole cell screen in a S. 
aureus ΔbshB background could identify inhibitors that sensitize cells to fosfomycin. 
B. subtilis encodes two BshB-type enzymes and B. anthracis possibly encodes three, 
thus BshC might be a better target in the Bacillus spp.  
The bacillithiol biosynthesis enzymes are obvious drug targets because of the 
participation of bacillithiol in the detoxification of fosfomycin. The natural substrates 
of the STL bacillithiol transferase enzymes are currently unknown, thus the enzymes 
have yet to be evaluated experimentally as drug targets. Thiol transferases are thought 
to have low affinity for a wide range of substrates and consequently, weakly catalyze 
the detoxification of a number of substrates. Thus, it is possible that even in 
combination therapy, bacillithiol transferases would not be good drug targets. In the 
case of fosfomycin resistance in B. subtilis, ΔfosB and ΔbshA mutants are equally 
sensitive to fosfomycin(1). However, because bacillithiol is involved in other 
resistance pathways that could be relevant during fosfomycin treatment, blocking 
bacillithiol biosynthesis would more effective than inhibiting FosB.  
It is possible that there could be members in the new STL superfamily that 
have high affinity for certain small molecules and antibiotics, which would make these 
enzymes suitable drug targets. However, inhibiting a single bacillithiol transferase in 
an organism like B. subtilis, which encodes more than one bacillithiol transferase, 
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might not be effective because of conceivable functional redundancy between the 
enzymes. S. aureus encodes only one STL bacillithiol transferase, BstA, and early 
predictions pointed toward the possible detoxification roles of this enzyme. Our 
studies show that cerulenin is a weak substrate of BstA, although ΔbstA and 
bacillithiol-deficient mutants are not sensitized to the drug. As additional S. aureus 
BstA substrates are determined, the therapeutic potential can be further studied.  
 
B. Possible strategies to use in the quest to identify natural substrates of STL 
bacillithiol transferases and the physiological role of bacillithiol  
The STL superfamiliy of thiol transferases is new and there is much to be 
learned from these proteins. One big question to consider is: why do some organisms 
encode more STL thiol transferases than others? There appears to be a correlation 
between the number of STL thiol transferase genes encoded and the number of 
secondary metabolite operons, leading to the hypothesis that STL enzymes detoxify 
endogenously produced metabolites. For example, Actinobacteria, which include the 
Streptomyces, contain the most genetically encoded secondary metabolite operons 
compared to other bacterial phlya and also encode largest number of STL thiol 
transferase genes. Mycothiol has been implicated in the detoxification of toxic 
metabolites and intermediates synthesized during metabolite production, but it is 
unclear whether these reactions are catalyzed by mycothiol transferases, let alone STL 
mycothiol transferases. Mycothiol transferases have been shown to be involved in the 
biosynthesis of ergothioneine and lincomycin, but bacillithiol transferases have yet to 
be implicated in secondary metabolite biosynthesis. A challenge one would face in 
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finding a role for bacillithiol in secondary metabolite production is that a number of 
secondary metabolites are produced under different conditions in the lab, and 
potentially each individual secondary metabolite must be studied separately. This 
could be time-consuming and is incompatible with large-scale screens. Another big 
question is: what are the natural substrates of these enzymes? Natural substrates of 
thiol transferases are notoriously difficult to identify: they can be any molecule inside 
or outside the cell and they might even need to be bioactivated before they are 
recognized by the thiol transferase. Thus there is a lack of knowledge for most thiol 
transferases that are confirmed to be active with model substrates(2).  A unique and 
informative strategy to consider is identifying potential binding partners that work in 
conjunction with bacillithiol transferases. To identify such protein partners, pulldown 
assays using immobilized bacillithiol transferases could be employed. Lysate can be 
prepared from cells in different growth phases, cells treated with oxidants, etc, and 
mass spectrometry could then be used to identify binding partners.  
Bacillithiol and the BSTs are not essential, and subtle decreases in viability or 
changes in redox state of the cytoplasm will likely be undetected in large scale 
phenotypic screens or sensitivity assays,. Endpoint assays, like MICs, could miss 
possible molecules that are detoxified by bacillithiol or bacillithiol transferase 
substrates. One approach is to identify bacillithiol-important conditions, perhaps using 
reporter systems, proteomics, microarray experiments, or a combination of these 
methods. There are a number of studies that document B. subtilis and S. aureus 
proteomic and transcriptomic changes during challenge with oxidants and stressors. 
Some of these oxidants, such as NaOCl, have been tested against bacillithiol-deficient 
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mutants and bst mutants, however these mutants are only marginally sensitive to 
NaOCl in both nutrient rich and minimal media. In my studies, I used transcriptional 
fusions to map expression of bacillithiol transferases during growth phases. Although 
the enzymes are not essential for sporulation, it is likely that they are utilized in 
currently unknown reactions or processes. The eight B. subtilis bacillithiol transferases 
can also be used as proxies to identify bacillithiol-important processes. These 
techniques will help aid in efforts to find the physiological role of bacillithiol and 
bacillithiol transferases. 
Another consideration is that bacillithiol could play a role in several 
physiological and cellular pathways. Although bacillithiol is not essential, in 
combination with another mutation, the lack of bacillithiol in the cell could cause 
synthetic lethality or at least help identify pathways which utilize bacillithiol as a 
cofactor. A transposon mutagenesis screen in a bacillithiol-deficient mutant would be 
informative and give clues into the physiological role of bacillithiol. 
 
C. Bacillithiol: beyond protective reactions  
Can a small molecule that is present at low concentrations be as useful or as 
potent as highly specialized proteins like superoxide dismutase and catalase when it 
comes to detoxifying oxidants? In vitro, bacillithiol can detoxify H2O2 spontaneously. 
However, bacillithiol-deficient mutants are not sensitive to H2O2 and are marginally 
sensitive to a number of other oxidants.  It would seem that bacillithiol would be more 
useful as a molecule to protect proteins for overoxidation or as a signaling molecule. 
The S-thiolation modification of proteins is a hallmark of the oxidative and nitrosative 
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stress response. S-bacillithiolation has been mostly studied under oxidative stress 
conditions. Indeed bacillithiol is involved in the regulation of key redox sensing 
proteins like OhrR and MetE (3, 4). It has become apparent over the years, however, 
that S-thiolation modifications that occur under unstressed, physiological conditions 
and play a significant role in the cell, as is the case with S-glutathionylation (5, 6). 
Indeed low levels of ROS in eukaryotic and prokaryotic cells can serve as signaling 
molecules involved in the regulation of cellular and physiological functions (7, 8). 
Studies during NaOCl show that the proteins PpaC and GuaB are modified on active 
site cysteine residues. Under non-stress conditions, I found that these two proteins 
were modified on non-active site residues. This observation is intriguing and should be 
pursued, perhaps using site directed mutagenesis and in vitro assays to measure 
protein activity.   
 
D. Bacillithiol utilization in different strains of B. subtilis 
Bacillithiol levels are different in various strains of S. aureus, with some 
strains producing ~10 fold less bacillithiol than others(9). This must be taken into 
account when assessing the importance of bacillithiol and examining sensitivity of 
bacillithiol-deficient mutants to stressors. Derivatives of the parent strain B. subtilis 
168 are similar genetically and are thought to behave similarly. However, there have 
been reports of differences between strains, one example being the difference in size 
of flotillin clusters in B. subtilis 168 and PY79 membranes (10). This observation in 
particular could be relevant to the bacillithiol system because the floT/yuaG, gene 
which encodes a flotillin scaffold protein, is in close proximity to bstB/yuaE. It would 
!!
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be interesting to see side-by-side comparisons of bacillithiol levels in the B. subtilis 
strains utilized by labs studying bacillithiol, similar to the study with various S. aureus 
strains(9). 
E. Concluding thoughts and remarks  
 As our understanding of bacterial physiology develops, we continue to 
appreciate the many protective mechanisms and resistance pathways bacteria employ. 
Bacillithiol is the newest LMWT identified and has potential implications in the 
agricultural and pharmaceutical applications. The S-transferase like superfamily is an 
incredibly divergent family of enzymes that has been implicated in a number of 
diverse reactions. This field is relatively new compared to the glutathione field, which 
is over 100 years old. While we can take cues from the glutathione and mycothiol 
fields, novel strategies will be the key to finding additional cellular functions of 
bacillithiol and bacillithiol transferases.  
!!
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Bacillithiol is a low-molecular-weight thiol analogous to glutathione and is found in several
Firmicutes, including Staphylococcus aureus. Since its discovery in 2009, bacillithiol has been
a topic of interest because it has been found to contribute to resistance during oxidative
stress and detoxification of electrophiles, such as the antibiotic fosfomycin, in S. aureus. The
rapid increase in resistance of methicillin-resistant Staphylococcus aureus (MRSA) to available
therapeutic agents is a great health concern, and many research efforts are focused on
identifying new drugs and targets to combat this organism. This review describes the
discovery of bacillithiol, studies that have elucidated the physiological roles of this molecule in
S. aureus and other Bacilli, and the contribution of bacillithiol to S. aureus fitness during
pathogenesis. Additionally, the bacillithiol biosynthesis pathway is evaluated as a novel drug
target that can be utilized in combination with existing therapies to treat S. aureus infections.
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. Staphylococcus aureus
Thiols in aerobic bacteria
Aerobic bacteria live in an oxidizing environ-
ment and often require this environment for
life, yet they maintain a reducing intracellular
environment. Generating and maintaining this
reducing environment requires not only energy
but also specialized molecules in the cell that
store this reducing potential and use it for vari-
ous biochemical processes. These molecules
include low-molecular-weight thiols such as
glutathione (GSH), cysteine (Cys) and coen-
zyme A (CoA), each of which play different
cellular roles [1]. Free cysteine levels are typi-
cally kept low because cysteine is prone to
metal-catalyzed oxidation [2], which produces
hydrogen peroxide, which can damage both
DNA and proteins. CoA has a high thiol pKa
compared to cysteine and glutathione (see
“Biophysical Properties” below, [3–5]), such that
the availability of the thiolate anion form of
CoA required for reaction with electrophiles
and thiol-disulfide exchange reactions is very
limited. CoA is not a storage form of cysteine
and cannot resupply the cell with Cys for pro-
tein synthesis during times of shortage, which
can occur during oxidative stress. GSH is oxi-
dized more slowly than is Cys, and it can be
broken down to release Cys when necessary, so
it plays a key role in redox reactions and redox
homeostasis. GSH is present in Gram-negative
bacteria and also in eukaryotic cells and was at
one time assumed to be present in all living
aerobic cells. However, many Gram-positive
bacteria were subsequently shown to lack GSH
and contain instead other low-molecular-
weight thiols [1,6,7]. For example, the Actinobac-
teria, which include human pathogens such as
Mycobacterium tuberculosis, use mycothiol
(MSH), whereas several Firmicutes, including
the human pathogens Bacillus anthracis and
Staphylococcus aureus, use bacillithiol (BSH).
Since its discovery, BSH has become the focus
of considerable biochemical and physiological
attention. In this review, we summarize this
work and we evaluate the BSH system in
Staphylococcus aureus as a potential target for
the development of chemotherapeutic agents.
The discovery of mycothiol & bacillithiol
Once it became clear that GSH was not
ubiquitous, the search was underway for alter-
native low-molecular-weight thiols. To study
these thiols, an assay was developed utilizing
the thiol-labeling compound monobromobi-
mane in combination with reverse phase
separation of the resulting fluorescent thiol-
bimane derivatives (RSmB) [8,9]. The bimanes
(such as the widely used 9,10-dioxa-syn-dime-
thylbimanes [10]) are among the smallest
informahealthcare.com 10.1586/14787210.2015.1064309 ! 2015 Informa UK Ltd ISSN 1478-7210 1089
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sulfhydryl-reactive fluorophores known and allow the thiol
moiety to dominate the physical chemical properties of the
conjugate and its chromatographic behavior. Another advan-
tage of the bimane label is that it is highly conjugated and
has a simple proton nuclear magnetic resonance spectrum,
which is beneficial in solving novel biological thiol struc-
tures [11–14]. Application of the bimane assay to a variety of
bacteria revealed novel thiols, but most were present at low
levels relative to GSH or CoA. An exception was the Actino-
mycetes where a major novel thiol, U17, was identified in
Streptomyces clavuligerus and in other actinobacteria [15]. The
structure of U17 was solved by three laboratories and
renamed mycothiol (FIGURE 1, [11,12,16]). Mycothiol would later
guide the determination of the structure and discovery of the
biosynthetic pathway for bacillithiol.
Although the Firmicutes were recognized to lack glutathi-
one [7], the biologically relevant low-molecular-weight thiol in
these bacteria remained unclear for several years because the
bimane derivative of bacillithiol (BSmB) coeluted with the cys-
teine bimane derivative (CySmB) [17] in the sodium acetate
buffer that was used in the HPLC separation method #1 [9].
The addition of an online mass detector in parallel with the
HPLC proved extremely productive because bimane-thiol deriv-
atives ionize easily in electrospray mass spectrometry. During a
systematic thiol survey of B. anthracis in 2006, an unknown
thiol was found to coelute with CySmB on the HPLC analysis
and had a different mass. After the pH of the buffer was
adjusted from 3.4 to 4.0, this novel thiol was fully resolved
from CySmB. In retrospect, this was due to the ionization of
the malate carboxylates of bacillithiol at the higher pH.
U12 had a mass of 398, which did not match any of the
biological thiols identified in previous surveys [18]. Subse-
quently, it was reported that treatment of Bacillus subtilis with
cumene hydroperoxide led to the formation of mixed disulfides
between the organic hydroperoxide regulator OhrR and either
cysteine, CoA or an unknown thiol of the same mass as
U12 [19]. U12 was reported soon afterward in Deinococcus
radiodurans [14]. Thus, the common occurrence of the novel
thiol justified solving the structure.
The structure of U12-bimane from D. radiodurans was
determined from a 2D NMR and analysis of acid hydrolysis
products, the same strategy used to solve the bimane deriva-
tive of mycothiol [12]. U12 was found to be the a-anomeric
glycoside of L-cysteinyl-D-glucosamine with L-malic
acid (FIGURE 1) and was named BSH because of its widespread
occurrence within the Bacilli [14]. Bacillithiol resembles myco-
thiol in that it has the same central cysteine moiety amide
bonded to glucosamine, but it has L-malate in an a-glycosidic
bond to glucosamine in place of the inositol moiety in myco-
thiol, and the cysteine of MSH is N-acetylated (FIGURE 1). Bacil-
lithiol was found in seven species of Bacillus, in Geobacillus
and in some but not all species of Staphylococcus and Strepto-
coccus [14]. A survey of Firmicutes growing exponentially in
trypticase soy broth with shaking at 37!C, including B. subti-
lis and S. aureus, revealed BSH levels at 0.2–0.7 mmol/g dry
weight [0.1–0.2 mM], some 10-fold lower than the concentra-
tion of GSH in Gram-negative bacteria or of MSH in Acti-
nomycetes, but similar to the levels of Cys and CoA in these
organisms. Thus, the Firmicutes appear to have three major
low-molecular-weight thiols (cysteine, coenzyme A and bacilli-
thiol) that are maintained at similar, low levels during expo-
nential growth.
Glutathione
Thiol pKa = 8.93†
Cysteine
Thiol pKa = 8.53§
Coenzyme A
Thiol pKa = 9.83¶
Mycothiol
Thiol pKa = ?
Bacillithiol
Thiol pKa = 7.97‡
Figure 1. Structures and pKa values of the major low-molecular-weight thiols found in bacteria. Thiols shown as the major
ionized form at pH = 7.7 and represent microscopic thiol pKa values.
†Rabenstein 1973 [5]; ‡Sharma et al. 2013 [20]; §Benesch and Benesch 1955 [4]; ¶Keire et al. 1992 [3].
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Biophysical properties of bacillithiol
The solution structure of BSH is domi-
nated by its zwitterionic character at
physiological pH [20], which also contrib-
utes to its biological activities. The redox
potential and the microscopic and macro-
scopic pKas for each ionizable group were
determined by a combination of spectro-
scopic techniques. The redox potential
for BSH is –221 mV, which is similar to
that of most biological monothiols
including Cys (–223 mV), CoA
(–234 mV) and GSH (–240 mV). In
contrast, all of the pKa values for BSH
are lower than the corresponding values
for Cys or GSH. The first two pKa val-
ues of BSH (3.1 and 4.4) correspond to
those of the malate moiety, which are
lower than the respective values for malic
acid alone (3.4 and 5.1). This indicates
that the malate moiety in BSH is a dia-
nion at physiological pH (FIGURE 2). The
most unusual aspect of BSH ionization is
the microscopic amine pKn of 7.63,
which is just ~0.3 pH units below that
of the thiol pKs of 7.97. Hence when BSH is at the physiologi-
cal pH of 7.7, there will be two major forms of BSH dianion,
the ! + ! ! and the 00! ! forms ([20], FIGURE 2). The amount
of BSH in the reactive thiolate form (RS–, 21.9%) is greater
than that of Cys (14.6%) and much greater than that of CoA,
the two other major thiols found in the B. subtilis and in S.
aureus. Thus, the major nucleophilic thiol available for reaction
with electrophiles or disulfides in these organisms is BSH.
Many of the unique biophysical properties of BSH may be
clarified by the solution structure of this thiol. A 3D structure
for a major physiologically relevant form of BSH shows a close
proximity of the carboxylate of malate to the amine of cysteine,
which may contribute to the deprotonation of the amine and
the low amine pKa (FIGURE 3). When the major 0+ ! ! ionized
form of bacillithiol (FIGURE 2) was analyzed in ChemDraw 3D,
the energy minimized structure rapidly converged to that
shown in (FIGURE 3) The proximity of the ammonium, carboxyl-
ate and thiol groups in BSH have previously been postulated
to contribute to metal chelation [14]. Importantly, in B. subtilis
bacillithiol has recently been shown to chelate Zn2+ and to act
as a Zn2+ buffer for metal homeostasis [21]. B. subtilis wildtype
and a bacillithiol (bshC) mutant did not show a Zn2+ or Cd2+
stress phenotype in the wildtype background; however a double
metal exporter mutant, cadA czcD, did show increased
sensitivity to Zn2+ and Cd2+ in the absence of BSH [21].
Bacillithiol-dependent Zn2+ sensitivity has not been reported
for S. aureus, but BSH mutants of S. aureus USA300 were
reported to be sensitive to Cd2+ [22]. Gene expression studies
revealed that metal-sensing regulators are more responsive to
zinc perturbation in a mutant lacking bacillithiol, presumably
because BSH buffers the zinc labile pool. This suggests that
bacillithiol plays a role in zinc homeostasis by holding free zinc
in a cytoplasmic pool, perhaps keeping the metal available for
the estimated 5–10% cellular enzymes that require a Zn2+
cofactor [23]. It has been noted that during S. aureus infection,
neutrophil proteins sequester and limit Zn2+ availability to the
pathogen, reducing S. aureus growth and making it more vul-
nerable to oxidative stress [21,24].
The dianion character of BSH drives the substrate specificity
of the BSH biosynthesis enzymes BshB1 and BshB2 and of the
fosfomycin detoxification enzyme FosB (see below) [25,26]. The
catalytic efficiency (kcat/Km) of BshB1 and BshB2 was
lonizable group
Thiol
Bacillithiol
0 + –
–
–
–
– –1 36.5
20.9 21.9%
14.6%
0.7%
41.6
1.0
79.1
14.4
6.3
0.2
0.7%
93.3%
–2
–2
–3
–1
–1
–2
–5
–4
0
–
–
–
–
–
–
–
+
+
+
0 0
0
0
0
0
0
0
–
–
–
–
–
Cysteine
CoA
SH NH2 COOH-1 COOH-2
% Total Total
RS–
Net
charge
Figure 2. Comparison of the major forms of bacillithiol, cysteine and CoA at pH
7.7. Proportions of each form are based on microscopic pKa values. The four major
forms of bacillithiol are depicted. The ionizable phosphate groups of CoA are not listed.
Figure from Sharma et al. 2013 [20].
Figure 3. 3-dimensional structure of bacillithiol in the
ionized 0 + - - form (FIGURE 2). The proximal location of thiol,
amine and carboxylate moieties in the energy-minimized struc-
ture may support divalent metal ion chelation. Atom labels: C,
green; N, blue; O, red; H, white, and S, yellow.
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produce no BSH. Analysis of a S. aureus USA300 strain con-
taining a transposon insertion in bshB demonstrated that this is
the case [22].
A Bacillus cereus BC1534 (BshB1) crystal structure, pub-
lished before the discovery of BSH, revealed a metalloprotein
with structural similarity to the metalloproteins LpxC and
MshB from M. tuberculosis [32]. Although the native substrate
of the BC1534 was not known, the protein was reported to
deactylate GlcNAc and chitobiose [33]. However, a detailed
analysis of the substrate specificity of BshB1 and BshB2 type
proteins from B. cereus and B. anthracis failed to confirm this
activity [25], perhaps because the malate moiety of the native
substrate GlcNAc-Mal is a major determinant for BshB sub-
strate specificity. Deacetylation of GlcNAc by BshB proteins is
found to be at least 105 fold lower (kcat/Km) than that of the
native substrate GlcNAc-Mal [25,30]. Interestingly, the BshB
enzymes have a second function in addition to their deacetyla-
tion activity, as they can also act as a bacillithiol conjugate ami-
dase (BCA) and cleave bacillithiol S-conjugates during
detoxification reactions (FIGURE 4). This activity is described
below.
BshC
The enzyme utilized in the third step in mycothiol biosyn-
thesis is the L-Cys, GlcN-Ins ligase MshC. This enzyme
was purified from crude extracts of M. smegmatis by follow-
ing activity, and the protein was identified by amino-
terminal sequencing [34]. The corresponding open reading
frame (ORF) in the M. tuberculosis genome, ORF
Rv2130c, had been designated cysS2 and annotated as a
second Cys tRNA synthase. However, neither the B. subtilis
nor S. aureus genome encoded a MshC homolog or a sec-
ond gene annotated as a putative Cys tRNA synthase, and
no BshC activity was associated with the one Cys tRNA
synthase in S. aureus [27]. Therefore, to identify candidate
BshC proteins, EMBL STRING was queried with a BshA
input sequence to identify genes that that co-occur with
bshA in the genomes of bacteria that produce bacillithiol.
This phylogenetic profiling identified yllA as a bshC candi-
date in B. subtilis. The product of this gene is a member
of DUF2317, but it has no recognizable Pfam domains.
The null mutant lacked BSH and produced excess GlcN-
Mal, which would be the expected substrate for BshC [27].
Thus, the bshC gene is essential for BSH production, and
in both B. subtilis and S. aureus bshC mutants are
completely devoid of BSH [22,27]. However, when the Bacil-
lus subtilis bshC gene was cloned and expressed in E. coli,
activity was not detected when purified BshC was assayed
under conditions that had been used to assay MshC activ-
ity [27]. The lack of activity may have been due to the
assay conditions or to misfolding of the 539 amino acid
BshC protein. Recently, B. subtilis BshC was crystallized as
a dimer with an overall architecture of the Rossman fold
active site similar to MshC and Cys t-RNA synthase except
for the absence of the canonical adenylate and zinc-binding
residues in MshC [35]. However, because BshC was enzy-
matically inactive, it is difficult to evaluate the biological
significance of this structure. It remains possible that addi-
tional cofactors or protein partners are necessary for BshC
enzymatic activity.
Bacillithiol as a redox buffer
Any thiol that serves as a redox buffer in aerobic organisms
must have the ability to regenerate the reduced thiol after
it is oxidized to the disulfide form. Glutathione disulfide
reductase (Gor) was originally isolated from E. coli and was
thought to be necessary for reduction of GSH during redox
stress [36]. The first complete genome of Mycobacterium
tuberculosis H37Rv [37] contained a gene that was annotated
as glutathione disulfide reductase (gor). It seemed likely that
the mycobacterial gor was instead a gene for a mycothiol
disulfide reductase because M. tuberculosis contains millimo-
lar levels of mycothiol but no glutathione. This was dem-
onstrated when the M. tuberculosis gene product Mtr was
found to reduce only disulfides of mycothiol and truncated
versions containing at least cysteinyl-glucosamine, but not
oxidized GSH (GSSG) or cystine [38].
Identifying a redox thiol in the Firmicutes was more dif-
ficult than in the Actinomycetes given the variety of low-
molecular-weight thiols present at low levels in the cell and
the absence of likely candidates for proteins involved in
redox recycling of these molecules. CoA disulfide reductase
(CoADR) was identified in Staphylococcus aureus and some
Bacillaceae including Bacillus anthracis [39–41]. A paradox
arose in the model organism Bacillus subtilis when a CoA
disulfide reductase (CoADR) homolog was not identified in
the complete genome sequence. Additionally, no cystine
disulfide reductase from Firmicutes had been reported, so
the search began for a bacillithiol disulfide reductase in
Bacillus subtilis. Although candidate proteins for the bacilli-
thiol disulfide reductase have been proposed, no flavin-con-
taining, NADH- or NADPH-utilizing reductase has been
identified in either B. subtilis or S. aureus [14,22]. It is possi-
ble that the highly reduced state of bacillithiol [14,20] is
maintained by a thioredoxin-thioredoxin reductase type sys-
tem as found for glutathione in gor mutants of E. coli
K12 [42].
Interestingly, a fluorescent reporter system has recently been
used to image real-time changes in the redox status of MSH
during M. tuberculosis infection of macrophages [43]. This tech-
nology could in principle be applied in S. aureus to evaluate
the BSH redox status during various stages of growth and
mammalian cell infection.
The role of bacillithiol in Firmicutes: phenotypes of
biosynthesis defective mutants
The first BSH mutants were produced in the genetically tracta-
ble B. subtilis [27]. Deletion of bshA, or of both bshB1 and
bshB2, or of bshC gives rise to completely bacillithiol-deficient
B. subtilis. Each of these deletion strains was readily constructed
Bacillithiol: a key protective thiol in Staphylococcus aureus Review
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the first example of mycothiol, a MCA, and a STL mycothiol
transferase being used in the biosynthesis rather than the detox-
ification of secondary metabolites.
The two bacillithiol transferases identified in the Firmicutes
thus far are members of two distinct superfamilies. The first
bacillithiol transferase to be identified in S. aureus is
FosB (FIGURE 5), which confers resistance to the antibiotic fosfo-
mycin. FosB is a member of the vicinal oxygen chelate
(VOC) superfamily. VOCs are metalloenzymes that catalyze a
diverse set of reactions, but all coordinate a divalent metal
cation through vicinal oxygen atoms of a substrate, intermedi-
ate or transition state in the reaction [55]. FosB was identified
before the discovery of bacillithiol, and cysteine was believed
to be the thiol cofactor of FosB [45]. Early studies with the
B. subtilis FosB reported a Km value for cysteine of 35 ±
3 mM, which is well above the calculated cysteine concentra-
tion for this organism (~230 mM, [14],). Since the discovery of
bacillithiol, the thiol cofactor of both the B. subtilis and S.
aureus FosB enzymes was reevaluated and determined to be
bacillithiol [26,46,47]. The S. aureus FosB Km for bacillithiol was
determined to be 4.2 ± 0.7 mM [26]. This value is also above
the intracellular concentration of bacillithiol. However, due to
the low thiol pKa of bacillithiol (see “Biophysical Properties”
above), there is more of the reactive thiolate form of bacilli-
thiol present than that of cysteine in S. aureus. Genetic data
also support these findings: fosB and bacillithiol null mutants
show similar sensitivity to fosfomycin [22,27,44]. Thus, the thiol
cofactor of FosB is bacillithiol.
The first non-FosB bacillithiol transferase identified was B.
subtilis YfiT (B. subtilis BstA), a member of the STL superfam-
ily [56]. The single predicted S. aureus Newman STL enzyme
(ORF ID NWMN_2591) was identified in a Superfamily
search (http://supfam.org/SUPERFAMILY/) using B. subtilis
BstA as a query sequence against the S. aureus Newman
genome. The S. aureus enzyme was confirmed to be a bacilli-
thiol transferase on the basis of biochemical studies of cell free
extracts [22] and the purified protein and was named S. aureus
BstA [52]. Kinetic studies with S. aureus BstA demonstrated that
the Km for BSH is 16 ± 4 mM, which is ~10-fold lower than
the intracellular concentration of bacillithiol in S. aureus, indi-
cating that the enzyme is saturated with bacillithiol in vivo [52].
S. aureus BstA was found to catalyze the addition of bacillithiol
to cerulenin [22] at a low rate in vitro [52]. This newly identified
STL superfamily is a diverse protein family that contains
~30,000 proteins with structural similarity but very little
sequence identity. Phylogenetic studies have demonstrated that
B. subtilis BstA and S. aureus BstA are distantly related, but are
more related to each other than they are to the non-STL bacil-
lithiol transferase S. aureus FosB (FIGURE 6). The number of pre-
dicted STL transferases varies between species, with only one
predicted structural homolog of YfiT in S. aureus Newman
(BstA) and eight in B. subtilis [56].
Figure 6. Close relatives of S. aureus Newman BstA in the S-transferase like (STL, formerly DinB/YfiT-like) superfamily.
Staphylococcus aureus BstA is distantly related to B. subtilis YfiT (BstA) and a B. anthracis STL superfamily member (BA_2721), and
unrelated to the bacillithiol transferase protein FosB. Bootstrap values are shown for the major branches.
Figure from Perera et al. 2014 [52].
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Although additional substrates of S. aureus BstA have not been
identified, the genomic context of bstA may give insight into its
function (FIGURE 7). Five genes downstream and in the same orienta-
tion as bstA is a gene encoding an N-acetyltransferase, an enzyme
that could N-acetylate the Cys-adduct product of the bacillithol
conjugate amidase, and three genes downstream is a gene encoding
RarD, an efflux transporter that might export acetylated Cys-
adducts (mercapturic acids, FIGURE 4). Products of these types of
enzymatic reactions have been previously observed in the detoxifi-
cation of electrophiles by S. aureus Newman [48]. A 2-oxoglutarate/
malate translocator is adjacent to the bstA gene, which is significant
because L-malate is a BshA substrate. Upstream of S. aureus bstA is
a gene encoding PadR, a component of the phenolic acid stress
response in B. subtilis that functions as a negative regulator of
padC, a gene encoding a phenolic acid decarboxylase that converts
toxic phenolic acids to their vinyl phenol derivatives [57]. The
ortholog of padC in Lactobacillus plantarum, padA, is transcribed
divergently from its negative regulator padR [58], just as S. aureus
padR is transcribed divergently from bstA. This organization of
genes can indicate a negative regulation relationship. In Lactococcus
lactis, the padR analog lmrR encodes a negative regulator of
lmrCD, which encodes an ATP-binding-cassette transporter, and
is in the operon with these genes [59]. The gene upstream of padR,
Newman_2589, encodes a hypothetical protein that shares struc-
tural motifs with efflux pumps. If PadR regulates expression of
bstA, then the natural BstA substrate(s) might bind PadR and
relieve transcriptional repression of bstA and could provide a
method to identify the BstA natural substrate(s).
BshB has bacillithiol conjugate amidase activity in addition
to GlcNAc-Mal deacetylase activity
The first mycothiol-dependent enzyme identified was mycothiol
conjugate amidase (MCA) from M. smegmatis (MSMEG_5261)
and M. tuberculosis (Rv1082) [60]. This enzyme cleaves a myco-
thiol S-adduct at the amide linkage between the cysteinyl and
glucosamine moieties to generate a N-acetylcysteinyl S-adduct.
The adduct is excreted and the residual glucosaminyl-inositol
pseudo-disaccharide is retained in the cell and cycles back to
MSH biosynthesis [60,61]. This is a commonly observed detoxifi-
cation reaction among mycothiol-containing actinomycetes.
Mycothiol conjugate amidase is a zinc-containing hydrolase
and a close homolog of the mycothiol biosynthetic amidase,
MshB [62]. These enzymes have both mycothiol conjugate
amide hydrolase and GlcNAc-Ins deacetylase activities [63].
It appears there are specialized enzymes that control the deg-
radation of the major low-molecular-weight thiols such as
GSH, MSH and BSH, which can ultimately supply the cell
with cysteine. The unique g-glutamyl peptide bond in GSH
(g-Glu-Cys-Gly) prevents the unwanted breakdown of GSH
by peptidases. For example, g-glutamyltranspeptidase is
required to hydrolyze the g-glutamyl-cysteine peptide bond,
which releases Cys-Gly, a substrate for carboxypeptidase.
g-glutamyltranspeptidase is found in eukaryotes and GSH-
producing bacteria. The obligate human pathogen M. tubercu-
losis, which does not produce GSH, contains a glutathione
ABC transport protein and g-glutamyltranspeptidase that can
supply Cys to M. tuberculosis from host GSH [64]. MSH-
containing organisms possess MCA, which has been shown to
hydrolyze the unusual Cys-GlcN amide bond of MSH to pro-
vide AcCys and ultimately Cys for protein synthesis [60,61,65]. It
was predicted that the same holds in true in BSH-containing
organisms: hydrolysis of the Cys-GlcN amide bond of BSH by
bacillithiol conjugate amidase should release of Cys in the cell.
A similar pathway was observed in the BSH containing
organisms B. cereus and B. anthracis, which encode two BshB
enzymes (BshB1 and BshB2) that have dual GlcNAc-Mal
Figure 7. Genomic context of S. aureus bshA, bshB, bshC and bstA genes in S. aureus Newman. The bacillithiol biosynthesis
genes bshA, bshB and bshC and the bstA gene are unlinked (in bold). Overlapping arrows represent overlapping ORFs.
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deacetylase and bacillithiol S-conjugate amidase activities [25].
A sensitive assay that monitors hydrolysis of the fluorescent
bimane derivative of bacillithiol (BSmB) to the corresponding
derivative of cysteine (CySmB) was developed to measure bacil-
lithiol conjugate amidase activity. Assays of purified B. anthracis
BshB1 (BA_1557) showed low amidase activity, about 10–5 in
comparison with the deacetylation rate with GlcNAc-Mal [25,30].
B. anthracis BshB2 (BA_3888) showed considerably more
BSmB deacetylase activity, only 100-fold less than the GlcNAc-
Mal deactylase activity. Both B. anthracis enzymes show low
amidase activity toward unmodified BSH that is about 10–3–
10–4 of the GlcNAc-Mal deacetylase rate. The authors indicated
that this low level of BSH amide hydrolysis activity was unlikely
to be sufficient to supply cysteine to the cell. However, the
MCA activity in M. smegmatis was also about 103 below that of
the MSmB amidase reaction and was shown to be responsible
for MSH degradation [60,65]. It remains unclear if this low level
of BCA activity with BSH is capable of supplying Cys in a rap-
idly growing organism such as S. aureus.
S. aureus contains only one BshB2-type enzyme and the
bshB NARSA transposon mutant (SAUSA300_0552) was deter-
mined by thiol analysis to be a complete BSH knockout [22,52].
The same bshB transposon mutant also lacks 90% of the
wildtype bacillithiol S-conjugate amidase activity, indicating
that this protein is responsible for all of the BshB activity and
the majority of bacillithiol conjugate amidase activity in S.
aureus [52]. An inhibitor of S. aureus BshB in combination with
fosfomycin might provide a novel cotherapy method against S.
aureus. Such a method would eliminate both BSH synthesis
and BCA detoxification and would prevent fosfomycin
detoxification.
Glyoxylases GlxA & GlxB
Methylglyoxal is a toxic, electrophilic byproduct formed dur-
ing many metabolic pathways such as glycolysis (e.g., the con-
version of dihydroxyacetone phosphate (DHAP) to
methylgloxal) [66] and can also diffuse into the cell from the
environment (FIGURE 8) [67]. Methylglyoxal detoxification in
E. coli and can be separated into glutathione-dependent and
-independent pathways. In the glutathione-dependent pathway,
methyglyoxal reacts spontaneously with glutathione to form
GS-hemithioacetal. The glyoxylase enzyme GlxI then converts
GS-hemithioacetal to S-lactoyl-glutathione, which GlxII then
converts to D-lactate and glutathione [68]. Production of S-lac-
toyl-glutathione activates the KefGB and KefKC potassium
efflux pumps, leading to cytoplasmic acidification and
Methylglyoxal
DHAP Methylglyoxal
Bacillithiol
Hemithioacetal
S-lactoyl-bacillithiol
Cytoplasmic
acidification
KhtSTU
pumpH+
K+
H+
H2O
Bacillithiol
GlxB
GlxA
Bacillithiol
D-lactate
Pi
Figure 8. Bacillithiol-dependent methylglyoxal detoxification pathway in Bacillus subtilis. Methylglyoxal can enter the cell via
diffusion or can be formed intracellularly (i.e., from dihydroxyacetone phosphate, abbreviated DHAP). Bacillithiol and both glyoxalase A
(GlxA) and glyoxylase B (GlxB) are utilized to convert methylglyoxal to D-lactate. Cytoplasmic acidification is mediated by the interplay of
the KhtSTU pump with bacillithiol and S-lactoyl-bacillithiol.
Model from Chandrangsu et al. 2013 [67].
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protection from methylglyoxal presumably by antagonizing its
reaction with cellular targets [69].
Recently bacillithiol-independent and dependent pathways for
methylglyoxal detoxification in B. subtilis have been character-
ized [67]. Unlike E. coli, the primary resistance pathway in B. sub-
tilis is thiol-independent. The BSH-dependent pathway is
similar to glutathione-dependent methylglyoxal detoxification.
Methylglyoxal reacts spontaneously with bacillithiol to form BS-
hemithioacetal. The glyoxylase GlxA then converts BS-
hemithioacetal to S-lactoyl-bacillithiol, which GlxB converts to
D-lactate and bacillithiol. This pathway involves the acidification
of the cytoplasm, which is both necessary and sufficient for
bacillithiol-dependent methylglyoxal resistance. Acidification
depends on both bacillithiol and a K+ efflux pump KhtU, which
is in the same family of transporters as the E. coli KefGB and
KefKC, and the ancillary proteins KhtS and KhtT (collectively
called KhtSTU). The authors propose that the S-lactoyl-BSH
conjugate gates the KhtU efflux pump in the manner similar to
the gating of the E. coli efflux pump by S-lactoyl-glutathione,
although direct evidence is still lacking. Thus, bacillithiol is pro-
posed to mediate methylglyoxal resistance through cytoplasmic
acidification rather than methyglyoxal detoxification (FIGURE 8).
The closest B. subtilis KhtU analog in S. aureus Newman is
NWMN_0880, a Na+/H+ transporter (23% sequence identity
with 69% coverage) in the same CPA2 family as the E. coli
transporter. Interestingly, glxA shares 25–30% sequence identity
with S. aureus FosB, depending on the subspecies. Structural
and biochemical studies could elucidate whether these enzymes
also bind bacillithiol.
Bacilliredoxins debacillithiolate proteins
Upon exposure of cells to oxidants such as cumene hydroperox-
ide or sodium hypochlorite (NaOCl), bacillithiol has been
shown to form mixed disulfides with the cysteine residues of
certain proteins. This process, termed S-bacillithiolation, pro-
tects protein cysteine residues from overoxidation and irrevers-
ible damage of the protein [19,70,71]. Transcriptomic and
proteomic studies revealed that several proteins are bacillithio-
lated, including the redox-sensing regulator OhrR, the methio-
nine synthase MetE and two proteins of unknown function
YtxJ and YphP. Inactivation of OhrR results in the upregula-
tion of ohrA, which encodes a peroxiredoxin that contributes to
NaOCl resistance. Bacillithiol biosynthetic gene mutants show
the same sensitivity to NaOCl as do ohrA knockouts,
suggesting that bacillithiolation of OhrR is essential for ohrA
expression [70]. S-bacillithiolation of MetE decreased the expres-
sion of methionine biosynthesis genes, resulting in transient
methionine autotrophy [71], which also occurs during S-gluta-
thionylation of E. coli MetE [72].
Debacillithiolation of protein mixed disulfides was hypothe-
sized to be analogous to deglutathionylation, which is a process
catalyzed by glutaredoxins. The first evidence that Firmicutes
contained glutaredoxin-like proteins emerged from a bioinfor-
matics search for the bacillithiol biosynthesis gene BshC. An
EMBL STRING analysis remarkably identified four putative
thiol-disulfide oxidoreductase proteins that had yet to be char-
acterized, including YtxJ, a putative monothiol (TCPIS) active
site glutaredoxin-like protein, and YpdA, a thioredoxin
reductase-like protein and putative bacilliredoxin reductase.
The other two proteins, YphP and YqiW, are paralogs of the
DUF1094 family (53% identity) and contain a CxC motif that
is typical of glutaredoxins [27]. Both proteins were recently dem-
onstrated to have bacilliredoxin activity and were renamed
BrxA (YphP) and BrxB (YqiW) [73]. These proteins were found
to debacillithiolate active site cysteine residues of OhrR and
MetE, two bacillithiolated redox-sensing proteins [19,70]. The
missing part of the bacilliredoxin story is the disulfide reductase
needed to recycle the bacillithiolated forms of BrxA and BrxB.
One candidate for this enzyme is the thioredoxin reductase like
protein YpdA found in early bioinformatics studies of
BSH [27], which was observed to be bacillithiolated in its puta-
tive active site [70,71].
The B. subtilis BrxA and BrxB proteins share a high level of
sequence identity with their S. aureus Newman homologs
NWMN_1339 (57% with 97% sequence coverage) and
NWMN_1420 (69% with 99% sequence coverage), respec-
tively. Thus, bacilliredoxins are likely to participate in the oxi-
dative stress response in S. aureus.
Response of Firmicutes to electrophilic & oxidative
stress
Data on cellular responses to electrophiles and oxidants predates
the discovery of bacillithiol, and reexamination of these tran-
scriptomic and proteomic studies provides significant evidence
for bacillithiol-dependent stress responses. Catabolism of pheno-
lic acids like salicylic acid occurs during the decay of plant mate-
rial in the soil and the response of Bacillus subtilis to salicylic
acid indicates a role for bacillithiol transferases in this process.
One of the eight putative STL enzymes from B. subtilis, yuaE, is
upregulated in response to salicylic acid along with bshB2, which
encodes an enzyme with both BshB deacetylase and bacillithiol
conjugate amidase activity (TABLES 1 & 2, [25,74]). Exposure of B.
subtilis to the fungal-related antimicrobial compounds methyl-
hydroquinone and 6-brom-2-vinyl-chroman-4-on elicited a
response similar to that of salicylic acid: two bacillithiol transfer-
ases (yjoA, yuaE), the bshB2 gene yojG and the bacillithiol bio-
synthesis gene bshC were upregulated (TABLES 1 & 2, [75]).
Bacilliredoxin (brxB) was also upregulated, indicating that exces-
sive protein thiolation might be occurring.
Firmicutes are exposed to hydrogen peroxide during infec-
tion, where bacillithiol-dependent defenses function as an
adjunct to catalase activity. In Bacillus anthracis exposed to
H2O2, all three bacillithiol biosynthesis genes as well as bshB2
and the bacilliredoxin reductase candidate ypdA are upregulated
(TABLES 1 & 2, [76]). Exposure of S. aureus MW2 to H2O2 resulted
in a twofold downregulation of bshA, but upregulation of bstA,
the glyoxylase genes glxA and glxB, and the two putative bacil-
liredoxins brxA and brxB (TABLES 1 & 2).
Furthermore, mammalian peptidoglycan recognition proteins
(PGRP) are a component of the host response and have been
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shown to kill B. subtilis by a combination of oxidative stress,
thiol depletion and metal stress from release of Zn2+ and Cu2+
ions [77]. Treatment with one isoform of PGRP (PGLYRP4)
increased expression of the bacillithiol transferase yuaE
~8 fold [77]. Diamide leads to disulfide stress by oxidizing cellu-
lar thiols to disulfides. S. aureus COL responds with
upregulation of the bacillithiol biosynthesis genes bshA and
bshC and downregulation of bstA [78]. The putative bacillire-
doxin reductase gene ypdA is also upregulated, which is consis-
tent with the observation that diamide increases protein
thiolation [79]. Oxidizing agents also induce bacillithiol-related
genes in S. aureus. Nitrite upregulates all three bacillithiol
Table 1. Bacillithiol-related genes in S. aureus and Bacillus strains.
Bacillithiol-related gene S. aureus Newman S. aureus USA300_
FPR3757
B. anthracis
Ames
B. subtilis 168
bshA NWMN_1369 SAUSA300_1349 BA_1558 BSU22460 (ypjH)
bshB1 – – BA_1557 BSU22470 (ypjG)
bshB2 NWMN_0530 SAUSA300_0552 BA_3524
BA_3888
BSU19460 (yojG)
bshC NWMN_1087 SAUSA300_1071 BA_4058 BSU15120 (yllA)
brxA NWMN_1339 SAUSA300_1321 BA_2173 BSU21860 (yphP)
brxB NWMN_1420 SAUSA300_1463 BA_4378 BSU23990 (yqiW)
Thioredoxin-reductase like enzyme NWMN_1388 SAUSA300_1369 BA_1515 BSU22950 (ypdA)
Thioredoxin family enzyme NWMN_0710 SAUSA300_0725 BA_4931 BSU29760 (ytxJ)
glxA NWMN_2420 SAUSA300_2461 BA_3208 BSU38370 (ywbC)
glxB NWMN_1416 SAUSA300_1458 BA_5452
BA_2111
BSU32660 (yurT)
fosB NWMN_2234 SAUSA300_2280 BA_4109 BSU17840 (yndN)
S-transferase-like (STL) superfamily genes NWMN_2591 SAUSA300_2626
BA_2700 BSU08390 (yfiT/bstA)
BA_1354 BSU31030 (yuaE)
BA_2379 BSU05630 (dinB)†
BA_2379 BSU10860 (yisT)†
BA_2937 BSU13070 (ykkA)
BA_2558 BSU10800 (yizA)
BA_4768 BSU26780 (yrdA)
BSU12410 (yjoA)
BA_2721
BA_3104
BA_2777
BA_3538
BA_2007
BA_3539
BA_2065
BA_2078
BA_2990
B. subtilis 168 ORF names are in parenthesis. STL proteins listed on the same line share ‡30% amino acid identity with ‡90% sequence coverage. ORF names in grey
share homology with more than one B. subtilis protein.
†B. subtilis genes that share >30% amino acid sequence identity with ‡90% sequence coverage.
B. anthracis: Bacillus anthracis; B. subtilis: Bacillus subtilis; S. aureus: Staphylococcus aureus; ORF: Open reading frame.
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Table 2. Transcriptomic and proteomic analyses of bacillithiol-related enzymes during treatment with
stressors.
Compound Structure Organism Gene Transcriptome Proteome
Salicylic acid O
OH
OH
Bacillus subtilis
168†
yuaE (STL) 6–8 5–6
yojG (BshB2) 3–4 –
yhdN (FosB) 3–4 3–4
2-methylhydroquinone OH
OH
Bacillus subtilis
168‡
yjoA (STL) 6 –
yojG (BshB2) 6–7 –
yuaE (STL) 10–14 4–10
yqiW (BrxB) 4–6 –
6-brom-2-vinyl-
chroman-4-on Br
O
O
Bacillus subtilis
168‡
yjoA (STL) 4–5 –
yojG (BshB2) 9–10 –
yuaE (STL) 7–10 3–8
yllA (BshC) 4 –
yqiW (BrxB) 4–6 –
Hydrogen peroxide H2O2 Staphylococcus
aureus MW2§
MW1348 (BshA) 0.5 ND
MW2611 (BstA/STL) 3 ND
MW2442¶¶ (GlxA) 2 ND
MW1463¶¶ (GlxB) 3 ND
MW1467¶¶ (BrxB) 6 ND
Bacillus
anthracis
Sterne¶
BA_1558 (BshA) 2 ND
BA_1557 (BshB1) 2 ND
BA_3524 (BshB2) 2 ND
BA_4058 (BshC) 3 ND
BA_1515¶¶ (YpdA) 2 ND
Diamide
N
O
O
N
N NH3C
CH3
CH3
CH3
Staphylococcus
aureus COL#
SACOL1498 (BshA) 2 ND
SACOL1190 (BshC) 5 ND
SACOL2717 (BstA/
STL)
0.3 ND
SACOL1553¶¶
(GlxB)
2 ND
SACOL1520¶¶
(YpdA)
4 ND
Numbers < 1 show down-regulated genes, where 1 is no change.
†Van Duy et al. 2007; treatment with 4 mM salicylic acid for 10 min, range shown is from duplicate experiments.
‡Van Duy et al. 2007; 100 mg/ml 6-brom-2-vinyl-chroman-4-on or 63 mg/ml of 2-methylhydroquinone (treatment for 10 min for both conditions), range shown is from
duplicate experiments.
§Palazzolo-Balance et al. 2008; treatment with 100 mg/ml azurophilic granule proteins, 5 mM H2O2, or 25 mM HOCl for 15 min for all conditions.
¶Pohl et al. 2011; treatment with 1.0 mM H2O2 for 10 min.
#Posada et al. 2014; treatment with 1 mM diamide for 20 min.
††Hochgrafe et al. 2008; treatment with 500 mM MAHMA NONOate (nitric oxide donor) 10 min, range shown is from duplicate experiments.
‡‡Schlag et al. 2007; treatment with 5 mM sodium nitrite for 6 h at 37!C.
§§Kashyap et al. 2014; treatment with 100 mg/ml PGLYRP4 for 30 min at 37!C.
¶¶Closest homolog to B. subtilis 168 gene.
ND: Not determined.
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biosynthesis genes, glxA and ypdA in S. aureus N315 [80]. Nitric
oxide leads to the upregulation of genes encoding the BSH
detoxification proteins bshB2 and ypdA [81]. Oxidizing agents
produced in neutrophils, hypochlorous acid, azurophilic granule
proteins and H2O2 downregulate bshA and brxA ~2-fold, but
induce bstA, glxA and brxB ~2-fold [78].
From these studies, we see that electrophilic compounds
tend to induce specific bacillithiol transferases in the Firmi-
cutes, whereas the major bacillithiol conjugate amidase protein
BshB2 is upregulated in response to both electrophiles and
oxidants. The bacillithiol biosynthesis genes are most often
upregulated in response to oxidants such as H2O2, diamide
and nitrite. Thus, bacillithiol is likely to play a key role in
responding to these toxic molecules for both B. subtilis in soil
and S. aureus infections.
Spontaneous enzyme-independent reactions with
bacillithiol
Thiols can react spontaneously with electrophilic substrates
such as monobromobimane and methylglyoxal. Preliminary
Table 2. Transcriptomic and proteomic analyses of bacillithiol-related enzymes during treatment with
stressors (cont.).
Compound Structure Organism Gene Transcriptome Proteome
Nitric oxide NO Bacillus subtilis
168††
yuaE (STL) ND 2–3
Staphylococcus
aureus COL††
SACOL0614 (BshB2) ND 3
SACOL1520¶¶
(YpdA)
ND 1–3
Nitrite NO2
- Staphylococcus
aureus N315‡‡
SA1291 (BshA) 3 ND
SA0525 (BshB2) 3 ND
SA1020 (BshC) 5 ND
SA2310¶¶ (GlxA) 8 ND
SA1311¶¶ (YpdA) 3 ND
Azurophilic granule
proteins
- Staphylococcus
aureus MW2§
MW1348 (BshA) 0.6 ND
MW0552 (BshB2) 0.5 ND
MW2611 (BstA/STL) 2 ND
MW1463¶¶ (GlxB) 0.7 ND
MW1318¶¶ (BrxA) 0.6 ND
MW1467¶¶ (BrxB) 2 ND
Hypochlorous acid HOCl Staphylococcus
aureus MW2§
MW1348 (BshA) 0.5 ND
MW2611 (BstA/STL) 2 ND
MW2442¶¶ (GlxA) 3 ND
MW1318¶¶ (BrxA) 0.6 ND
MW1467¶¶ (BrxB) 2 ND
Mammalian
peptidoglycan
recognition protein
(PGLYRP4)
– Bacillus subtilis
168§§
yuaE (STL) 8 ND
Numbers < 1 show down-regulated genes, where 1 is no change.
†Van Duy et al. 2007; treatment with 4 mM salicylic acid for 10 min, range shown is from duplicate experiments.
‡Van Duy et al. 2007; 100 mg/ml 6-brom-2-vinyl-chroman-4-on or 63 mg/ml of 2-methylhydroquinone (treatment for 10 min for both conditions), range shown is from
duplicate experiments.
§Palazzolo-Balance et al. 2008; treatment with 100 mg/ml azurophilic granule proteins, 5 mM H2O2, or 25 mM HOCl for 15 min for all conditions.
¶Pohl et al. 2011; treatment with 1.0 mM H2O2 for 10 min.
#Posada et al. 2014; treatment with 1 mM diamide for 20 min.
††Hochgrafe et al. 2008; treatment with 500 mM MAHMA NONOate (nitric oxide donor) 10 min, range shown is from duplicate experiments.
‡‡Schlag et al. 2007; treatment with 5 mM sodium nitrite for 6 h at 37!C.
§§Kashyap et al. 2014; treatment with 100 mg/ml PGLYRP4 for 30 min at 37!C.
¶¶Closest homolog to B. subtilis 168 gene.
ND: Not determined.
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evidence indicates that bacillithiol participates in a wider
range of spontaneous reactions than other major low-molecu-
lar-weight thiols, presumably because its thiol group is more
acidic and thus more reactive at cytoplasmic pH (FIGURES 2
and 3). This property would help ensure rapid detoxification
of certain harmful substances. The uncatalyzed reaction of
H2O2 with bacillithiol was the first such reaction to be
described, and it was found to proceed at a rate of
~80 nmol min–1 mg–1, 40-fold higher than the rate with
glutathione or mycothiol [56]. Bacillithiol has been found to
react in an enzyme-independent manner with a number of
substrates, such as the antibiotic rifamycin S and the thiol-
reactive molecules etacrynic acid, 4-hydroxynonenal and sul-
foraphane [52]. The antibiotic cerulenin also reacts with bacil-
lithiol spontaneously [52], but the S. aureus bacillithiol
transferase BstA enhances this rate of reaction 2 fold [20,52,56].
These results suggest that bacillithiol may be more reactive
than glutathione or mycothiol in uncatalyzed reactions with
certain electrophiles.
Contribution of bacillithiol to pathogenesis
The model for bacillithiol-dependent detoxification
The models for GSH- and MSH-dependent detoxification
pathways involve similar enzymatic components and both
produce a mercapturic acid, an N-acetylated cysteine-toxin
conjugate that is excreted from the organism and is usually
non-toxic [60,61,82,83]. In S. aureus, bacillithiol conjugate ami-
dase and N-acetyltransferase activity were both detected
using cell-free extracts [48]. Studies with whole cells demon-
strated that BSH was added to the toxins prior to the
appearance of the cysteine-toxin conjugate, demonstrating
that the cysteine-toxin conjugate was likely the product of
cleavage of the bacillithol-conjugate. The cysteine-toxin con-
jugate is then N-acetylated and excreted from the cells. In
support of this interpretation, the levels of GlcN-L-malate
increased with the appearance of the cysteine-toxin
conjugate [48].
Bacillithiol protects S. aureus against mammalian cells
involved in immune responses
Bacteria that have been engulfed by macrophages and neu-
trophils are exposed to a number of reactive oxygen and
nitrogen species, and bacillithiol likely serves as a cellular
redox buffer that can neutralize these highly damaging mole-
cules. Indeed, the BSH-deficient Staphylococcus aureus
strain NCTC 8325 showed diminished survival in murine
macrophages in comparison to strains that produce BSH [49].
A similar deficiency was observed in whole blood with the
BSH deficient S. aureus strain SH1000 as compared with
the BSH containing methicillin-resistant S. aureus strain
COL [44]. Taken together with the increased sensitivity of
bacillithiol-deficient mutants to H2O2 [44] and with the rapid
rate of reaction of bacillithiol with H2O2 [56], the decreased
survival of the bacillithiol mutants in macrophages might be
explained by their increased susceptibility to oxidative stress.
Bacillithiol levels have been reported to be relatively low in
exponentially growing S. aureus [14,26,44] compared with the
glutathione levels in Gram-negative bacteria, but comparable
to the bacillithiol levels in B. subtilis. Bacillithiol levels in
B. subtilis continue to increase to ~5.2 mM during late station-
ary phase, but it is unclear whether the same occurs in
S. aureus. Cysteine and bacillithiol levels did rise rapidly in
S. aureus in response to treatment with rifamycin S, however [48].
Interestingly, S. aureus has been found to import glutathione
from the growth medium during stationary phase [49]. Although
S. aureus does not encode any known enzymes that utilize this
thiol as a cofactor, glutathione can react spontaneously with
thiol-reactive molecules and may still serve as a protective redox
buffer for the bacterium. Other Gram-positive bacteria such as
Streptococcus mutans [84] and Streptococcus pneumoniae have also
been reported to import glutathione, which conferred oxidative
stress resistance and increased survival in the mouse model of
infection [85]. Interestingly, the S. aureus genome encodes a pro-
tein (NWMN_0147) that shares 27% sequence identity with
91% coverage to the M. tuberculosis g-glutamyltranspeptidase,
which is required to hydrolyze the g-glutamyl-cysteine peptide
bond of GSH to release cysteine in glutathione producing
organisms [86]. M. tuberculosis g-glutamyltranspeptidase provides
this intracellular pathogen the critical activity to utilize macro-
phage GSH as a source of cysteine for protein synthesis during
infection [64]. The S. aureus g-glutamyltranspeptidase analog
has not been studied to the same extent as the M. tuberculosis
g-glutamyltranspeptidase, and it is unclear whether this enzyme
is expressed during uptake of GSH. It remains an open ques-
tion whether glutathione is imported by S. aureus during
eukaryotic infection and whether it contributes to the fitness of
the pathogen.
Expert commentary & five-year view
The rapid rate of the development of resistance of
methicillin-resistant S. aureus to the current therapeutic
options is a great health concern, and many research efforts
are focused on identifying new antibiotics and new antibi-
otic targets to combat this organism [87,88]. The cell wall
synthesis inhibitor fosfomycin is currently used in the treat-
ment of urinary tract and gastrointestinal S. aureus infec-
tions. Fosfomycin can enter the cell via the L-a-
glycerophosphate transport system and/or the hexose-
monophosphate transport system (UhpT) [89]. Mutations in
these transporters contribute to fosfomycin resistance and
are presumably a major mechanism of fosfomycin resis-
tance [90]. The plasmid borne fosB gene has been identified
in 34% of fosfomycin-resistant clinical Staphylococci iso-
lates [91]. Recently, deletion of the chromosomally encoded
fosB or bshA in clinically relevant MRSA isolates was deter-
mined to be the major source of inherent fosfomycin sus-
ceptibility [44]. The use of fosfomycin as a monotherapy has
resulted in rapid development of resistance [92]. The FDA
recently recommended that one antimicrobial therapy that
should be considered for streamlined development are those
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incorporating an agent that inhibits drug resistance. We
predict that the bacillithiol biosynthetic enzymes would be
good targets for neutralizing resistance, because mutants
lacking bacillithiol show increased sensitivity both to oxida-
tive stress and to drugs such as fosfomycin that are detoxi-
fied by a FosB/bacillithiol-dependent process [22,27,44,49].
Thus, inhibition of BSH biosynthesis should sensitize S.
aureus to the innate immune response and to antibiotics
such as fosfomycin.
The glycosyltransferase BshA may be a problematic drug target
when used in combination therapy with fosfomycin due to
increases in UDP-GlcNAc levels. Treatment of S. aureus with
fosfomycin, which targets peptidoglycan biosynthesis by
inhibiting MurA and MurZ, has been
shown to increase levels of UDP-GlcNAc,
the substrate of BshA [51]. This accumula-
tion of a BshA substrate could hinder the
ability of a potential competitive inhibitor
to effectively block BshA activity and
decrease bacillithiol levels. Thus, bacilli-
thiol would still be synthesized at some
level and would confer resistance to fosfo-
mycin. BshC, the final enzyme in the BSH
biosynthesis pathway, has yet to be charac-
terized, so significant development would
be required before a BshC inhibitor screen
could be devised.
S. aureus BshB may be a good candi-
date drug target, as this enzyme is
involved in bacillithiol biosynthesis and
also provides most of the bacillithiol con-
jugate amidase detoxification activ-
ity [22,25,52]. Unlike the Bacillus species
discussed in this review, there are no
compensating activities for S. aureus
BshB, so the appropriate drug could
completely inhibit BSH biosynthesis. S.
aureus BshB is ~25% identical with M.
tuberculosis MshB (Rv1170) and MCA
(Rv1082), and is easily expressed in
E. coli. A screen for natural product
inhibitors yielded mM inhibitors of M.
tuberculosis MCA and MshB (FIGURE 9,
[93–95]), and these would constitute a logi-
cal starting point for S. aureus
BshB2 inhibition studies. Inhibition of S.
aureus BshB2 activity would diminish the
production of bacillithiol and thereby
render the organism more susceptible to
being killed by the host defenses such as
the oxidizing environment of macro-
phages, neutrophils and blood [44,49].
Depletion of bacillithiol would also
diminish the BCA detoxification activity
of BshB2 and inhibit excretion of mer-
capturic acids. A decrease in bacillithiol levels could result in a
15- 60-fold decrease in resistance to fosfomycin [44], suggesting
a combination therapy of fosfomycin and a BshB/BCA inhibi-
tor could be effective against multidrug resistant S. aureus
infections. Identifying an inhibitor of this enzyme should be
feasible within the next 5 years, especially with the numerous
inhibitor chemotypes identified for the homologous M. tuber-
culosis MCA (FIGURE 9).
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Nicholas et al., 8 [93]
Metaferia et al., 43 [95] 7 ± 1
Psammaplin A [93]
Psammplysin A [93]
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Figure 9. Natural product and synthetic inhibitors of M. tuberculosis metallopro-
teins MshB and MCA. Oceanapiside (compound 1) is a non-competitive inhibitor of M.
tuberculosis MCA; a brominated derivative of tyrosine (compound 2) and psammplysin A
(compound 3) are competitive inhibitors of MCA. Psammaplin A (compound 5) and
(compound 2) contain oxime moieties, known to chelate metal ions. Compound 4 is a
synthetic substrate analog of GlcNAc-Ins (substrate of MshB), and one of the few com-
pounds that inhibits both M. tuberculosis MshB and MCA.
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Key issues
. Bacillithiol is a recently discovered low-molecular-weight thiol found in the Firmicutes, which include the pathogens Staphylococcus
aureus and Bacillus anthracis.
. The low-molecular-weight thiols bacillithiol and mycothiol are related by their Cys-glucosamine core moiety.
. In S. aureus, three unlinked genes encode the bacillithiol biosynthesis enzymes, which are each essential for bacillithiol biosynthesis.
. The BshB enzyme has dual activities: it is a deacetylase utilized in the second step of bacillithiol biosynthesis and a bacillithiol conjugate
amidase that can cleave S-conjugates.
. Compared to other low-molecular-weight thiols found in bacteria, bacillithiol has structural differences that make it more reactive with
hydrogen peroxide, xenobiotics and drugs, particularly fosfomycin.
. Bacillithiol is the thiol cofactor of the enzyme FosB. Collectively, bacillithiol and FosB-derived fosfomycin resistance is the major
detoxification mechanism of multi-drug resistant Staphylococcus aureus to fosfomycin.
. S. aureus mutants deficient in bacillithiol are more susceptible to killing by macrophages, neutrophils and whole blood.
. A possible new strategy for treatment of multidrug resistant Staphylococcus aureus is the combination therapy of a bacillithiol
biosynthesis inhibitor with fosfomycin.
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